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Abstract 
Although the occurrence, fate and behaviour of micropollutants in the urban water cycle is 
reported extensively in literature, the biotransformation of micropollutants in the sewer 
network has only received little attention. Rising main (RM) and gravity main sewer biofilms 
(GS) are capable of transforming sulfur species and organic compounds biochemically. 
Moreover, first laboratory-based and full-scale studies demonstrated the capability of sewer 
biofilms to transform illicit drugs, human drug metabolites and other human biomarkers, such 
as caffeine. However, the in-sewer biotransformation of pharmaceutically active compounds 
(PhACs) and pesticides has not received much attention. The aim of this thesis was to 
understand the role of sewer biofilm during the removal of micropollutants by specifying the 
removal mechanisms, identifying the contributing microbial communities and elucidate in-
sewer transformation products (TPs) and pathways. Thus, the fate and behaviour of 30 
PhACs of various therapeutic groups and 4 pesticides was investigated in RM and GS sewer 
biofilm reactors, as well as pilot full-scale RM and GS sewers. 
 
The capability of RM biofilm to remove the investigated micropollutants and corresponding 
removal mechanisms were assessed during laboratory-based batch experiments at 
elevated initial concentrations of 50 µg L-1. Biotransformation was the dominant removal 
mechanism, with significant sorption of cationised and/or lipophilic compounds (by 80-100%, 
i.e. propranolol, enrofloxacin, erythromycin, lincomycin, ranitidine, sertraline, fluoxetine and 
sulfasalazine). A comparison of the overall removals of the investigated micropollutants at 
different concentration levels, i.e. 50 µg L-1 and 5 µg L-1, exhibited significantly higher 
removal of sorbed compounds at lower initial concentrations. Furthermore, negative 
removals of sulfadiazine, dapsone and erythromycin were observed at lower initial 
concentrations, likely due to deconjugation of human metabolites in the utilised sewage or 
the release of faeces-bound compounds into the aqueous phase. A comparison of removal 
efficiencies in RM with GS at 50 µg L-1 indicated higher capability of RM to transform 
compounds that are persistent to aerobic treatment, such as carbamazepine, trimethoprim 
or macrolide antibiotics and halogenated compounds.  
 
The contributions to transformation of micropollutants by the dominant RM microbial biofilm 
communities, i.e. sulfate-reducing bacteria (SRB) and methanogenic archaea (MA) were 
investigated during laboratory-scale experiments after the inhibition of either SRB, MA or 
both simultaneously. Significantly lower micropollutant removal efficiencies were yielded 
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when SRB and MA were inhibited simultaneously compared to uninhibited RM. Furthermore, 
inhibition of either SRB or MA yielded similar removals to those obtained without inhibition. 
The results demonstrate the vital role of SRB and MA during the in-sewer biotransformation 
of micropollutants, with both microbial communities capable to transform many compounds. 
In particular, atrazine, iopromide, DEET and metolachlor were removed by SRB, however 
not by MA. Trimethoprim and atenolol, on the other hand, were only removed by MA. While 
no clear relationship was found between removal by the functional organism and the 
compounds’ molecular properties, the functional groups of a micropollutant may be the 
determining factor for the preferred transformation by SRB or MA. 
 
Analysis of the in-sewer metabolic pathways of the antibiotics roxithromycin and 
trimethoprim revealed the formation of 8 in-sewer TPs. Roxithromycin mainly underwent 
microbial inactivation through hydrolysis of the lactone ring or phosphorylation of the 
desosamine moiety, yielding previously unreported anaerobic in-sewer TPs. Also, four 
anaerobic in-sewer TPs of trimethoprim were elucidated, three of which with preserved 
antibiotic activity due to an intact diamino pyrimidine moiety. These results highlight the 
capability of SRB and MA to transform pharmaceuticals into TPs with potentially preserved 
active antibiotic activity.  
 
Experiments in pilot full-scale RM and GS sewer pipes were conducted at ambient initial 
concentrations. Removal efficiencies in RM and GS were up to 60% and 70%, respectively, 
however with readily degradable sulfasalazine and cephalexin yielding up to 100% removal. 
Furthermore, full-scale RM exhibited negative removal of 10 compounds, including 
diclofenac, while only 3 compounds exhibited negative removal in GS. The overall removal 
of the majority of micropollutants was lower than observed during laboratory-based 
experiments, especially in RM, likely due to i) different flow conditions, ii) possibly different 
microbial biofilm community between full-scale and laboratory biofilms and iii) lowered 
removal of parent compounds due to their introduction into the bulk sewage by 
deconjugation of human metabolites or release of faeces-bound compounds. In-sewer 
biotransformation was confirmed, as ~3% of removed trimethoprim was transformed into 3-
desmethyl-trimethoprim and 48% of the removed N4-acetyl-sulfamethoxazole was 
deconjugated into the parent compound sulfamethoxazole. The low transformation ratio 
between these compounds and their TPs strongly suggest the formation of other unknown 
in-sewer transformation products and pathways.  
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The outcomes of this thesis enhance our understanding of the fate and behaviour of selected 
micropollutants in sewers. The biotransformation kinetics and pathways reported here can 
be of great interest when predicting the pharmaceutical loads in the wastewater treatment 
plant inlet after sewer passage, but also in sewage-based epidemiology, where neglected 
biotransformation of drugs leads to wrong estimations of consumption in a target population. 
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1 Introduction  
The provision and supply of appropriate amount and quality of drinking water remains a 
major global challenge in the year 2018, according to the World Health Organisation.1 
Population increase, demographic change, unstable climate and increasing reports of water 
pollution intensify the water stress along with already limited naturally occurring and 
accessible fresh water resources. As analytical techniques improved over the last decades, 
the ubiquitous occurrence of organic micropollutants in the aquatic environment became 
more evident. The potential effects of pharmaceutically active compounds (PhACs), 
pesticides, personal care products, food additives, etc. include bioaccumulation in animal 
tissue and soils,2 endocrine disruption and behavioural changes of aquatic organisms3,4 and 
the development and spread of antibiotic resistance genes (ARGs).5 The origin of most 
micropollutants in the aquatic environment is the effluent of sewage treatment plants (STPs). 
Although STPs were originally designed to remove macropollutants from wastewater, high 
removal efficiencies for some PhACs have been reported, such as acetaminophen and 
ibuprofen (>99 %).6,7 Other compounds, such as carbamazepine, remain persistent and are 
emitted into the aquatic environment. 
PhACs in wastewater originate from human consumption, incomplete metabolisation and 
excretion of the active ingredient and metabolisation products. Depending on the compound, 
the proportion of excreted unchanged active ingredient can be as high as 90 %, as is the 
case for the radiocontrast agent diatrizoate.8 After excretion, the active ingredients and 
metabolites pass through the sewer system, which is an underground infrastructure 
composed of drains, pipes and pumping stations with the primary purpose to collect and 
transport wastewater. Sewer pipes can be either anaerobic, fully filled rising main sewers 
(RM) or partly filled gravity sewers (GS). Sewer networks are typically associated with bad 
odours, concrete corrosion or explosion risks, due to the biochemical production of hydrogen 
sulfide (H2S) and methane (CH4) by the sulfate-reducing bacteria (SRB) and methanogenic 
archaea (MA), which inhabit the sewer pipe walls as biofilms.9  
While sewer biofilms have long been known to biochemically transform carbon and sulfur 
contained in raw sewage,10–12 only little is known about their ability to transform 
micropollutants, especially PhACs and pesticides. Increasing attention is currently given to 
the in-sewer stability of PhACs and illicit drugs in the field of wastewater based epidemiology 
(WBE), where the consumption of illicit and prescription drugs within a population is 
monitored based on the concentrations of these compounds in raw sewage.13–15 Hence the 
persistence of these compounds to transformations in sewers is desirable to reduce the 
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uncertainty of the estimations. However, the limited previous studies also suggested the 
capability of lab-scale RM and GS sewers to remove the illicit drug cocaine,16 and the PhACs 
acetaminophen, salicylic acid and caffeine.17 Full-scale RM sewers were capable of up to 
60% removal of some pharmaceuticals (e.g., amlodipine), whereas the concentrations of 
sulfamethoxazole and irbesartan increased during the passage through sewer pipe due to 
biochemical transformation of their human metabolites.18  
The detailed investigation of the fate and behaviour of micropollutants during sewer passage 
can be of great interest when predicting the pharmaceutical loads in the wastewater 
treatment plant inlet after sewer passage, but also in WBE, where neglected 
biotransformation of drugs leads to wrong estimations of consumption in a target population. 
Thus, filling this knowledge gap is essential for gaining a holistic view on the fate and 
behaviour of micropollutants from consumers to their emission into the environment, and 
eventually controlling their ubiquitous occurrence in the aquatic environment. 
1.1 Aim of the thesis 
With the focus in current literature being on illicit drugs the fate and behaviour of the majority 
of PhACs and pesticides remains unknown. This thesis aims to fill this knowledge gap by 
systematically investigating the fate and behaviour of 30 PhACs of various therapeutic 
groups and 4 pesticides in RM and GS sewer biofilm reactors. Laboratory-based and full-
scale pilot experiments were carried out to understand the role of sewer biofilm during the 
removal of micropollutants by specifying the removal mechanisms, identifying the 
contributing microbial communities and elucidating in-sewer transformation products (TPs) 
and pathways. 
1.2 Organisation of the thesis 
This thesis is organised in 8 chapters.  
• After this introductory chapter, relevant literature concerning the fate and behaviour 
of micropollutants during human metabolism, wastewater treatment and sewer 
passage will be summarised and discussed in chapter 2, 
• Research objectives, based on the identified knowledge gaps in literature will be 
presented together with a brief description of the research methodology in chapter 3, 
• Chapter 4 describes the materials and methods applied, i.e. substances, 
experimental setups, experiment protocol and analysis, 
• Chapter 5 is divided into four sub-chapters, each presenting and discussing the 
results linked with one research question, 
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• An overall conclusions based on the obtained results can be found in chapter 6, 
including recommendations for future research, 
• The appendices (chapter 8) follow the bibliography (chapter 7) and contain 
information about the studied PhACs and pesticides, analytical parameters, 
schematics of modified experimental setups and supporting information for the result 
chapters. 
4 | 
2 Literature review  
This literature review presents and discusses relevant literature regarding the fate of organic 
micropollutants in the environment and their anthropogenic origin as well as their fate and 
behaviour during human metabolism and wastewater treatment. The state of research 
regarding in-sewer processes of biochemical and physico-chemical nature will be discussed 
in section 2.4, before discussing current research activities in the context of the 
biotransformation of micropollutants in sewers and existing research gaps. 
2.1 Micropollutants: Sources and fate in the environment 
The term “micropollutants” is used to define a variety of substances in the environment which 
are present in concentrations of up to a few µg L-1 and mostly anthropogenically introduced. 
Micropollutants comprise inorganic compounds, such as arsenic, lead and other heavy 
metals, and organic compounds, including PhACs, personal care products, food additives, 
surfactants, flame retardants and pesticides. Organic micropollutants have been classified 
as chemicals of emerging concern due to the potential detrimental effect of these 
substances on human and environmental health. The pathways of organic micropollutants 
into the environment are diverse and depend on the use of each compound. 
2.1.1 Pharmaceutically active compounds (PhACs) 
Rising global demand of PhACs has been linked with a shift of disease burden from 
predominately acute illness to chronic illness. Among the possible reasons for this change 
is increasing average life-expectancy (year 1955: 45 years; 2005: 66 years), global 
population rise, demographic change and lifestyle choices (e.g. smoking, diet).19 In the case 
of antibiotics, over-prescription and increasing consumption may promote antibiotic 
resistance and thus deplete the efficacy of antibiotics against bacterial infections.20 
The presence of PhACs in the environment has previously been linked with incomplete 
removal during treatment in STPs. Wastewater in STPs originates from multiple sources 
with major contributions from households and human health facilities. A study conducted by 
Ort et al., demonstrated that 15% of the total PhAC load in the STP originated from a local 
hospital, with some antibiotics, such as roxithromycin, accounting for 56% of the load.21 
Although improper disposal of unconsumed medication may contribute to PhAC loads in 
STPs (i.e. as landfill leachate),22 the PhAC load is predominately comprised of excreted 
metabolised and unmetabolised active pharmaceutical ingredient (API) from human 
consumption. 
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When administered orally, the API passes through the gastrointestinal tract, where it is 
absorbed, distributed and metabolised before excretion via the urine or faeces (Figure 2-1). 
While in the body, the fate of the API is determined by its physical and chemical properties. 
For instance, the acidic environment in the stomach causes the dissociation of many weak 
acids (pKa around 4), such as ibuprofen and aspirin. The dissociated form remains in 
solution and continues to the small intestine. The molecular form passes through the lipid 
barrier of the stomach wall by passive diffusion and is absorbed into the blood plasma for 
distribution in the body. Absorption of most APIs occurs in the small intestine due to the high 
surface area of the small intestine in comparison to the stomach. Once absorbed into the 
blood plasma, the API is considered bioavailable and able to reach its location of action. 
Generally, polar and charged APIs tend to remain soluble in water, while non-polar and 
uncharged APIs are more likely to pass through the organs lipid wall.23  
 
 
Figure 2-1: Schematic pathway of enterally administered APIs through the human body after 
consumption. Organs related to the processes are underlined. Dotted lines represent 
hydrophilicity, while dash-dotted lines represent lipophilicity. All information is compiled from 
Golan et al. (2012).23 
 
When passing through the liver, a range of transformation reactions may be induced by 
enzymes belonging to cytochrome P450, such as monooxygenases. Transformations occur 
in two phases, however their occurrence is compound-dependent and not necessarily 
successive:24  
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• Phase I: Modification and introduction of polar groups by oxidation (ibuprofen), 
azoreduction (sulfasalazine), aromatic ring oxidation (acetanilide to acetaminophen), 
O-dealkylation (phenacetin to acetaminophen), etc. 
• Phase II: Conjugation with glucuronic acid (“glucuronisation”), sulfate (“sulfation”), 
amino acids, etc.  
Phase I and II metabolism increase the water-solubility of more lipophilic APIs, in order to 
aid excretion via the kidneys. The APIs and their metabolites, which are partly excreted via 
the bile instead of the kidney, comprise macrolide antibiotics, ibuprofen and the β-blocker 
atenolol, with excreted fractions ranging as high as 100% (e.g. clarithromycin or ibuprofen).25 
2.1.2 Pesticides 
In agriculture, plant and plant products are protected from pests through the application of 
pesticides. Pesticides include insecticides, herbicides, bactericides, fungicides and other 
substances. Pesticides are emitted into the aquatic environment via two pathways:  
i) surface run-off from agricultural land during rain events and ii) pesticide uptake by humans 
though diet and household use. Similarly to PhACs, the pesticides in the human body are 
subject to metabolisation and excretion.26,27 
2.1.3 Fate in the environment 
The presence of PhACs and pesticides in the aquatic environment is likely to have occurred 
since the production of the first synthetised compound, however, it is only in recent years 
that detection and quantification has been made possible through improved analytical 
methods and instrumentation.28 The continuous contact between micropollutants and 
aquatic organisms makes it difficult to describe and quantify the effect these substances 
may have had previously. In the literature, bioaccumulation, endocrine disruption, inhibitory 
and toxic effects, and increased resistance towards these compounds, are discussed as 
potential effects of micropollutant exposure.29 
Commonly detected PhACs in surface waters comprise the widely consumed over-the-
counter drugs such as acetaminophen and ibuprofen. Other commonly detected 
compounds, such as carbamazepine and the radiocontrast agent iopromide, are considered 
to be persistent to biodegradation.30 Concentrations of <10 ng L-1 are typically reported for 
rivers, however, may be higher in presence of an upstream STP discharge. 
Fluoroquinolone antibiotics, such as ciprofloxacin and enrofloxacin, have been identified as 
accumulating in shrimp, river snails, crabs and multiple carp species.2 These substances 
were found to have accumulated in locations very remote to the site of production and usage, 
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which suggests persistence and accumulation in smaller aquatic animals which serve as 
food for larger aquatic organisms. The biomagnification of other compounds, such as the 
antidepressants sertraline and venlafaxine, has been observed in lab experiments of 
Daphnia Magna.31  
In addition to their accumulation or biomagnification, micropollutants in the environment may 
provoke endocrine disruption in an organism. For instance, Daphnia Magna exhibited 
changes in mating behaviour when exposed to the antidepressants sertraline and 
venlafaxine,31 and the antibiotics enrofloxacin, ciprofloxacin and trimethoprim.4 Other 
endocrine disrupting effects, including the feminisation and demasculinisation of fish, are 
still a controversial topic in the literature. While the majority of research suggests that 
steroids from anthropogenic use have the biggest impact on endocrine disruption of aquatic 
organisms,32–34 Green et al. claim that the exposure to multiple steroids is required to 
precipitate the effects.35 
Other aquatic organisms that are affected by micropollutants are microorganisms. For 
instance, denitrifying bacteria are reportedly inhibited by sulfamethazine, resulting in 
potential eutrophication and increased N2O production, a greenhouse gas with 200 times 
the potential of CO2.36 Although resistance to the effects of micropollutants would be 
beneficial in this case, it remains alarming that bacteria develop resistance towards PhAC 
because of long-term exposure to anthropogenically excreted compounds or animal faeces 
in farming. Fang et al. studied ARGs carried by human pathogenic bacteria (HPB) in chicken 
manure and green house soils and found a positive correlation between ARG carrying HPB 
and antibiotic presence.5 The research findings demonstrate that antibiotics, which are given 
to cattle, can make their way back to the consumer through consumption of the meat itself, 
and through consumption of vegetables that have been grown in green houses where 
manure was applied as fertiliser. Thus, rivers and soils have been considered as reservoirs 
for ARGs.37–39 
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2.2 Removal of micropollutants during wastewater treatment 
Conventional treatment of wastewater aims to protect public health and minimise the 
adverse effects of dissolved wastewater components on the aquatic environment. Besides 
particulate matter and microbial contamination, deterioration of receiving water quality can 
be caused by insufficient removal of organic compounds and nutrients (e.g. phosphate or 
ammonium).40 Although not specifically designed for the removal of micropollutants, 
biochemical wastewater treatment technologies, such as conventional activated sludge 
(CAS) or membrane bioreactors (MBR) were shown to partly remove many 
micropollutants.30 The occurrence, fate and behaviour of micropollutants in the urban water 
cycle has been studied extensively,7,30 however, the mechanisms and influencing factors for 
improved removal have not, as yet, been fully elucidated. 
2.2.1 Conventional activated sludge treatment (CAS) 
STPs usually contain at least four treatment steps:  
1. Preliminary treatment: removal of solids, fat, oil and grease; 
2. Primary treatment: sedimentation and removal of settleable solids (primary sludge); 
3. Secondary treatment: biological conversion of dissolved and colloidal organic matter; 
and 
4. Sludge treatment. 
Additional treatment steps, including advanced chemical or electrochemical oxidation or the 
adsorption to activated carbon, may enable further removal of micropollutants. In Germany 
and Switzerland, dedicated systems for micropollutant removal (fourth treatment step) have 
been installed in STPs, however these systems are not common.41,42 
The secondary treatment step is most commonly designed as CAS treatment.43 Activated 
sludge is a conglomerate of microorganisms which are organised in flocs and surrounded 
by extracellular polymeric substances (EPS). Continuous flow and recirculation of 
wastewater through an aerated nitrification and an anoxic denitrification tank maintains the 
sludge in suspension (Figure 2-2). Nitrifying organisms, such as Nitrosomonas, obtain 
energy from oxidising ammonium in the wastewater to nitrite and nitrate while utilising 
carbon dioxide as a carbon source (autotrophic). Nitrite and nitrate are reduced to nitrogen 
by denitrifying organisms in the anoxic denitrification tank, such as Nitrobacter, with 
simultaneous oxidation of an organic carbon source for energy and biomass growth 
(heterotrophic).44,45 The denitrifiers and the slow-growing nitrifying organisms are enriched 
by returning settled sludge from the clarifier to the secondary treatment tanks.  
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Figure 2-2: Schematic representation of treatment steps during conventional activated 
sludge treatment. 
 
Micropollutant removal during CAS treatment is commonly attributed to active biomass, 
however, does not necessarily imply biotransformation as the removal mechanism. Volatile 
compounds, such as phenols, are likely removed via the gas phase, dependant on aeration, 
mixing, temperature and other operating conditions. However, volatilisation is usually not 
considered relevant for compounds with low Henry constants, such as pharmaceuticals and 
pesticides.46 
Solid-liquid partitioning describes the distribution of a substance between the solid phase 
and the liquid phase. In this context, the term “absorption” refers to the partitioning of a 
solute into the solid phase, i.e. passage through the bacterial cells’ lipid membrane by 
lipophilic substances (Figure 2-3). Adsorption defines the accumulation of a solute at the 
solid-liquid interface due to Van der Waals-type interactions or electrostatic interactions of 
the negatively charged surface of microbial cells and EPS with positively charged groups of 
a substance.25,47 Both processes can be influenced by pH changes around the pKa value of 
a substance due to the increase of cationic or anionic species after dissociation. Prediction 
of sorption due to lipophilicity, as expressed by high octanol-water partition coefficients 
(LogKOW >4) (Eq. 2-1), is biased when the substance is dissociated at experimental pH. This 
is accounted for in the distribution coefficient LogD (Eq. 2-2).  
 =  	
	     (Eq. 2-1) 
 =  	
(	,,		,)    (Eq. 2-2) 
where the concentration of a substance is detected in octanol (CO) and water (CW) as ionised 
(CW,i) or neutral (CW,n) species. In general, pharmaceuticals are more polar than other 
Solids 
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Return activated 
sludge Waste activated 
sludge
Excess sludge removal for treatment
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micropollutants, especially when excreted via urine. The release of a sorbed substance into 
solution is referred to as “desorption”. Partitioning is at equilibrium when sorption and 
desorption occur at the same rate. 
Sorption of micropollutants varies greatly depending on the substance and is expressed as 
the solid-water distribution coefficient Kd, which represents the ratio of substance detected 
in solid phase (Cs) vs. the aqueous phase (Ca) (Eq. 2-3). Kd values below 0.5 L g-1 are 
considered negligible.48  
 = 		     (Eq. 2-3) 
Elevated sorption to activated sludge compared to primary sludge was found for the 
fluoroquinolones ciprofloxacin (Kd = 26±7.3 and 2.6±1.6 L g-1) and norfloxacin (Kd = 37±13 
and 2.5±1.5 L g-1, respectively), likely due to interactions between the protonated secondary 
amine and the negatively charged biomass surface. Furthermore, accumulation in the 
primary sludge could occur due to recirculation of excess activated sludge in the primary 
treatment for sludge removal.49 Generally, sorption to primary sludge was higher for many 
compounds, including ketoprofen, erythromycin, trimethoprim, propanolol and diclofenac, 
however below 0.5 L g-1.48,50  
 
Figure 2-3: Selection of miropollutant removal pathways in presence of active biomass. 
Ovals represent microbial cells with lipid membranes in a sludge floc; MP: micropollutant; 
TP: transformation product; EPS: extracellular polymeric substance. 
 
Biotransformation can be considered the key removal mechanism of pharmaceutical 
residues during CAS treatment; however, incomplete removal results in their discharge via 
the effluent.30 Micropollutants in STP influents are usually not detected above low µg L-1 
levels (i.e. <5 µg L-1), hence they are considered to be removed as secondary substrate in 
Adsorption
Absorption
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TPMP
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Co-metabolism
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Sorption
Metabolism
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the obligatory presence and transformation of a primary microbial carbon and energy source 
(co-metabolism, Figure 2-3). However, the utilisation of micropollutants as a sole carbon 
source has been reported previously (e.g. for ketoprofen and aniline).51  
Besides substance-specific properties, such as charge or lipophilicity, operational process 
parameters may play a prominent role during micropollutant removal in CAS treatment. 
Besides temperature, pH, sludge concentration and hydraulic retention time (HRT, average 
time that wastewater remains in STP, ~6 h), solids retention time (SRT, average duration of 
activated sludge recirculation before disposal, up to 15 d) was shown to be a crucial 
parameter with regard to the versatility of activated sludge biocenosis.25 In particular, the 
slow-growing ammonia oxidising bacteria benefit from elevated SRT and have been 
associated with removal of many micropollutants.30 
Analgesics and antibiotics are among the most studies PhACs during CAS treatment, likely 
due to their high abundance in STP inlets. In particular, acetaminophen and ibuprofen, both 
over-the-counter drugs in most countries, are present in concentrations of up to 9.9 µg L-1 
and 21.7 µg L-1, respectively, with removal rates of 99% reported.30 Indomethacin, diclofenac 
and tramadol were found at 0.9 µg L-1, up to 1.5 µg L-1 and even 48.5 µg L-1. While no 
elimination was reported for indomethacin, diclofenac was removed by about 22% and 
Tramadol by about 42%.30 These three compounds are the more persistent analgesics 
during CAS treatment, as illustrated in Figure 2-4.  
Among many other PhACs, antibiotics were mostly detected below 5 µg L-1 in CAS for 
treatment of domestic wastewater with reported removal of those compounds between 73% 
and 95%. Removal efficiencies for sulfonamides between 72% and 100% have been 
reported for CAS, however, negative removal for sulfasalazine and other sulfonamides has 
been reported, suggesting release of API after the breakdown of composite material and the 
process of deconjugation.30  
 
12 | 
 
Figure 2-4: Relative removal (bars) and initial concentration (●) of common pharmaceuticals 
and a selection of pesticides during CAS treatment. Negative removal has been reported for 
compounds marked with #. All values are means and taken from Verlicchi et al. (2012).30 
 
2.2.2 Anaerobic treatment  
Waste activated and primary sludge from wastewater treatment are usually stabilised and 
harvested for methane by anaerobic digestion (AD). As opposed to aerobic CAS treatment, 
AD occurs in the absence of oxygen. This facilitates the growth of specialised microbial 
communities that decompose organics via hydrolysis, fermentation and methanogenesis 
(Figure 2-5). During hydrolysis, particulate matter and dissolved organics are decomposed 
into monomers, i.e. amino acids, monosaccharides and short chained fatty acids. The 
monomers are then fermented into volatile fatty acids (VFAs), CO2 and H2, via multiple 
pathways. For instance, during acidogenesis, the momomers are fermented into larger VFAs 
(butyrate, valerate, hexanoate), which are subsequently fermented into propionate. 
Acetogenesis specifically describes the fermentation of monomers or VFAs into acetate. 
During methanogenesis, H2 and acetate are consumed by hydrogen-utilising and 
aceticlastic methanogenic organisms, respectively, to produce CH4 (Figure 2-5). 
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Figure 2-5: Simplified conceptual model of biochemical processes during anaerobic 
digestion. Other VFAs formed during acidogenesis are butyrric acid and valeric acid. 
 
The majority of the influent during the AD process is aqueous, due to the low solids content 
less than 15%,43 which results in dissolved and sorbed micropollutants entering during this 
treatment step. Anaerobic digestion was shown to be effective at removing PhACs that are 
persistent to aerobic treatment during CAS, such as the antibiotics sulfamethoxazole and 
trimethoprim (i.e. <90% removal) (Figure 2-6).52–55 The high removal of these compounds 
was correlated with the methanogenic activity during AD, which does not occur during CAS 
treatment. But also carbamazepine and diclofenac exhibited removal of approximately 40% 
and 70%, respectively.52–55 As such, anaerobic treatment methods may be promising 
alternatives to aerobic treatment for the removal of micropollutants.  
In general, minimal attention has been given to the capability of anaerobic microbial 
communities to remove micropollutants from wastewater.56 Anaerobic technologies that 
were shown to successfully remove selected micropollutants in wastewater comprised 
anaerobic membrane bioreactors (AnMBR), upflow anaerobic sludge blankets (UASB) and 
the subsurface treatment of groundwater (Figure 2-6).52,57–62  
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Figure 2-6: Maximum removal efficiencies obtained for PhACs and pesticides during 
treatment with anaerobic digestion (AD), Upflow anaerobic sludge blanket (UASB), 
anaerobic memebrane bioreacors (AnMBR) and the subsurface treatment of 
groundwater.52–55,57–62 
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2.3 Biodegradation products of micropollutants 
Similarly to the transformation reactions occurring during human metabolism of PhACs, 
micropollutants can be transformed by active biomass during the biological treatment of 
wastewater. In order to understand the transformation pathways and to analyse the TPs 
environmental toxicity, it is crucial that the formation of currently unknown transformation 
products (TPs) is understood. For instance, clofibric acid is transformed to p-chlorophenol 
during activated sludge treatment, which exhibited higher toxity than the parent compound.63 
The deconjugation of human metabolites during wastewater treatment was previously 
suggested to lead to negative removal of the corresponding parent compound.30,64 In 
particular, the deacetylation of the human metabolite N4-acetyl-sulfamethoxazole to the 
corresponding parent compound sulfamethoxazole during CAS treatment was previously 
observed to lower the sulfamethoxazole removal efficiency to -24%, which lead to an 
increase of parent compound concentration rather than its removal (Figure 2-7).30 The 
deconjugation of human metabolites into the parent compound were also reported to occur 
for carbamazepine, diclofenac or ibuprofen.24,30 
 
 
Figure 2-7: Deacetylation of the human metabolite N4-acetyl-sulfamethoxazole to the 
corresponding parent compound sulfamethoxazole. 
 
A variety of transformation reactions involving parent compounds have been reported, 
including hydroxylation and carboxylation.30,51,65–67 For instance, ibuprofen was 
carboxylated during treatment with activated sludge. Furthermore, ibuprofen was 
hydroxylated to 1-OH-ibuprofen and 2-OH-ibuprofen during MBR treatment and 
experiments using activated sludge.51,65 Other compounds that undergo hydroxylation 
include trimethoprim (in nitrifying activated sludge)66 and irbesartan (by activated sludge).67 
More complex transformation pathways were previously described for trimethoprim, which 
was hydroxylated and oxidised at its diamino pyrimide moiety during treatment with nitrifying 
activated sludge.66 Diclofenac was found to form a heterocyclic structure between the phenol 
and the secondary amine during activated sludge treatment.63 Other transformations 
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pathways that were observed during CAS treatment were the hydrolysis of atenolol at its 
primary amine to form atenolol acid and the deethylation or the oxidation of DEET at the 
tolyl group (Figure 2-8).68 
 
a) Atenolol 
 
b) DEET 
 
Figure 2-8: Transformation products and transformation pathways a) transformation product 
of atenolol, atenolol acid. b) transformation products of DEET.68  
 
Most research has focused on the elucidation of previously un-reported transformation 
products and pathways, rather than the transformation process itself. For example, it has 
not been reported whether the transformation occurs with the studied compound as primary 
substrate or cometabolically, while using another carbon source for growth and 
reproduction. Quintana et al.51 conducted experiments with activated sludge and found that 
ketoprofen was used as the sole carbon source while being transformed into two TPs. 
During a second experiment, the researchers added powdered milk as a carbon source and 
observed the co-metabolic transformation of ibuprofen, naproxen and benzafibrate, while 
diclofenac remained persistent. 
 
Literature describing TPs generated under anaerobic conditions is scarce. However, 
Redeker et al. suggested transformation pathways for multiple deionisation and 
deacetylation steps during the degradation of the X-ray contrast medium diatrizoate in soil 
(Figure 2-9).69 While diatrizoate was completely metabolised, its transformation only started 
between 40 and 60 days after injection, which indicates lower removal rates in anaerobic 
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environments. Other reported transformation pathways are O-demethylation under 
anaerobic conditions, such as in venlafaxine, tramadol or naproxen, which may be induced 
enzymatically.56 However, regarding the high removal efficiencies that can be obtained for 
some micropollutants under anaerobic conditions (see chapter 2.2.2), the lack of 
investigations regarding anaerobic TPs and their transformation pathways is surprising. 
 
 
Figure 2-9: Proposed transformation pathway of diatrizoate in anaerobic soil: (1) 
deiodination, (2) deacetylation. The exact positions of deiodination and deacetylation could 
not be determined. The transformation steps with dashed arrows are proposed, but have 
not been confirmed yet.69 
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2.4 Sewer systems 
The sewer network collects and transports sewage from the point of disposal towards the 
STP for treatment. During the 19th century, the introduction of a sewer network in growing 
cities helped to control outbreaks of typhoid and cholera.9 In a poll among readers of the 
British Medical Journal in 2007, sanitation was considered the most important medical 
milestone since 1840, even more important than antibiotics (15.8% and 15% of votes, 
respectively).70  
While storm sewers collect storm water run-off during heavy rain events, sanitary sewers 
collect mostly domestic wastewater, including black water and grey water. Due to the 
continuous exposure of sewer pipes to microorganisms in human excretion, the sewer pipe 
walls are populated with biofilms. Biofilm production is influenced by the sewer environment, 
with two distinct transportation modes: 
• Rising main sewers (RM) are ascending in slope and require pumping stations for 
wastewater transport; therefore the RM pipes are full to capacity. The absence of 
oxygen makes RM biofilm anaerobic. 
• Gravity main sewers (GS) have a descending slope; the partly filled pipelines and 
short hydraulic retention time (HRT) create turbulence that allows for low 
concentrations of oxygen to be dissolved. As such, GS biofilms are considered partly 
aerobic/anoxic. 
 
2.4.1 In-sewer processes 
In addition to flow and operational conditions, microbial processes are also governed by the 
type of transport mode. As opposed to GS, RM pipes are fully filled with wastewater, thus 
any oxygen entering RM pipes is consumed rapidly and anaerobic conditions dominate the 
biochemical processes. Similarly to anaerobic digestion, hydrolysis of composite 
particulates to easily fermentable organics provides the microbial communities with carbon 
(Figure 2-10). Volatile fatty acids (VFAs), including propionic acid and acetic acid, as well 
as hydrogen and glucose, are further converted to yield methane (Eq. 2-4ff).  
 	→ 3	 + 	3		     (Eq. 2-4) 
! → 	 + 	     (Eq. 2-5) 
 + 4	 → 	 + 	2	    (Eq. 2-6) 
The methanogenic archaeum (MA) of the genus Methanosaeta was found to be dominant 
in RM biofilms.71 Another anaerobic process that is mainly associated with RM sewers is 
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sulfidogenesis. Sulfate-reducing bacteria (SRB) consume VFAs and hydrogen as electron 
donors with sulfate as the terminal electron acceptor, which forms sulfide (S2-).12. The 
predominant genera were found to be Desulfobulbus, Desulfomicrobium, Desulfovibrio, 
Desulfatiferula, and Desulforegula.71 With pKa values of 7 and 14, sulfide is usually present 
in wastewater as its cationic species bisulfide (HS-) or hydrogen sulfide (H2S). 
2	! + $% +		 → 2	! + 2	 + 2		 + $%  (Eq. 2-7) 
2	! + 3	$% + 3		 → 6	 + 6		 + 3	$%   (Eq. 2-8) 
 
 
Figure 2-10: Simplified conceptual model of major biochemical processes occuring in RM 
sewers. The dash-dotted box entails sulfidogenesis in the presence of sulfate, while the 
processes in dashed boxes also occur in anaerobic digestion in absence of sulfate. 
Information adapted from Sun et al.71 and Hvitved-Jacobsen et al.9 
 
MA and SRB have been shown to co-exist in a stratified structure within RM biofilms, with 
SRB growing adjacently to bulk sewage and up to 300 µm depth. Abundance of MA was 
found to increase with increasing depth of biofilm, i.e. from 10% to 75% at depths of 200 µm 
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and 700 µm, respectively. In addition to the protection from inhibiting chemicals due to 
spatial advantage of MA, they were shown to outcompete SRB for substrate, however this 
did not apply when sulfate was highly abundant.71 Generally, provision of substrate to MA is 
limited by diffusion through the biofilm. 
Methane and hydrogen sulfide produced by RM biofilm have limited solubility in water 
(<20 mg L-1 and 3 g L-1 at 30 °C, respectively) and partition into the gas phase. In GS, mass 
transfer of hydrogen sulfide and methane into the gas phase (sewer “atmosphere”) allows 
for interactions with the aerobic biofilm, while anaerobic conditions may prevail in the 
sediment and submerged biofilm (Figure 2-11). Thiobacilli in the aerobic biofilm oxidise H2S 
and produce sulfuric acid (H2SO4).9 The acidic environment is detrimental to sewer pipes, 
as it dissolves the alkaline concrete and reverses the passivation of the reinforcing steel, 
which ultimately causes concrete pipes to collapse. 
 
Figure 2-11: Schematic of typical in-sewer biochemical process during passage of 
wastewater through RM and GS. 
 
Damages due to sulfide-induced sewer concrete corrosion are estimated to cost billions of 
dollars each year, yet the major source of sulfide in wastewater has only recently been 
identified as coagulants in drinking water treatment.72 In addition to its detrimental effect on 
sewer pipes and escalating cost, hydrogen sulfide is an odorous compound with a 
characteristic smell of rotten eggs and is considered toxic (LC50 at 800 ppm, eye irritation 
starting as low as 20 ppm). Sulfide concentrations in full-scale sewers were below 
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14 mgS- H2S L-1, however prolonged HRT in RM even resulted in hydrogen sulfide 
concentration above 80 ppm.10,73 
Measurements by Guisasola et al. suggested super-saturation of methane in pressurised 
RM sewers (> 22 mg L-1), thus mass transfer into the atmosphere can be expected when at 
atmospheric pressure, i.e. in GS.39 Methane concentrations between 5-15% (by volume in 
air) are explosive. With a global warming potential of 21-23 times higher than CO2, it is 
remarkable that official guidelines of the Intergovernmental Panel on Climate Change 
(IPCC) is yet to consider methane emission from sewers as significant.74 
 
2.4.2 Micropollutants in sewers 
The sewer system is the first receiver of excreted micropollutants from domestic use 
however their presence in the sewer network has been neglected until recently. Furthermore 
RM and GS biofilms are almost continuously exposed to these substances and thus likely 
to develop protective mechanisms in presence of substances that are biocidal, such as 
antibiotics. Indeed, Auguet et al. (2017) identified sewers as potential reservoir of antibiotic 
resistance and demonstrated significant increase of the ARGs qnrS, sul1, sul2 and blaTEM, 
which are commonly associated with resistance to fluoroquinolones, sulfonamides and 
ampicillin, repsectively.75,76 In addition, they measured a decrease in concentration of 
fluoroquinolones and clarithromycin in the bulk water phase between the inlet and outlet of 
an RM pipe, which suggests that micropollutants may be transformed in RM sewers. 
Research concerning micropollutants in sewers is often linked with community-wide 
monitoring of substance abuse, such as consumption of illicit drugs. Daughton (2001) 
proposed a program to confidentially and non-intrusively monitor the consumption of illicit 
substances via analysis of the excreted API or human metabolite in real-time in 
wastewater.77 Sewage epidemiology or wastewater-based epidemiology (WBE) have since 
been applied to elucidate dominantly recreational use of MDMA (commonly known as 
ecstasy) and cocaine on weekends in European cities,78,79 fluctuations in illicit drug excretion 
in an Australian prison,80 alcohol consumption during festivals,81 high contributions of a 
Swedish hospital to antibiotic concentrations in STPs82 and excessive consumption of over-
the-counter antibiotics in China,83 among others.  
Major difficulties in WBE are the estimation of the contributing population in a sewer 
catchment and substance stability. Substance concentrations in wastewater vary temporally 
(diurnal pattern, seasonal or recreational consumption, etc.), spatially (rural vs. urban area, 
commuting and travel of consumer, etc.), but also based on non-consumer parameters, such 
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as high temperatures or dilution due to rain or infiltration by groundwater or stormwater. 
O’Brien et al. (2014) compared catchment population based Australian census data with 
wastewater concentrations of various substances in differently-sized sewer catchments. The 
artificial sweetener acesulfame was found to correlate well with population size, suggesting 
consumption by a large fraction of the population. However, the modelling-based estimation 
of population size yielded best results when considering multiple substances.84 Substances 
that are excreted exclusively by humans and ideally stable after excretion are usually 
referred to as “human biomarkers”. The stability of artificial sweeteners after excretion 
makes acesulfame an excellent biomarker that was even used to estimate urine volumes in 
public and private swimming pools (up to 75 L in a 840 m3 pool),85 which usually contain 
chlorine and are exposed to sunlight. However, artificial sweeteners are not consumed by 
each contributing person, which might result in an underestimation of population size or 
overestimation of per capita consumption.  
Unstable concentrations of micropollutants in sewers suggest losses during sewer passage 
due to exfiltration via leaking pipes, physico-chemical or biochemical removal. A catchment-
wide sampling campaign conducted by Lindberg et al. (2014) revealed unstable mass flows 
among some of 105 studied PhACs and suggested removal of e.g. two fluoroquinolone 
antibiotics and introduction of e.g. the macrolide antibiotic clindamycin.82 Without specific 
flow tracers (e.g. rhodamine, isotopically labelled substances, etc.), assessing the fate of 
substances in ng-µg L-1 levels is challenging in such an extensive study area, however the 
stability of many other studied compounds (i.e. β-blocker sotalol, antibiotic tetracycline, etc.) 
support the reliability of these results. Jelić et al. (2014) studied 43 PhACs in a single RM 
sewer pipe with a length and HRT of 7.6 km and 23 h, respectively.18 Although sampling 
uncertainty was considered high, with samples collected only at the inlet and outlet of the 
pipe, the macrolide antibiotic clarithromycin and PhACs of other therapeutic groups 
(benzafibrate, amlodipine, citalopram and diltiazem) were removed by more than 20%, 
however removal mechanisms could not be distinguished. Interestingly, negative removal 
of the antibiotics erythromycin (on average 30%) and sulfamethoxazole (66±15%) were also 
observed, suggesting release of API after the breakdown of composite material and 
deconjugation, respectively, during sewer passage. These processes have also been 
observed to occur during CAS or other anaerobic treatment (see chapter 2.2). Despite the 
uncertainties, the results of this study are of outstanding importance, as they support two 
ideas concerning micropollutants during sewer passage:  
1) Stability of biomarkers in WBE is not guaranteed, 
2) In-sewer removal mechanisms change PhAC concentrations. 
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During the past three years, these hypotheses have been increasingly tested in more easily 
controlled lab-based experiments. A pioneering study on the effect of sewer biofilms on illicit 
drug stability was only published in 2014 by Thai et al.16 The results confirmed the stability 
of benzoyl ecgonine (a human metabolite of cocaine) during 12 h, while the parent 
compound was extensively removed in GS (~60%) and RM (~40%). Since then, more 
elaborate sampling campaigns and modelling approaches were published to account for the 
in-sewer biotransformation of human biomarkers.15,86,87 Commonly, these studies include 
selected benchmarking compounds, such as the stable carbamazepine, diclofenac and 
tramadol and the easily degradable caffeine and acetaminophen, to allow the comparison 
of biofilm activity between studies.88 However, the focus of these studies was to assess the 
suitability of substances as human biomarkers for WBE. As such, only minimal information 
has been obtained on the fate and behaviour of PhACs and no information is available 
pertaining to pesticides.  
 
2.5 Research gaps in literature 
The removal of PhACs and pesticides during various aerobic and anaerobic wastewater 
treatment technologies has previously been shown to occur via physico-removal 
mechanisms and biotransformation along various pathways. In sewers, however, only little 
attention was given to the removal mechanisms of PhACs and pesticides.  
Filling this knowledge gap is essential for gaining a holistic view on the fate and behaviour 
of micropollutants from consumers to their emission into the environment, and eventually 
controlling their ubiquitous occurrence in the aquatic environment. In particular, an improved 
understanding of the fate and behaviour of micropollutants during sewer passage can be of 
great interest when predicting the pharmaceutical loads in the wastewater treatment plant 
inlet after sewer passage, but also in WBE, where neglected biotransformation of drugs 
leads to wrong estimations of consumption in a target population. Moreover, the in-sewer 
transformation of micropollutants, antibiotics in particular, may produce unknown 
biotransformation products with preserved active antibiotic sites, which may exert similar 
antibiotic activity to the parent compound. Thus, the removal efficiencies of antibiotics during 
downstream treatment may be biased due to in-sewer transformation products. 
Based on this literature review, the following major research gaps have been identified. 
While this list is not exhaustive, it represents the topics that require the most urgent attention 
to fill the major knowledge gaps concerning the in-sewer removal of PhACs and pesticides. 
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• PhAC of various therapeutic groups are commonly present in raw sewage, however 
information about their fate and behaviour during sewer passage is scarce; 
• The removal mechanisms of micropollutants during sewer passage, including PhACs 
and pesticides, are largely unknown; 
• In case biotransformation is the dominant removal mechanism during in-sewer 
removal of PhACs and pesticides, in-sewer TPs should be detectable, however have 
not been reported to date and their pathways remain unknown; 
• The contribution of the biofilm microbial communities, SRB and MA, has not been 
investigated. 
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3 Research objectives 
3.1 Research objective 1: Understanding the fate of key micropollutants in rising 
main and gravity sewer systems. 
Research gaps 
The occurrence, fate and behaviour of PhACs and pesticides in the urban water cycle has 
been studied extensively, including during wastewater treatment. Although sewer biofilms 
were previously shown to biochemically transform sulfur species and organic substrates, the 
fate and behaviour of PhACs and pesticides in sewers has only received little attention to 
date. Jelić et al. investigated the removal of forty-three pharmaceuticals in a full-scale RM 
sewers and suggested removal of amlodipine (~60%), clarithromycin (~20%) and 
bezafibrate (~20%).23 In contrast, sulfamethoxazole was introduced into the bulk water 
phase (~66%), which was linked with deconjugation from human metabolites (i.e. N4-acetyl-
sulfamethoxazole). Removal of fluoroquinolone, macrolide and sulfonamide antibiotics in a 
full-scale RM sewer was also observed by Auguet et al.25 In the context of WBE, the stability 
of illicit drugs few PhACs, such as caffeine, carbamazepine or norfloxacin was 
investigated.88 However, no systematic study of the fate and behaviour of PhAC from 
different therapeutic groups and pesticides has been published to date. Furthermore, the 
removal mechanisms, i.e. biotransformation or physico-chemical mechanisms, are yet to be 
elucidated. 
 
Aim of the study 
Research objective 1 aims to close the research gaps above, by testing the following 
hypotheses: 
1. Common PhACs and pesticides are removed during sewer passage, 
2. RM and GS biofilms contribute to in-sewer removal of PhACs and pesticides, 
3. Active RM biofilm contributes more to in-sewer removal of PhACs and pesticides 
than inactive biofilm. 
Experimental data will be generated in laboratory-scale RM and GS, which is currently very 
limited in literature. The results from this comprehensive screening are expected to support 
the selection of suitable substances for further investigation in research objectives 2 to 4. 
 
Research approach 
Laboratory-based screening experiments will provide information about the potential of 
sewer biofilms to remove PhAC from various therapeutic groups and common pesticides 
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from the aqueous phase. Experiments will be carried out in three sets, in order to test the 
hypotheses above: 
1. RM with initial concentrations of 5 µg L-1 and 50 µg L-1 to investigate micropollutant 
capability of RM biofilm and confirm validity of results at elevated concentration for 
further experiments, 
2. RM and GS at initial concentration of 50 µg L-1 to investigate removal capability under 
different redox conditions, 
3. Inhibited and active RM biofilm to investigate contribution of physico-chemical 
removal mechanism to in-sewer removal. Additional experiments in a reactor without 
biofilm will reveal the impact of wastewater in absence of biofilm on removal (i.e. 
hydrolysis, sorption to particles, etc.). 
Analysis will be performed using LC/MS/MS, accompanied by biofilm activity assessment, 
i.e. quantification of sulfide and methane production and conversion of VFAs. Extent of 
removal and removal rates of micropollutants will be quantified using a first-order kinetic 
model. 
 
3.2 Research objective 2: Revealing the role of microbial communities for in-sewer 
biotransformation and the pathways. 
Research gaps 
SRB and MA have previously been identified as the predominant microbial communities in 
sewer biofilms.71 They populate sewer pipe surfaces in a stratified distribution within the 
biofilm layer.9,71 While the contribution of SRB and MA on biotransformation of sulfide, 
methane and many other has been reported before,10,71 little is known about the fate of 
PhAC and pesticides when in contact with sewer biofilm. So far, no attention has been given 
to the responsible microbial communities or pathways during in-sewer biotransformation of 
PhAC and pesticides. Moreover, removal of PhACs and pesticides during in-sewer 
biotransformation is assumed to occur co-metabolically, as the usually low concentrations 
of micropollutants are not expected to serve as growth substrate.  
 
Aim of the study 
Research objective 2 aims to close the research gaps above, by testing the following 
hypotheses: 
1. Biofilm microbial communities contribute differently to in-sewer removal of 
micropollutants; 
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2. Substrate competition of SRB and MA might affect extent of removal of 
micropollutants. 
Experimental data is required due to the lack of information in literature.  
 
Research approach 
The substances studied in objective 1 will be used during lab-based experiments in RM 
biofilm reactors. Chemical inhibition of either SRB or MA or both simultaneously will 
elucidate their contribution on PhAC and pesticide removal. Analysis will be performed 
analogously to the research approach in objective 1. 
 
3.3 Research objective 3: Transformation products as result of anaerobic in-sewer 
biotransformation 
Research gaps 
A thorough literature review demonstrated the ability of aerobic (i.e. CAS, MBR, etc.) and 
anaerobic (i.e. AD, soil, etc.) microbial communities to transform PhACs and pesticides into 
TPs. In addition, Jelić et al. (2014) suggested deconjugation of human metabolites to be the 
cause for an increase of sulfamethoxazole concentration during full-scale sewer passage.18 
To date, no studies were presented with dedicated experiments to confirm the in-sewer 
formation of biotransformation products.  
 
Aim of the study 
This objective aims to demonstrate the ability of RM biofilms to produce in-sewer TPs from 
the model antibiotics roxithromycin and trimethoprim. The antibiotics roxithromycin and 
trimethoprim were selected as these compounds are commonly consumed PhACs20 and 
yielded high removal > 50% during the experimental work for research objectives 1 and 2. 
The hypotheses tested during this objective are: 
1. RM biofilms produce in-sewer TPs by transforming the antibiotics trimethoprim and 
roxithromycin, 
2. Previously not reported TPs are formed, 
3. Previously reported TPs are formed. 
 
Research approach 
Trimethoprim and roxithromycin are spiked in lab-based experiments with elevated 
concentrations and extended HRT to amplify the production of TPs. An LTQ-ESI(+)-Orbitrap 
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system will be used to analyse the production of several potential TPs during the experiment 
duration and to elucidate their chemical structure. The removal rates will be compared with 
those obtained at lower initial antibiotic concentration. 
3.4 Research objective 4: Demonstrating in-sewer biotransformation of 
micropollutants in full-scale sewer pipes. 
Research gaps 
Concentration changes of common PhACs during RM sewer passage were presented by  
Jelić et al.18 Furthermore, McCall et al. suggested a comprehensive model to describe the 
catchment-wide fate and behaviour of illicit drugs, carbamazepine and diclofenac.86 
However, fluctuations in flow rates due wastewater production,71 as well as varying 
concentrations of the compounds may have a major impact on the micropollutant distribution 
in real full-scale sewers.  
 
Aim of the study 
The investigation of the fate and behaviour of selected PhACs during passage of full-scale 
pilot sewer pipes is expected to confirm the applicability of results from objectives 1, 2 and 
3. The sewer pilot offers the ability to sample the fate and behaviour of PhACs in wastewater 
slugs between pump events, while operational parameters (flow, HRT, etc.) are controllable. 
Furthermore, the pilot sewer pipes allow for higher frequency sampling at dedicated 
sampling ports along the length of the pipes, as opposed to only at the inlet and outlet, which 
is the case in full-scale sewer pipes in operation. This unique setup is highly beneficial for 
the investigation of in-sewer removal kinetics at environmental concentrations. The following 
hypotheses will be tested: 
1. Micropollutants are removed in full-scale RM and GS sewers; 
2. Removal occurs at different rate than in lab-scale biofilm reactors; 
3. Micropollutant removal rates vary depending on the pipe section. 
Research approach 
A full-scale RM and GS sewer pilot has been constructed and operated in the Innovation 
Centre on site of the WWTP Luggage Point by PhD candidate Adam Shypanski. 
Experiments will be conducted in RM with HRT of 8 h and regular pump events (1 h per pipe 
section) and 6 h without pump events (across the entire pipe), to distinguish PhAC removal 
linked with local biofilm activity. GS experiments will be conducted at a HRT of 5 h. All PhAC 
sampling will be accompanied by sampling for sulfur species, methane and VFAs.  
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4 Materials and methods 
4.1 Substances 
The standards for pharmaceuticals and pesticides were analytical grade, with exception of 
erythromycin and roxithromycin (purity >90%). A list of compounds, their suppliers and 
properties is available in Table 8-1. A mix of standards used in the analysis and spiking of 
the lab-scale reactors was prepared from individual standards at a final concentration of 
1 g L-1 in methanol. Isotopically labelled standards of the studied compounds used in the 
analyses (Table 8-2) were purchased from Toronto Research Chemicals (North York, 
Canada) and prepared in methanol from individual stock solutions. Acetonitrile and methanol 
were HPLC grade (Merck, Darmstadt, Germany) and MilliQ water was generated using a 
Merck MilliQ® system. Raw sewage was collected on a fortnightly basis from a wet well in 
St Lucia, Brisbane (Australia) and stored at 4°C. The sewage typically contained 9.7 to 
22.1 mg S L-1, 0.5 to 3.0 g COD L-1, of which 0.3-0.9 g COD L-1 were soluble. The pH ranged 
between 6.9 and 8.2. The investigated PhACs and pesticides were present in raw sewage 
at concentrations < 2 µg L-1, with the exception of caffeine and acetaminophen, which are 
frequently consumed by the wider population25 (Table 8-3). 
4.2 Biofilm reactors 
4.2.1 Laboratory-based setup 
Cylindrical sewer biofilm reactors (1000 mL, Perspex®, ø 80 mm) were inoculated using raw 
sewage and mature biofilm maintained for at least 6 years. During pump events, sewage 
was heated up in a water bath to reach 20°C and pumped into the reactors at a rate of 500 
mL min-1 for 2 min every 4 h for at least 12 months in continuous mode. Four reactors were 
maintained as RM biofilms (no exposure to atmosphere) and one reactor as GS (exposure 
to atmosphere at the water surface). During the experiments conducted at the initial 
concentrations of target pollutants of 50 µg L-1, pump events were paused and the RM and 
GS setups operated in batch mode (Figure 4-1). In the experiments conducted at lower initial 
concentrations (i.e., 5 µg L-1), three RM reactors were connected in series and the sewage 
was recirculated in batch mode (appendix, Figure 8-1). This was necessary to increase the 
applied volume, as sample volumes (i.e. 50 mL per sample) would exceed the total volume 
of one reactor. TP elucidation experiments were conducted with modified RM setup to allow 
for feeding the biofilm over the extended experiment duration of 13 days (appendix, Figure 
8-2). All reactors were completely covered to exclude light, hence photolysis can be 
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excluded as a potential removal mechanism. The biofilm surface to sewage volume ratios 
(A/V) are 55 m2 m-3 in RM, 50 m2 m-3 in GS and 33  m2 m-3 for RM with lower initial 
concentration. 
 
Figure 4-1: Schematic representation of experimental setup used during experiments at 
initial concentration 50 µg L-1. A: RM reactors. Biofilm grows on the reactor walls and under 
the lid. B: GS reactor. Biofilm only grows on the walls. 
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4.2.2 Luggage Point Innovation Centre Sewer pilot 
The experimental full-scale sewer pipes are located in the Luggage Point STP in Brisbane 
and began operation in 2015. Two RM pipes (ø 100 mm) and two GS pipes (ø 300 mm) of 
300 m length each were inoculated and the mature biofilms maintained with wastewater 
from the STP inlet.89 Schematic representations of both setups can be found in the appendix 
(Figure 8-4 and Figure 8-5). Prior to conducting experiments in June 2017, pump events in 
the RM were scheduled for 1 min each hour at a flow rate of 275 L min-1. The GS pipes were 
operated continuously at a flow rate of 200 L min-1. During the experiments, sewage was 
recirculated in GS and lead to a fill level <50%. 
 
4.3 Batch experiments 
All experiments were conducted as batch experiments, which will be described in more detail 
in the following sections. Table 4-1 on the next page offers an overview of the batch 
experiments conducted for each of the four research objectives, including the purpose of 
the particular setup, the biofilm used, the concentration of spiked micropollutants and 
experiments duration. Experiments were run in parallel per objective, with the exception of 
full-scale pilot experiments. 
  
32 | 
Table 4-1: Overview of batch experiments conducted during this project and described in 
the foloowing method chapters. “Spiked conc. [µg L-1] refers to the concentration of spiked 
micropollutants. 
Objective Purpose Biofilm 
Spiked 
conc. 
[µg L-1] 
Duration Description in chapter 
1 
Control: Sewage only 
(accounting for hydrolysis 
or sorption to particles in 
sewage) 
no biofilm 50 8 h 4.3.2 
In-sewer biotransformation RM 50 8 h 4.3.1 
In-sewer biotransformation GS 50 8 h 4.3.1 
Sorption, abiotic removal RM, inhibited 50 8 h 4.3.2 
In-sewer biotransformation RM 5 8 h 4.3.1 
2 
Control: Sewage spiked 
with inhibitor (accounting 
for abiotic reactions 
between inhibitor and 
micropollutants) 
no biofilm 50 8 h 4.3.3 
Biotransformation,  
MA inhibited 
RM, partly 
inhibited 50 8 h 4.3.3 
Biotransformation,  
SRB inhibited 
RM, partly 
inhibited 50 8 h 4.3.3 
Biotransformation,  
MA and SRB inhibited 
RM, partly 
inhibited 50 8 h 4.3.3 
3 
Control: Sewage spiked 
with antibiotic (accounting 
for hydrolysis) 
no biofilm 13,000 13 d 4.3.4 
Control: no antibiotic 
spiked (accounting for 
changes in biofilm activity 
due to the use of synthetic 
wastewater) 
RM 13,000 13 d 4.3.4 
In-sewer formation of TMP 
TPs RM 13,000 13 d 4.3.4 
In-sewer formation of ROX 
TPs RM 13,000 13 d 4.3.4 
4 
In-sewer biotransformation 
with hourly pump events Pilot RM 4 8 h 4.3.5 
In-sewer biotransformation 
without pump events Pilot RM 4 6 h 4.3.5 
In-sewer biotransformation Pilot GS 4 5 h 4.3.5 
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4.3.1 Biotransformation in RM and GS 
Sewage was spiked with the target compounds dissolved in methanol (i.e., 30 
pharmaceuticals and 4 pesticides) to a final concentration of 5 or 50 µg L-1. Given that the 
added methanol in the mix was very low, i.e., ≤1 mL, it was considered that it did not affect 
the biofilms. To compare the capability of RM and GS biofilms to remove micropollutants, 
the experiments were conducted at higher initial concentration of 50 µg L-1. Although 
50 µg L-1 is higher than typically reported to occur in STP inlets, the elevated concentration 
was chosen for three reasons: i) in-sewer processes with residual pharmaceuticals and 
pesticides in the collected sewage may lower the removal efficiency, such as the 
deconjugation of human metabolites into the parent compounds or release of faeces-bound 
compounds.30 Thus, the capability of sewer biofilms to remove micropollutants from sewage 
would be obscured due to simultaneously occurring introduction mechanisms at lower 
concentrations; ii) Antibiotic consumption has been described as excessive in China. STP 
influent concentrations of fluoroquinolones were up to 2.7 µg L-1, which are likely exceeded 
in the sewer systems closer to the point of excretion; iii) Some compounds are excreted by 
up to 100% after consumption (as parent compound and metabolites), such as 
clarithromycin, ibuprofen or tramadol.25 The consumption of active ingredient per dose may 
be as low as 25 mg (tramadol) or as high as several hundred mg (acetaminophen).90 Thus, 
micropollutants concentrations in the sewer system might reach 50 µg L-1, however have 
not been captured during monitoring previously. Excreted concentrations of PhACs were 
previously reported to range between 20 mg L-1 d-1 (carbamazepine) and 469 mg L-1 d-1 
(trimethoprim),91 hence, 50 µg L-1 is not unrealistic. 
The reactors were operated with a hydraulic retention time (HRT) of 8 h. At the beginning of 
the experiments, sewage was replaced by pumping for 10 min, and samples were collected 
for the analysis of sulfur species, methane and volatile fatty acids (VFAs) and subsequent 
spiking of a micropollutant mix. Previous mixing tests demonstrated even distribution of 
micropollutants in the reactor after 10 min (data not shown), thus the concentration after 
10 min was used as initial concentration (C0) for kinetic analysis. Samples for micropollutant 
analysis were taken using a plastic syringe (Terumo, Japan), immediately frozen in two 2 
mL cryovials (Eppendorf, Germany) and subject to further analysis as described in the 
chemical analysis section. Samples for monitoring sulfur species, methane and VFAs were 
filtrated through a syringe filter (Merck millipore, 0.22 µm, PES) and subject to further 
analysis. To investigate the removal of target contaminants at more environmentally relevant 
concentration, experiments were carried out at the initial concentration of 5 µg L- 1 with active 
RM biofilm in the modified setup (Figure 8-1). Sampling was done analogously to the 
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previously described experiment, however taking 50 mL of sample for micropollutant 
analysis that were further subjected to solid phase extraction (SPE). 
4.3.2 Abiotic removal mechanism 
A reactor without biofilm was used to evaluate the removal of target pollutants by hydrolysis 
and/or sorption to the suspended solids in the sewage. In parallel, an inhibited RM biofilm 
was used to study potential sorption of the studied micropollutants. Inhibition was achieved 
using 120 mg NO2--N L-1, which was spiked 24 h prior to the experiments and a second time 
immediately after replacing all sewage in the reactor by pumping for 10 min prior to the 
experiment.92 Micropollutants were spiked at 50 µg L-1 after collecting initial samples for 
analysis of sulfur species, methane and VFAs. Further sampling was conducted for 8 h 
analogously to the biotransformation experiments in RM and GS reactors. Both reactors 
were covered in order to exclude photolysis as a removal mechanism for micropollutants. 
Inhibition tests were not performed at 5 µg L-1 in the modified setup, due to the destructive 
nature of biofilm inhibition with nitrite and the slow recovery of the biofilm.  
4.3.3 Sewer microbial community inhibition experiments 
20 pharmaceuticals and 4 pesticides were tested simultaneously in 8 h batch experiments. 
An elevated initial concentration of 50 µg L-1 was applied to surmount interference with 
desorption or deconjugation from residual micropollutants in the sewage. In order to study 
the contribution of SRB and MA biofilm communities, selective inhibiting substances were 
spiked, i.e. sodium molybdate (Mb) for the inhibition of SRB (7 mM) and sodium 2-
bromoethanesulfonic acid (BES) for the inhibition of MA (70 mM), as previously suggested 
by Sun et al. (2014).71 Interference of Mb and BES with micropollutants was negligible, as 
tested in preliminary experiments analogously to those in biofilm reactors, however in 
MilliQ® water (data not shown). 
Prior to inhibition experiments in biofilm reactors, sewage in the reactors was replaced by 
pumping for 10 min and samples taken for analysis of sulfur species, methane and VFAs. 
Mb or BES were spiked and incubated for 10 min to allow mixing. Additional experiments 
were carried out with inhibition of both, SRB and MA. Reactors that were spiked with BES 
were pre-treated with BES for 10 h (i.e. spiking of 70 mM BES 10 h prior to the experiments), 
since the inhibition of MA occurs with a lag time.93 After the incubation of inhibitors, a mix of 
the investigated micropollutants was spiked, analogously to the biotransformation batch 
experiments (chapter 4.3.1). The concentration measured after 10 min was considered as 
initial concentration C0. Samples for micropollutant analysis were taken using a plastic 
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syringe (Terumo, Japan), immediately frozen in two 2 mL cryovials (Eppendorf, Germany) 
and subject to further analysis as described in the chemical analysis section. Samples for 
monitoring sulfur species, methane and VFAs were filtrated through a syringe filter (Merck 
millipore, 0.22 µm, PES) and subject to further analysis.  
4.3.4 Transformation products of trimethoprim and roxithromycin 
To elucidate the biotransformation pathways of ROX and TMP, batch experiments were 
conducted at higher initial concentration (i.e., 13 mg L-1) and prolonged retention time (i.e. 
13 days). The experimental setup (Figure 8-2) and substrate dosing were adjusted as 
described further in the text. Raw sewage was replaced by flushing the reactors with 10 L 
of synthetic wastewater. A 200-fold concentrated stock solution of synthetic wastewater was 
prepared based on OECD guidelines94 and adapted to sulfate, acetate and propionate 
concentrations found in raw sewage (22 g yeast extract, 11.4 g K2HPO4, 23.15 g sodium 
acetate, 15.8 g sodium propionate, 14.45 ammonium sulfate, in 1000 mL tap water). 3 L of 
synthetic wastewater was prepared using autoclaved synthetic wastewater stock solution 
(0.17%, v/v) and recirculated at 500 mL min-1 between the reactors and a reservoir. In order 
to feed the biofilm, 5 mL of synthetic wastewater stock solution were dosed into the 
reservoirs every 4 h. Three reactors were operated in parallel for 13 days, with one reactor 
serving as control for the biofilm activity and potential substrate accumulation. Additional 
control reactors without biofilm were used in order to account for the hydrolysis of ROX and 
TMP at the same initial concentration of 13 mg L-1 each. The biofilm activity was assessed 
before and after the experiments, when the reactors were filled with raw sewage. In 
particular, sampling for the biofilm activity prior to the TP elucidation experiments was 
conducted prior to the replacement of sewage with synthetic wastewater. Sampling for the 
biofilm activity after the experiments were conducted just after the synthetic wastewater has 
been replaced again with collected sewage. This ensured the assessment of the biofilm 
activity in its usual environment without potential accumulation of substances from substrate 
metabolism, and containing sufficient amounts of all relevant substances. The 
biotransformation experiments aiming at the elucidation of TPs were conducted in duplicate, 
and the results are expressed as mean with standard error. Peak intensities of all TPs were 
obtained from extracted ion chromatograms (XIC) in LTQ-Orbitrap and plotted versus 
duration of the experiment. For better legibility of the plot, only the first of two experiments 
was considered.  
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4.3.5 Full-scale pilot experiments 
Batch experiments were carried out using the full-scale RM and GS pilot setup at the 
Luggage Point STP Innovation Centre. The main purpose of the experiments was to confirm 
and quantify the biotransformation of the antibiotics trimethoprim, roxithromycin, 
sulfamethoxazole and the human metabolite N4-acetyl-sulfamethoxazole. The feed 
concentrations of the compounds of interest in the pilot setup were lower than the 
concentrations observed in collected sewage for laboratory-based experiments (i.e. 
<5 µg L- 1, except caffeine, acetaminophen and iopromide), due to the lower overall 
consumption in this specific catchment, less toilet flushes of antibiotic consumers at the time 
of sewage collection or high biotransformation in the sewer catchment prior to entering the 
STP inlet. In order to ensure the occurrence of the highlighted antibiotics trimethoprim, 
roxithromycin, sulfamethoxazole and its major human metabolite, N4-acetyl-
sulfamethoxazole (as isotopically labelled compound N4-acetyl-sulfamethoxazole-d4), the 
sewage was spiked with 4 µg L-1 each. This concentration represents a simulated toilet flush 
of one consumer, distributed across the monitored sewage slug. Further targeted PhACs 
were monitored but not amended and serve as benchmarking compounds, i.e. 
carbamazepine, diclofenac, acetaminophen, caffeine and tramadol. These compounds are 
frequently monitored in chemical stability studies of human biomarkers during wastewater-
based epidemiology and serve as a comparison between studies. Furthermore, the removal 
of these compounds during sewer passage serves as an assessment of the biofilms 
capability to remove micropollutants, with acetaminophen and caffeine being easily 
degraded and carbamazepine, diclofenac and tramadol considered persistent.14,88 
Batch experiments were initiated by spiking the flow tracer rhodamine together with the 
antibiotic mix. Experiment duration, sampling times and locations depended on the pipe in 
use and the specific objective of the experiment, as described further in the text. Three sets 
of experiments were conducted: 
I. Removal in GS: Spike micropollutants; HRT 5 h with continuous recirculation of 
wastewater at a flow rate of 125 L min-1, 
II. Removal rates in RM: Spike micropollutants; HRT 8 h with 8 pump events (1 min 
pumping at 237 L min-1, 59 min between pump events); the observed wastewater slug 
proceeds by 30 m with each pump event, 
III. Removal rate variation depending on biofilm activity: Spike micropollutants; HRT 6 h 
with one pump event (8 min pumping at 275 L min-1, 6 h between pump events); the 
observed wastewater slug spreads across the entire pipe length, as all wastewater is 
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replaced. Biofilm activity and micropollutant removal monitored at three sampling 
locations. 
Sampling was conducted frequently at various times at the sampling locations presented in 
Table 4-2. Due to the high frequency of sampling (i.e. 5 min to 60 min), single samples were 
collected. All samples were analysed for pH, temperature, sulfur species, methane, VFAs 
and micropollutants as described in the chemical analysis. In addition, online sensors were 
used to monitor concentrations of rhodamine (CYCLOPS-7 with rhodamine WT optics and 
logger, Aqualab scientific Pty Ltd., Australia), bisulfide and pH (spectro::lyser™ and 
pH::lyser™, s::scan, Austria). Bisulfide and pH measurements were used to monitor the 
activity of the biofilm on-site only. Biofilm activity data presented in the results section were 
derived from the posterior analysis of sulfur species as described in the chemical analysis 
section (4.4). 
 
Table 4-2: Sampling periods and locations during experiments in RM and GS sewer pilot 
pipes. Sampling locations are relative to the feed, i.e. wastewater inlet. Sampling periods 
(i.e. HRT) indicate the period during the experiment during which the wastewater carried the 
spiked rhodamine and micropollutants at the corresponding location. “s:scan” refers to the 
location of online bisulfide and pH measurement during the entire experiment. “R” indicates 
the location of online rhodamine measurement at the time of sampling. 
Sampling location 
(relative to feed) 
I. GS II. RM III. RM 
4 m s:scan s:scan  
#1 - 15 m  HRT 1; R HRT 1-6; R 
#2 - 45 m  HRT 2; R  
#3 - 75 m  HRT 3; R  
#4 - 105 m  HRT 4; R HRT 1-6; R 
#5 - 135 m  HRT 5; R  
#7 - 195 m  HRT 7; R  
#B7 - 210 m   HRT 1-6; R 
280 m  HRT 8; R; s:scan HRT 1-6; R; s:scan 
300 m HRT 1-5; R   
Total HRT 5 h 8 h 6 h 
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Online measurement of rhodamine yielded a stable rhodamine signal between pump events 
in RM, confirming that rhodamine is not degraded by the sewer biofilm. However, decreasing 
rhodamine concentrations up to 50% were observed after the sewage slug has been moved 
by a pump event. Decreasing rhodamine concentrations suggest the dilution and widening 
of the monitored wastewater slug during pump events, resulting in decreasing micropollutant 
concentrations due to dilution. In order to focus on the biotransformation of micropollutants, 
rather than their dilution, the ratio of rhodamine concentration in the sample vs. the initial 
rhodamine concentration was used to normalise the concentration of spiked micropollutants 
and their suspected transformation products (Eq. 4-1): 
' =	()*,' 	× 		,,-	,,.     (Eq. 4-1) 
Where Ct is the normalised micropollutant concentration at time t [µg L-1], Craw,t is the 
measured micropollutant concentration at time t [µg L-1], CR,0 is the stable rhodamine 
concentration at time 0 [mg L-1] and CR,t is the rhodamine concentration at time t [mg L-1]. 
Monitoring of the rhodamine concentration during GS operation was advantageous for the 
localisation of the spiked rhodamine and micropollutant mix. Due to the recirculation of 4 m3 
of sewage, even distribution of sewage across the GS pipe was only achieved after 1.5 h. 
Analogously to micropollutant concentrations in RM, the ratio of rhodamine concentration in 
the sample vs. the stable rhodamine concentration after 1.5 h was used to normalise the 
micropollutant concentrations (Eq. 4-2): 
' =	()*,' 	× 		,,/.12	,,.      (Eq. 4-2) 
Where Ct is the normalised micropollutant concentration at time t [µg L-1], Craw,t is the 
measured micropollutant concentration at time t [µg L-1], CR,1.5h is the stable rhodamine 
concentration after 1.5 h [mg L-1] and CR,t is the rhodamine concentration at time t [mg L-1]. 
Micropollutants that were monitored without spiking were not normalised, as the 
neighbouring sewage slugs as assumed to contain similar concentrations of these 
compounds. Chemical analysis of micropollutants (with prior extraction), sulfur species, 
methane and VFAs was performed as described in the chemical analysis section. 
4.4 Chemical analysis 
4.4.1 Analysis of biofilm activity parameters 
For analysis of sulfur species, 1.5 mL of filtrated sample were added to 0.5 mL sulfide 
antioxidant buffer containing ascorbic acid and sodium hydroxide. 2 mL glass vials 
containing a glass bead each were used and sealed with split lids. Samples were kept at 
Biotransformation of micropollutants in sewers –Materials and methods | 39  
4°C and measured within 4 days using a Dionex ICS-2000 ion chromatograph with an AD25 
absorbance (230 nm) and DS6 heated conductivity detector (35°C). Chromatographic 
separation was achieved using an IonPac AS18 (4x250 mm) column.95 Filtrated samples for 
methane analysis were injected into 12 mL evacuated glass vials (039W, Labco Limited, 
UK). The gas phase was analysed after equilibration with 99.999% nitrogen (BOC gases, 
Brisbane, Australia) at room temperature using a gas chromatograph (Agilent GC7890A, 
Agilent Technologies, USA) equipped with a flame ionisation detector. Chromatographic 
separation was achieved using a Supelco 6 feet x 1/8-inch steel packed column (HayeSep 
Q 80/100). Calculations using Henry’s law yielded the concentration of methane in the liquid 
phase.71 Measured VFAs contain acetate, propionate, valerate and butyrate. 0.9 mL filtrated 
sample were added to 0.1 mL formic acid in a vial with septum lid. Concentrations were 
measured using gas chromatograph (Agilent GC7890A, Agilent Technologies, USA) 
equipped with a flame ionisation detector. Chromatographic separation was achieved using 
a polar capillary column DB-FFAP 30m x 0.53 x 1 µm (Agilent Technologies, USA).10  
 
4.4.2 Analysis of micropollutants  
Samples for micropollutant analysis were centrifuged (Eppendorf Centrifuge 5424, rotor FA-
45-25-11, 20238xg, 3 min) and the supernatant spiked with a mix of deuterated standards 
to yield a final concentration of 50 µg L-1. Samples from experiments with initial concentration 
5 µg L-1 were concentrated by solid-phase extraction prior to analysis. Liquid 
chromatography-mass spectrometry (LC/MS/MS) analyses of micropollutants were 
performed using a Shimadzu liquid chromatograph (Shimadzu, Japan) coupled with a 4000 
QTRAP quadrupole-linear ion trap mass spectrometer (QqLIT-MS) equipped with a Turbo 
Ion Spray source (Applied Biosystems-Sciex, USA).  
 
Solid-phase extraction (SPE) 
For experiments that required solid-phase extraction, 3 x 50 mL samples were analysed per 
sampling. The method has been adapted from Gros et al.96 After defrosting. Samples were 
vacuum filtrated through 1 µm glass fiber filters and 0.45 µm nylon membrane (Whatman, 
UK), spiked with EDTA to yield a final concentration of 0.01% and stirred for 30 min. For 
pre-concentration and extraction, Oasis HLB cartridges (200 mg) were used in a Baker 
vacuum system (J.T.Baker, The Netherlands). Cartridges were conditioned with 2 x 5 mL 
methanol and subsequently rinsed with 2 x 5 mL MilliQ water, both without application of 
vacuum. Samples were loaded onto the cartridges at 1 mL min-1. After extraction, cartridges 
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were rinsed with 2 x 5 mL MilliQ water and dried using the vacuum system, to remove excess 
water. Samples were eluted with 2 x 5 mL methanol and 2 x 5 mL Hexane/Acetone (1:1) 
and solvents evaporated to dryness in a Turbovap®LV (Biotage, Sweden) at 40°C and 
<2.5 psi. Samples were reconstituted with 1 mL of methanol/ water (25:75, v/v). Finally, a 
mix of all deuterated standards in Table 8-2 was added to yield a final concentration of 
50 µg L-1 in each sample. 
 
Micropollutant analysis using UPLC-ESI-MS/MS (4000 qTRAP) 
Liquid chromatography-mass spectrometry (LC-MS) analyses of MPs were performed in a 
multiple reaction monitoring (MRM) mode using a Shimadzu Prominence ultrafast liquid 
chromatography (UFLC) system (Shimadzu, Japan) coupled with a ABSciex 4000 QTRAP 
triple quadrupole-linear ion trap mass spectrometer (QqLIT-MS) equipped with a Turbo Ion 
Spray source (Applied Biosystems-Sciex, USA). Chromatographic separation was 
accomplished using an Alltima C18 column (5 µm; 4.6 mm x 250 mm) and ESI positive mode 
for the majority of compounds, with 10 compounds in ESI negative mode. In ESI positive 
mode, mobile phases were 95% acetonitrile with 0.1% with formic acid in HPLC grade water 
(A) and 1% acetonitrile and 0.1% formic acid in HPLC grade water (B). The gradient elution 
at a flow rate of 1 mL min-1 was: initial conditions 5% A; 0.5-5 min, 5-60% A; 5-13 min, 60-
90%; 13-15 min, 90-100%; 17-18 min, return to initial conditions; 18-23 min, equilibration of 
the column. In ESI negative mode, mobile phases were acetonitrile/methanol (1:1; v/v) (A) 
and 5% acetonitrile/methanol (1:1; v/v) with 1 mM ammonium acetate in HPLC grade water 
(B). The gradient elution at a flow rate of 1 mL min-1 was: initial conditions 5% A; 0.5-7 min, 
5-90% A; 10-12 min, 90-100%; 15-16 min, return to initial conditions; 16-21 min, equilibration 
of the column. Precursor ions and MRM transitions, expressed as their mass-to-charge ratio 
m/z were used with MS method parameters declustering potential (DP), collision energy 
(CE) and cell exit potential (CXP) and displayed in Table 8-2. Entrance potential (EP) was 
set at 10 for all analytes. The following source-dependent parameters were applied: curtain 
gas (CUR), 30 V; nitrogen collision gas (CAD) high; source temperature (TEM) was 700◦C; 
ion spray voltage was 5500 V in ESI positive mode and -4500 V in ESI negative mode; ion 
source gases GS1 and GS2 were set to 50 V. Quantification using an eight point calibration 
curve was done using Analyst 1.5.1 software. 
 
Trimethoprim and roxithromycin analysis using HPLC-ESI-MS/MS (5500 qTRAP) 
During TP elucidation experiments performed at ICRA (Girona, Spain), Trimethoprim and 
roxithromycin quantification was performed in MRM mode using a Waters Acquity Ultra-
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PerformanceTM liquid chromatograph (Milford, MA, USA) coupled with a 5500 QTRAP 
QqLIT-MS equipped with a Turbo Ion Spray source (Applied Biosystems-Sciex, USA). Only 
ESI positive mode was applied after chromatographic separation using an Acquity Ultra-
PerformanceTM liquid chromatography (UPLC) C18 column (50 mm x 2.1 mm, 1.7 mm). The 
mobile phases were acetonitrile (A) and HPLC grade water acidified at 0.1% with formic acid 
(B). The gradient elution at a flow rate of 0.3 mL min-1 was: initial conditions 3% A; 0-7 min, 
3-60% A; 7-9 min, 60-100%; 12-12.1 min, return to initial conditions; 12.1-13 min, 
equilibration of the column. Precursor ions and MRM transitions, expressed as their mass-
to-charge ratio m/z were used with DP, CE and CXP (in this order) for ROX, TMP and their 
corresponding deuterated standards: TMP m/z 291.02  m/z 230.20 (91-33-12), m/z 291.02 
 m/z 261.0 (31-35-10); ROX m/z 837.38  m/z 158.00 (91-43-14), m/z 837.38  m/z 
679.0 (91-31-26). EP was set to 10 V. Source-dependent parameters CUR, CAD and TEM 
were 30 V, medium and 650 °C, respectively with ion spray voltage of 5500 V and ion source 
gases GS1 and GS2 set to 60 and 50 V. Quantification using an eight point calibration curve 
was done using Analyst 1.5.1 software. 
 
4.4.3 Analysis of transformation products 
For structural elucidation of TPs a quadrupole-Orbitrap mass spectrometer (Q Exactive 
Orbitrap™, Thermo Scientific, Waltham, MA, USA) with an electrospray ionization (ESI) 
interface was used. Mass calibration and mass accuracy checks were performed prior to 
every sample sequence. The instrument was calibrated using the manufacturer's calibration 
solution (containing caffeine, tetrapeptide MRFA, and a mixture of fluorinated phosphazines 
ultramark 1621). Mass accuracy was always within ±5 ppm. The mass spectrometer 
acquired full scan data within a range of m/z 50–1000 at a resolving power of 60,000 FWHM 
with additional recording of MS/MS spectra of TMP, ROX and their identified TPs, using 
normalized collision energies (NCE) of 25 and a resolution of 35,000 FWHM. In all MS/MS 
modes, the isolation window of the quadrupole was set to 1.0 Da. Data-dependent analysis 
was triggered by using an underfill ratio of 5% and a dynamic exclusion of 5 s, the intensity 
threshold was set to 8.3 x 104 and the appex trigger was activated. Chromatographic 
separation was accomplished using an Acquity Ultra-PerformanceTM liquid chromatography 
(UPLC) C18 column (50 mm x 2.1 mm, 1.7 mm) and mobile phases acetonitrile (A) and 
HPLC grade water acidified at 0.1% with formic acid (B). The gradient elution at a flow rate 
of 0.3 mL min-1 was: initial conditions 3% A; 0-1 min, 3-50% A; 1-6 min, 50-95%; 8-10 min, 
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return to initial conditions; 10-12 min, equilibration of the column. Chromatographic analysis 
and data interpretation was performed using XCalibur™ 2.2 (Thermo Scientific) software. 
 
4.5 Data analysis 
4.5.1 Kinetic parameter fitting 
Production rates of methane and sulfide-S, as well as consumption of sulfate-S and VFAs 
were calculated using linear regression in GraphPad PRISM 7.00. The studied 
micropollutants were not fully removed, but plateaued at a concentration >0. Data was fitted 
to a first-order model (Eq. 4-3)97 in AQUASIM 2.1d, using the rate law as depicted in Eq. 4-
4. 
' = (3 −	5) × 6%7' +	5    (Eq. 4-3) 
	
' = −8 × (' −	5)     (Eq. 4-4) 
Where Ct is the compound concentration at time t, C0 the compound concentration at time 
0, corresponding to 10 min after spiking, and Cp the compound plateau concentration (all in 
µg L-1). The first-order kinetic rate constant k (h-1) was normalised to each reactors A/V, 
where mentioned in the result chapters.88 Coefficients kn were determined per reactor using 
their corresponding A/V (Eq. 4-5). Reactors without biofilm were not normalised. 
89 = 	8	 × 	
:;<=;
>?@ABC
     (Eq. 4-5) 
Removal (R) represents the ratio of difference between initial and plateau concentration per 
initial concentration and is expressed as per cent. Concentrations of compounds that did not 
reach Cp after 8 h were interpolated using the fitted kinetic coefficients. The normalised 
removed fraction Rn was calculated as below: 
D9 = E1 −	
	G
	-
H 	×	 :;<=;>?@ABC     (Eq. 4-6) 
Ratios of removal in GS reactors vs. RM reactors or inhibited RM biofilm vs. active RM 
biofilm were calculated as quotient, with removal in active RM biofilm reactors as 
denominator and expressed as ηg and ηs (dimensionless), respectively. 
During full-scale pilot experiments, the concentrations of the studied micropollutants 
converged towards 0, hence Cp was set to 0 in Eq. 4-3. 
All results are composed of mean and standard error of triplicate experiments and displayed 
using GraphPad PRISM 7.00. 
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4.5.2 Statistical analysis 
All linear regression analyses were performed using GraphPad PRISM 7.00. Multiple t-tests 
were used to determine statistically significant (p<0.05) differences between the different 
experiments using GraphPad PRISM 7.00. All results are composed of mean and standard 
error of triplicate experiments, unless otherwise stated. 
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5 Results and Discussion 
5.1 Fate and behaviour of key micropollutants in rising main and gravity sewers 
In order to understand the fate and behaviour of PhACs and pesticides in RM and GS 
environments, the removal mechanisms of a wide range of compounds were studied during 
systematic laboratory-based experiments. Also, the different removal capabilities of RM and 
GS biofilms will be discussed in this chapter. 
The results in this chapter were obtained during biotransformation experiments (chapter 
4.3.1) and abiotic removal experiments (chapter 4.3.2) in the setup described in chapter 
4.2.1. An overview of removal efficiencies and removal rate constants by all active biofilms 
in this chapter can be viewed in the appendix, Figure 8-6 and time series in Figure 8-7. 
 
5.1.1 Activity of microbial biofilm communities 
The biofilms in RM and GS reactors were active and mimicked in-sewer processes well, as 
indicated by the production of sulfide and methane and the conversion of VFAs.  
SRB were active in all biofilm reactors. Sulfide production did not differ significantly between 
RM and GS with higher biofilm area to sewage volume ratio (A/V) of 55 and 50 m2 m-3 
(i.e.  48.8±10.6 and 63.0±9.0 mgS2--S m-2 h-1, respectively) (Figure 5-1). The observed 
sulfide production rates are in accordance with previously reported sulfide production in full-
scale/lab-scale.71 Compared to RM with higher A/V (i.e. 55 m2 m-3), RM with lower A/V of 
33 m2 m-3 exhibited three times higher sulfide production and acetate consumption rates 
(181.9±48.7 mgS2--S m-2 h-1 and 276.1±8.1 mgCOD m-2 h-1, respectively). Tripled sulfide 
production and acetate consumption rates can be attributed to the tripled biofilm surface 
area in the setup with lower A/V and the high abundance of available substrate, i.e. sulfate 
and VFAs. Furthermore, SRB were shown to populate the biofilm layer closest to the 
sewage, which facilitates the substrate uptake.71  
Methane production was ten times lower in GS than in RM reactors 
(75.7±34.6 mgCOD m- 2 h-1 vs. 671.3±71.7 mgCOD m-2 h-1), which suggest a less active MA 
community in GS. Significantly lower methane production in the GS than in the RM reactor 
has also been observed in previous lab-based studies.16 In RM with lower A/V, methane 
production rate was similar to the rates observed in RM with higher A/V. Possibly, MA were 
outcompeted for substrate by the highly active SRB.71  
In absence of biofilm, sulfidogenesis and methanogenesis were not observed. However, 
consumption of low amounts of VFAs was likely the result of heterotrophic activity (appendix, 
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Figure 8-8). Inhibited RM biofilm did not exhibit significant activity and is representative of 
inactive biofilm. Potential residual activity could derive from autotrophic CO2 or H2-
consuming organisms or heterotrophic denitrifying organisms. The specific activity of these 
organisms was not monitored and cannot be excluded, however sulfide and methane 
production rates prior to normalisation by A/V ratio were comparable or lower than in the 
control and therefore represent and inactive biofilm. The evolution of concentrations of sulfur 
species, methane and VFAs during the experiment duration of 8 h in all reactors can be 
viewed in the appendix (Figure 8-8 and Figure 8-9). 
 
Figure 5-1: Sulfur species, methane and VFA production rates suggest active biofilm 
microbial community in GS and RM with different A/V ratios. Inhibited RM biofilm has an A/V 
ratio of 55 m2 m-3. 
 
5.1.2 Micropollutant removal mechanism in RM sewer 
PhAC and pesticide removal in biofilm reactors is attributed to biotransformation and 
sorption to the biofilm. LogKOW > 3 for 11 investigated compounds and LogD (pH 8.0) > 2.5 
for 5 compounds suggest sorption, such as adsorption or absorption, as an important in-
sewer removal mechanism. In contrast to sorption protocols reported in literature, that 
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require freeze-drying and resuspension of disrupted biomass ex situ, sorption experiments 
in this section were carried out in situ, which was beneficial for the investigation of sorption 
without disrupting the biofilm. However, estimation of partitioning coefficients Kd was not 
feasible due to the destructive nature of biomass quantification, thus literature values only 
serve as comparison for trends within micropollutant groups. Hydrolysis and sorption to 
particulate matter in sewage play a minor role, as indicated by experiments using sewage 
in a reactor without biofilm (appendix, Figure 8-10 and Figure 8-11). Given the low Henry´s 
law coefficients of the target pollutants (Table 8-1), their removal due to volatilization was 
unlikely. All reactors were covered during operation, hence photolysis can be excluded as 
potential removal mechanism.  
Removal of micropollutants was significantly lowered when RM biofilm was inhibited 
compared to active RM biofilm. Thirteen compounds exhibited removal by inhibited biofilm 
(normalised by A/V) of <0.3 m3 m-2, corresponding to 20% relative to the initial concentration 
(Figure 5-2). Lower overall micropollutant removal by inhibited biofilm compared to active 
biofilm, was confirmed by linear regression, yielding a slope of 0.57 in a moderate significant 
trend, (R2=0.41; p<0.0001). Positive slopes with negative y-intercept suggest increasing 
proportion of removal by inactive biofilm, i.e. through sorption, with increasing overall 
removal, as occurring in reactor with active biofilm. However, a comparative assessment of 
the first-order rate constants did not yield increasing rate constants of inhibited biofilm with 
increasing rate constants of active biofilm (Figure 8-12). 
Compounds with high ratios of removal by inhibited RM biofilm vs. active RM biofilm (ηs>0.8) 
were removed by sorption as a major mechanism. Seven out of eight sorbed compounds 
were cationised at pH 8, such as propanolol, ranitidine, fluoxetine, lincomycin, sertraline, 
erythromycin and the zwitterionic compound enrofloxacin. Possibly, cationised ion species 
are subject to electrostatic interactions with the negatively charged biofilm surface, as 
previously observed for pharmaceutical sorption in MBBR.98 High Kd values were observed 
for fluoxetine and sertraline in primary and secondary sludge in CAS at pH 8 (i.e. 
8.7±1.6 L g- 1 and 26±4 L g-1, respectively).99 Fluoroquinolones, such as enrofloxacin, were 
zwitterionic at experimental pH of 8. With sorption previously identified as the major removal 
mechanism for structurally similar norfloxacin, ofloxacin and ciprofloxacin, this likely applies 
for enrofloxacin as well.100 However, the cationised compounds roxithromycin, atenolol, 
venlafaxine and tramadol exhibited low sorption affinity (ηs<0.5), suggesting that further 
driving mechanisms to electrostatic interactions are involved during sorption. 
The cardiovascular drug propanolol exhibited exclusive removal by sorption (ηs=1). The 
lipophilicity of propanolol allows the passage of the human blood-brain barrier and is 
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essential for the exertion of its pharmacological activity.101 In contrast, the structurally similar 
cardiovascular drug atenolol exhibited low sorption, i.e. ηs<0.5. Higher sorption of propanolol 
compared to atenolol by up to one order of magnitude have been previously observed in 
MBBR98 and MBR.50 High sorption of the sulfonamide antibiotic sulfasalazine (ηs>0.8) was 
in contrast to low or negligible reported sorption of sulfamethoxazole and sulfadiazine in 
other biological systems (i.e. MBBR,98 MBR50,99,102 and activated sludge99). Sulfasalazine, 
unlike the other sulfonamides, contains an azo bond (R’-N=N-R). Significant sorption of 
compounds with azo bonds to biomass has previously been reported and is understood to 
precede biotransformation by active biomass.103 Similarly, the most lipophilic pesticide, i.e. 
metolachlor, yielded the highest removal by sorption among the investigated pesticides, 
however with ηs<0.5. Other pesticides residues in sewage, for instance from food 
preparation or excretion after consumption with food, might sorb to sewer biofilm as well, 
which requires further attention. 
Compounds with large molecular weight exhibited low or negligible sorption, as observed 
for the macrolide antibiotic roxithromycin and the radiocontrast agent iopromide. Based on 
Lipinski’s “rule of five”, the drug-likeness of a compound decreases with a molecular weight 
>500 g mol-1 due to limitations of diffusion through tissue.104 Furthermore, a recent study 
has shown that micropollutant sorption and diffusion through biofilm in a MBBR are limited 
by biofilm porosity,98 which may have limited the penetration of roxithromycin and iopromide 
through the biofilm in this study as well. 
Negligible sorption of diclofenac, tramadol, ibuprofen, sulfadiazine and iopromide 
(<0.3 m3 m- 2, ηs<0.5) is in accordance with the previously reported low removal of tramadol 
and diclofenac in sewers88 and negligible removal of ibuprofen, sulfadiazine and iopromide 
in MBBR.98 In contrast, relative sorption of acetaminophen was higher than sorption 
observed for other analgesics (ηs=0.6). In literature, higher sorption of acetaminophen was 
reported for activated sludge7,105 than for MBRs7 and anaerobic MBR.57 Sorption of 
carbamazepine and caffeine in this study was <0.5 m3 m-2, which corresponds to <30% 
relative removal by inhibited biofilm. Although these values are higher than the previously 
reported negligible sorption of carbamazepine and caffeine by sewer biofilm,88 sorption can 
be considered a minor removal mechanism for these compounds. Higher observed sorption 
in this study compared to data from literature might be attributed to differences in the 
biomass, such as microbial community, biofilm thickness and density or other properties of 
the extracellular polymeric substance.  
48 | 
 
Figure 5-2: Comparative assessment between normalised removals of micropollutants by 
active RM biofilm (x-axis) vs. inactive RM biofilm (y-axis). Micropollutants have been 
arranged by their lipophilicity (LogD>1.8: circles; LogD<1.8: triangles), charge at pH 8 
(cationic: yellow; anionic: black; neutral: white) and molecular weight (MW>500 Da: thick 
symbol outline). The diagonal dotted line denominates a slope of 1, representing identical 
removal by active and inactive biofilm. Error bars that exceed the graph area were cropped. 
Numbers in or next to the symbols refer to the displayed micropollutant: 1-iopromide, 2-
ibuprofen, 3-perindopril, 4-sulfamethoxazole, 5-gemfibrozil, 6-diclofenac, 7-tramadol, 8-
atenolol, 9-venlafaxine, 10-hydrochlorothiazide, 11-DEET, 12-phenytoin, 13-
carbamazepine, 14-erythromycin, 15-dapsone, 16-lincomycin, 17-propanolol, 18-sertraline, 
19-doxylamine, 20-roxithromycin, 21-fluoxetine, 22-ranitidine, 23-trimethoprim, 24-2,4-D, 
25-atrazin, 26-caffeine, 27-acetaminophen, 28-metolachlor, 29-sulfasalazine, 30-
enrofloxacin, 31-diuron, 32-sulfadiazine. 
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5.1.3 Removal capability of rising main and gravity sewer biofilm 
Micropollutant removal was significantly enhanced in the presence of active RM and GS 
biofilm compared to inactive biofilm. Moreover, RM biofilm exhibited higher removal 
efficiencies than GS biofilm for the majority of micropollutants, as indicated by a comparative 
assessment of micropollutants removal efficiencies in GS vs. RM (Figure 5-3). The removal 
of target pollutants by GS biofilm was between 9% (sulfamethoxazole, corresponding to 
0.18±0.03 m3 m-2 removal normalised to A/V) and 96% (sulfasalazine, 1.92±0.81 m3 m-2). In 
comparison, the lowest removal in RM was significantly higher than the lowest removal in 
GS, i.e. 15% (sulfadiazine, 0.27±0.01 m3 m-2). The highest removal in RM was obtained for 
acetaminophen, i.e. 99% (1.80±0.31 m3 m-2). Linear regression of all data points revealed a 
significant trend (p<0.05, R2=0.72) with a slope close to 1. The negative y-intercept of -0.2 
confirms overall lower removal in GS (y-axis) than in RM (x-axis) (Figure 5-3). In contrast to 
removal efficiencies, first-order kinetic rate constants in RM and GS did not differ 
significantly. The lowest rate constants were observed for iopromide in RM and GS 
(1.6±0.9 x 10-3 and 0.6±0.4 x 10-3 m3 h-1 m-2) and the highest for sulfasalazine in RM 
(34.6±19.8 x 10-3 m3 h-1 m- 2) and fluoxetine in GS (39.4±22.8 x 10-3 m3 h-1 m-2)(Figure 
8-6  B). A comparative assessment of first-order rate constants did not yield significant 
trends (Figure 8-13). An overview over all removal efficiencies and first-order kinetic rate 
constants can be found in the appendix, Figure 8-6. 
Similar removal in GS and RM was observed for compounds that are prone to sorption. 
Propranolol, sulfasalazine, ranitidine, fluoxetine, sertraline and enrofloxacin in RM were 
mostly removed by sorption (>80%) and had ratios of removal in GS vs. RM (ηg) of 0.8 to 
1.3. With similar biofilm surface area in the GS and RM reactor, removal of these compounds 
under GS conditions possibly occurred by sorption as well. Similar removal by GS and RM 
biofilm, i.e. with ηg of 0.8 to 1.3, was also observed for the analgesics acetaminophen, 
indomethacin and diclofenac. Almost complete removal of acetaminophen (i.e. >99% after 
8 h) was previously observed in laboratory-scale GS and RM biofilm reactors.17 The removal 
of diclofenac and indomethacin by <40% and <44%, respectively, exceeded literature values 
for their removal in full-scale RM (~-10% and ~-20%, respectively).18 The removal 
efficiencies reported in literature may be lowered due to in-sewer transformation of human 
metabolites into the parent compounds. However, elevated concentrations used in this study 
demonstrate the capability of RM and GS biofilm to also remove diclofenac and 
indomethacin. Significantly higher removal of diclofenac was previously reported in other 
anaerobic or partially anaerobic biological systems, such as anaerobic digestion (<60%)52–
55
 and the subsurface treatment of groundwater (~30%),61 while the removal of indomethacin 
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during AD by 30% was similar to its removal in this study.54 The capability to remove these 
compounds in other anaerobic environments suggests the general potential of RM and GS 
biofilm communities to remove these compounds as well. 
In comparison to GS, RM exhibited higher removal of compounds that are considered 
persistent during aerobic CAS treatment. For instance, average removal of carbamazepine, 
tramadol and the macrolide antibiotics erythromycin and roxithromycin was reported 
between 18% and 32% during CAS treatment.30 In RM, removal of these compounds was 
between 30% and 55% (i.e. 0.54 to 1.00 m3 m-2), which clearly exceeded their removal in 
GS (i.e. between 18% and 24%; corresponding to 0.36 to 0.48 m3 m-2) (Figure 5-3). Lower 
or negligible removal was previously reported for carbamazepine in laboratory-scale RM 
and GS, i.e. <10%,17 and tramadol in full-scale.88 The biotransformations of roxithromycin 
and erythromycin were previously not studied in RM or GS conditions, however their removal 
exceeded 85% and 50%, respectively, during anaerobic digestion.52–55 The average removal 
efficiencies of the antibiotics sulfamethoxazole and trimethoprim in CAS were 52% and 40%, 
respectively, with negative removal observed for both compounds.30 Sulfamethoxazole 
removal in RM and GS in this study was lower, i.e. 28% and 9%, respectively. However, 
positive removal of sulfamethoxazole in this laboratory-based study exceeded the negative 
removal observed in full-scale RM, i.e. -66%.18 Similarly, trimethoprim removal in RM and 
GS was 69% and 40%, respectively, and exceeded the negative removal by -20% in full-
scale RM.18 During anaerobic treatment, however, removal efficiencies of sulfamethoxazole 
and trimethoprim exceeded 90% and were correlated with methanogenic activity.58 Possibly, 
the removal efficiency of sulfamethoxazole and trimethoprim was lowered in full-scale due 
to the deconjugation of human metabolites during sewer passage. With MA being more 
active in RM than in GS, higher removal of sulfamethoxazole and trimethoprim in RM than 
in GS may be attributed to methanogenic activity. 
Only three halogenated compounds exhibited similar removal in RM and GS (i.e. diclofenac, 
indomethacin and fluoxetine) as discussed in the previous paragraphs. Nine other 
halogenated compounds exhibited higher removal in RM than in GS, i.e. up to 24% higher 
for the fluorinated fluoroquinolone antibiotics, 38% higher for iopromide and 23-63% higher 
for chlorinated compounds (pesticides, sertraline, hydrochlorothiazide) (Figure 5-3). In 
addition to reactions that may occur under both aerobic and anaerobic conditions (enzymatic 
transformation, hydrolysis), in strictly anaerobic conditions halogenated contaminants can 
also undergo reductive dehalogenation.106 
Higher removal in RM than in GS was likely caused by differences in biofilm microbial 
community. Both reactors were maintained equally, however the GS reactor was exposed 
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to atmosphere, which allows oxygen to partition into the bulk liquid via the water surface. 
Possibly, a vertical oxygen gradient in GS facilitated the development of a different microbial 
community than in RM. Furthermore, GS biofilm was previously shown to exhibit higher 
biomass growth rates than RM biofilm, which facilitates the growth of facultative anaerobic 
microorganisms compared to obligate anaerobic organisms.15 With similar sulfide 
production in both reactors, but significantly lower methane production in GS (Figure 5-1), 
lower micropollutant removal efficiencies in GS possibly lacks the contribution of the active 
methanogenic microbial community. Thus, higher micropollutant removal efficiencies in RM 
than in GS may be attributed to the different redox state in RM and GS biofilm reactors.  
In comparison with removal in full-scale, different removal efficiency could be due to 
operational differences between full-scale sewers and our laboratory-based setup: In the 
laboratory setup, the sewage was mixed continuously to obtain even distribution and 
representative samples. Mixing of wastewater in full-scale occurs mainly during pump 
events. Between two pump events the biofilm is only exposed to and able to remove 
micropollutants in its vicinity, which leads to concentration gradients across the cross-
section of sewer pipes with larger diameter, with the highest micropollutant concentration 
expected in the centre of the pipe. The PhAC removal efficiencies reported by Jelić et al. 
(full-scale RM with a diameter of 500 mm)18 are therefore exceeded by our laboratory-based 
setup (diameter 80 mm), which represent sewer pipes with smaller diameter. The 
importance of sewer pipe diameter with regard to contact of micropollutants with the biofilm 
on the pipe walls was previously acknowledged in reports about laboratory-scale and full-
scale sewer systems.17,88 Other operational factors that may affect micropollutant removal 
efficiencies in sewers are the adaptation of the biomass to the micropollutants or hydraulic 
retention time within the pipe. The biomass can be considered equally adapted in full-scale 
and laboratory-scale (both are continuously exposed to sewage that contains 
micropollutants), while HRT was adapted in laboratory-scale to match HRT in full-scale. 
Thus, biomass adaptation and HRT are not expected to influence the differences in removal 
efficiencies between laboratory-scale and full-scale. 
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Figure 5-3: Comparative assessment between normalised removals of micropollutants in 
RM (x-axis) and GS sewer biofilms (y-axis). The diagonal dotted line denominates a slope 
of 1, representing identical removal by RM and GS biofilm. Error bars that exceed the graph 
area were cropped. Numbers in or next to the symbols refer to the displayed micropollutant: 
1-DEET, 2-carbamazepine, 3-phenytoin, 4-caffeine, 5-diuron, 6-2,4-D, 7-atrazin, 8-
metolachlor, 9-sertraline, 10-venlafaxine, 11-fluoxetine, 12-perindopril, 13-
hydrochlorothiazide, 14-gemfibrozil, 15-atenolol, 16-propanolol, 17-sulfadiazine, 18-
sulfamethoxazole, 19-erythromycin, 20-lincomycin, 21-dapsone, 22-roxithromycin, 23-
trimethoprim, 24-norfloxacin, 25-enrofloxacin, 26-sulfasalazine, 27-ibuprofen, 28-tramadol, 
29-diclofenac, 30-indomethacin, 31-acetaminophen, 32-doxylamine, 33-ranitidine, 34-
iopromide. 
 
5.1.4 Micropollutant removal in RM at lower initial concentration 
PhAC and pesticide removal in RM may be lowered due to simultaneously occurring 
reactions that introduce micropollutants. Previously reported mechanisms are deconjugation 
of human metabolites in the sewage or the desorption or release of faeces-bound 
compounds.18,30 At lower initial concentration, i.e. 5 µg L-1 compared to 50 µg L-1, these 
processes lead to negative removal of micropollutants. Negative removal at an initial 
concentration of 5 µg L-1 was observed for sulfadiazine, erythromycin and dapsone (i.e. -
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10%, -27% and -11%, corresponding to -0.30 to -0.81 m3 m-2, Figure 5-4). Furthermore, 
significantly lowered removal was observed for sulfamethoxazole, roxithromycin, ibuprofen 
and diclofenac in comparison with removal at an initial concentration of 50 µg L-1, i.e. 0-22% 
(0-0.66 m3 m-2) vs. 28- 55% (0.51- 1.00 m3 m- 2). Significant lowered or negative removal of 
sulfonamides, diclofenac and ibuprofen were previously attributed to deconjugation of 
human metabolites during CAS treatment30 and passage of full-scale RM sewer (e.g., 
sulfamethoxazole, irbesartan),18 while the macrolides erythromycin and roxithromycin are 
bound to faeces in the sewage and likely released during the decomposition of faecal 
matter.30 Dapsone in humans is extensively metabolised via hydroxylation, acetylation and 
conjugation, with the acetylated compound observed to partly deacetylate in the body.107 
Deacetylation or deconjugation to dapsone during sewer passage or wastewater treatment 
might also occur, however has not been reported to date.  
While the majority of compounds was removed to similar extents at initial concentration of 
5 µg L-1 and 50 µg L-1, higher removal was observed for sulfasalazine, acetaminophen, 
propranolol, ranitidine and fluoxetine at lower initial concentrations than at 50 µg L-1. These 
compound were prone to sorption at 50 µg L-1 (see chapter 5.1.2). Possibly, the enlarged 
biofilm surface area during the experiments at 5 µg L-1 offered more sorption sites within the 
biofilm for a lower concentration of micropollutants as compared to the experiments at 
50 µg L-1. However, the impact of A/V on the sorption and biotransformation of target 
pollutants remains unclear and should be further studied. 
First-order kinetic rate constants are significantly higher in RM at initially 5 µg L-1 than in RM 
at initially 50 µg L-1. Plateau concentrations at initial concentration 5 µg L-1 were reached 
rapidly for many compounds, i.e. approximation of Cp by~97% within 1.5 h, resulting in large 
errors and unreliable rate constants. Although removal rates were normalised, the increased 
biofilm surface area and decreased initial concentration of micropollutants yielded increased 
rates by a factor of 2 to13 (appendix, Figure 8-14). Higher removal rates with larger biomass-
to micropollutant ratios were obtained previously during trimethoprim removal in activated 
sludge.108  
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Figure 5-4: Comparative assessment between normalised removals of micropollutants in 
RM setups at initial concentration of 50 µg L-1 (x-axis) and 5 µg L-1 (y-axis). The diagonal 
dotted line denominates a slope of 1, representing identical removal by RM at both initial 
concentration ranges. Error bars that exceed the graph area were cropped. Numbers in or 
next to the symbols refer to the displayed micropollutant: 1-DEET, 2-carbamazepine, 3-
phenytoin, 4-caffeine, 5-diuron, 6-2,4-D, 7-atrazin, 8-metolachlor, 9-venlafaxine, 10-
sertraline, 11-fluoxetine, 12-gemfibrozil, 13-atenolol, 14-perindopril, 15-hydrochlorothiazide, 
16-propanolol, 17-dapsone, 18-erythromycin, 19-sulfadiazine, 20-sulfamethoxazole, 21-
lincomycin, 22-roxithromycin, 23-norfloxacin, 24-trimethoprim, 25-enrofloxacin, 26-
sulfasalazine, 27-diclofenac, 28-ibuprofen, 29-tramadol, 30-indomethacin, 31-
acetaminophen, 32-doxylamine, 33-ranitidine, 34-iopromide. The slope of linear regression 
was 1.73 (R2=0.75, p<0.005). 
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5.1.5 Implications 
Biotransformation was identified as dominant removal mechanism during in-sewer removal 
of the investigated compounds. However, depending on the molecular properties of a 
compound, such as lipophilic or cationised micropollutants, sorption can be an important in-
sewer removal mechanism.  
Recently published studies about in-sewer removal of micropollutants is mostly focused on 
the application of wastewater-based epidemiology (WBE) and estimation of population sizes 
using human biomarkers (i.e. illicit drugs, caffeine, carbamazepine, diclofenac). Usually, 
compounds with a removal efficiency of <20% during sewer passage are considered 
suitable as human biomarkers.14,17,88 In this study, most compounds were removed by >20% 
in laboratory-scale, which makes them unsuitable as human biomarkers in WBE, at least 
with regard to estimation population size or quantification of drug consumption within a 
population.  
The primary purpose of this objective is to enhance the fundamental understanding of in-
sewer removal mechanisms of frequently detected PhACs and pesticides, with focus on the 
removal capability of RM and GS biofilms. Further studies should include the quantification 
of in-sewer desorption, deconjugation and other mechanisms that introduce micropollutants 
into the aqueous phase.  
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5.2 Role of microbial communities for in-sewer biotransformation and the pathways 
Rising main biofilm have been shown to consist of sulfate-reducing bacteria (SRB), 
methanogenic archaea (MA) and other microorganisms, however their contribution to the in-
sewer biotransformation of micropollutants has not been elucidated previously.  
Batch experiments were performed in RM sewer biofilm reactor and data analysed 
analogously to those in objective one. In order to distinguish the contribution of sewer 
microbial communities on micropollutant removal, the selective inhibitors 2-
bromoethanesulfonic acid (BES) and molybdate (Mb) were used to deactivate MA or SRB, 
respectively, as well as both. An overview of all removal efficiencies and removal rates 
constants obtained in this chapter can be found in the appendix (Figure 8-15), as well as 
time series (Figure 8-16). 
 
5.2.1 Biofilm activity and the effective inhibition of SRB or/and MA 
Prior to inhibition, RM biofilm was active and mimicked in-sewer processes well. Biofilm 
activity was demonstrated with the production of sulfide (2.7±0.6 mgS2--S L-1 h-1) and 
methane (37.0±3.9 mgCOD L-1 h-1), as well as the conversion of VFAs (Figure 5-5). Biofilm 
activity was previously shown to be comparable with full-scale sewers (see chapter 5.1.1), 
thus, the activity of the RM biofilm is considered representative of active RM sewer biofilms. 
The residual activity after inhibition of either SRB or MA or SRB and MA simultaneously will 
be discussed further in the text. The evolutions of sulfide, methane and VFAs in the four 
studied conditions are depicted in more detail in the appendix (Figure 8-17). 
Significantly decreased methane production rates after spiking BES (i.e. 
1.8±1.1 mgCOD L- 1 h- 1) indicate an inactive MA community, while sulfide production was 
not affected (Figure 5-5). The opposite was observed after spiking Mb, thus negligible sulfide 
production and similar methane production to uninhibited RM confirmed the selective 
inhibition of SRB. Simultaneous inhibition of MA and SRB by spiking BES and Mb was 
confirmed with negligible sulfide and methane production rates (1.3±0.4 mgCOD L-1 h-1 and 
0.0±0.1 mgS2--S L-1 h-1, respectively).  
Due to the selective inhibition of SRB and MA, residual microbial activity during the inhibition 
experiments cannot be excluded. Contributing microbial communities might be located in 
the biofilm, such as fermenting organisms, or in the bulk water phase, such as autotrophic 
bacteria (CO2- or H2-consuming), however their activities were not monitored. Regardless 
of the potential activity of other microbial communities than SRB and MA, the residual 
activities are representative of effectively inhibited SRB and MA microbial communities. 
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Figure 5-5: Production rates of sulfide-S and methane-COD and conversion of VFAs in RM 
sewer biofilm reactors without inhibition (white bars), with inhibition of SRB using molybdate 
(white, hatched), inhibition of MA using BES (grey bars) and inhibition of SRB and MA 
simultaneously (grey, hatched). 
 
5.2.2 In-sewer biotransformation of PhACs and pesticides is typically driven by SRB 
and MA 
Micropollutant removal was significantly reduced after inhibition of SRB and MA compared 
to active RM biofilm without inhibition. After inhibition of SRB and MA, negligible removal 
was observed for ibuprofen, atenolol, phenytoin and perindopril, compared to removal 
efficiencies between 27% and 44% in RM without inhibition (Figure 5-6). The highest 
removal in inhibited RM was observed for acetaminophen (52.2±0.1%), which was clearly 
exceeded in active RM biofilm reactor, however the difference was not significant 
(99.1±17.1%; p=0.051). In contrast, similar removal efficiencies were obtained with and 
without inhibition for sulfamethoxazole (27.2±1.9% and 28.1±6.4%, respectively) and 
sulfadiazine (11.7±1.2% and 15.1±0.8%, respectively), suggesting that SRB and MA do not 
contribute to the in-sewer removal of these compounds. Linear regression of all removal 
efficiencies obtained in inhibited and active RM biofilm reactor yielded a fair but significant 
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trend (R2=0.34; p<0.01) with a slope of 0.31, indicating significantly lower removal 
efficiencies after inhibition of SRB and MA in comparison with uninhibited active RM. 
Moreover, a significantly lower 75%-percentile of removal (28.4%) after inhibition of SRB 
and MA compared to RM without inhibition (66.0%) demonstrate that SRB and MA 
contributed significantly to the in-sewer biotransformation of the majority of the investigated 
micropollutants.  
Residual removal observed after inhibition of the predominant biofilm microbial communities 
SRB and MA is likely a combination of sorption and biotransformation by less abundant 
active microbial communities. The abiotic removal of the investigated micropollutants by the 
employed chemical inhibitors, i.e. Mb and BES, was negligible and can be excluded as 
potential removal mechanism (data not shown). Linear regression indicated high similarities 
between residual removals after inhibition of SRB and MA and removal by sorption with a 
slope of 0.73 (R2=0.6, p<0.05) (Figure 8-18). Similar removal of 19 compounds after 
inhibition of SRB and MA to removal by sorption indicated that their residual removal after 
inhibition is likely driven by sorption. Conversely, roxithromycin, sulfadiazine, 
sulfamethoxazole, venlafaxine and diuron yielded significantly higher removal by partly 
inhibited biofilm (i.e. SRB and MA inhibited) than removal by sorption, suggesting that these 
compounds were partly removed by another biofilm microbial community than SRB and MA. 
Since selective inhibitors of SRB and MA were employed and only selected activity 
parameters monitored (i.e. sulfur species, methane and VFAs), the presence of other active 
microbial communities, such as fermenting organisms or autotrophic (H2- or CO2-
consuming) organisms, is likely.  
In summary, SRB and MA are the dominant and almost exclusive contributors to in-sewer 
biotransformation of the investigated micropollutants, with other microbial communities 
contributing to transformation of roxithromycin, sulfadiazine, sulfamethoxazole, venlafaxine 
and diuron.  
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Figure 5-6: Comparative assessment between removals of micropollutants by active RM 
biofilm (x-axis) vs. RM biofilm with inhibited SRB and MA community (y-axis). The thin solid 
diagonal line through zero denominates identical removal with and without inhibition ±10% 
difference (dashed lines). Results of linear regression were significant and are represented 
by the thick lines. Error bars that exceed the graph area were cropped. Numbers in or next 
to the symbols refer to the displayed micropollutant: 1-sulfadiazine, 2-ibuprofen, 3-
perindopril, 4-iopromide, 5-DEET, 6-diclofenac, 7-gemfibrozil, 8-sulfamethoxazole, 9-
atenolol, 10-phenytoin, 11-carbamazepine, 12-hydrochlorothiazide, 13-tramadol, 14-
dapsone, 15-diuron, 16-venlafaxine, 17-doxylamine, 18-roxithromycin, 19-2,4-D, 20-atrazin, 
21-trimethoprim, 22-metolachlor, 23-caffeine, 24-acetaminophen. 
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5.2.3 Contribution of SRB and MA to biotransformation of PhACs and pesticides  
Exclusively SRB-driven transformation was obtained for the pesticide atrazine, the 
radiocontrast agent iopromide, the insect repellent DEET and the pesticide metolachlor. 
Between 37% (atrazine) and 51% (metolachlor) lower removal after inhibition of SRB was 
observed compared to removal with uninhibited biofilm, suggesting substantial contribution 
of the SRB microbial community to the in-sewer transformation of these compounds (Figure 
5-7 A). MA did not transform atrazine, iopromide, DEET or metolachlor, as indicated by their 
similar removal efficiencies after the inhibition of MA to those obtained without inhibition. 
The information about the role of SRB in micropollutant biotransformation is limited to only 
few micropollutants, with no published studies reporting SRB-driven biotransformation in 
sewers. However, SRB populate other anaerobic environments, such as river and marine 
sediments or soil, where transformations of other homocyclic and heterocyclic compounds 
were previously observed.109–112 Atrazine was removed by 80-99% in wetland soil and soil 
slurry under sulfate-reducing conditions, which yielded the transformation products hydroxy 
atrazine, cyanuric acid and deethylatrazine, as well as partial mineralisation to ammonium 
and chloride.113,114 The transformation of metolachlor under sulfate-reducing conditions in 
soil and soil slurry yielded removal >75% and the transformation products ethanesulfonic 
acid and oxanilic acid.114 Anaerobic post-treatment of activated sludge under sulfate-
reducing conditions yielded removal of iopromide by ~30%,115 which is twice as high as 
observed in this study, possibly due to the lower biomass concentration of sewer biofilms 
compared to suspended sludge.  
The removals of the antibiotic trimethoprim and the cardiovascular drug atenolol were 
exclusively driven by the MA microbial community. Significantly lowered removal efficiencies 
by 49% (trimethoprim) and 92% (atenolol) were yielded after inhibition of MA compared to 
uninhibited biofilm, while the inhibition of SRB was comparable to removal without inhibition 
(Figure 5-7 B). Methanogenic environments were previously shown to be beneficial for the 
transformation of trimethoprim and atenolol. Trimethoprim removal efficiencies reached over 
90% during anaerobic digestion52–55,116 or in upflow anaerobic sludge blankets (UASB),58 
and were linked with methanogenic activity.116 Removal of Atenolol under methanogenic 
conditions was previously reported for anaerobic post-treatment of activated sludge 
(>50%),115 With such high removal efficiencies for trimethoprim and atenolol reported in 
other engineered methanogenic environments than sewers, the contribution of MA to in-
sewer removal of these compounds can be expected. 
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Figure 5-7: Removal of investigated compounds by RM without inhibition (dark grey bars), 
with inhibition of MA (green, hatched), SRB (red) and MA and SRB simultaneously (white, 
dotted). Compounds in figure A are dominantly removed by SRB without significant 
contribution of MA. Compounds in figure B are dominantly removed by MA without 
contribution of SRB. The asterisk (*) indicates significantly lower removal compared to 
uninhibited RM. P-values for iopromide in after SRB inhibition was 0.077, while p-values for 
DEET were <0.181 after inhibition of SRB and SRB and MA simultaneously.  
 
The inhibition of either SRB or MA yielded similar micropollutant removal efficiencies to 
uninhibited biofilm for the majority of the investigated compounds (n=17). Moreover, 
inhibition of either SRB or MA yielded higher micropollutant removal efficiencies than 
simultaneous inhibition of SRB and MA, suggesting that both biofilm microbial communities 
have the capability to transform these compounds (Figure 5-8). Negligible contributions of 
SRB and MA to removal of sulfamethoxazole suggest the transformation of this compounds 
by another active microbial community. 
For instance, similar ibuprofen removal by uninhibited biofilm and after inhibition of either 
SRB or MA (i.e. 29-35%) suggested no impact of the inhibition of either SRB or MA on the 
overall removal of ibuprofen in RM (Figure 5-8). Apparently, the inhibition of SRB facilitated 
the transformation of ibuprofen by MA and vice versa, possibly due to the abundance of 
available substrate after inhibition of one community. With SRB and MA competing for 
acetate and H2,10,71,117 higher substrate abundance after inhibition of one community 
possibly facilitated the co-metabolic transformation of ibuprofen by the uninhibited microbial 
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community. Without significant sorption of transformation by other microbial communities 
(see chapter 5.1.1), similar removal efficiencies in reactors without inhibition and after 
inhibition of either SRB or MA suggest similar ibuprofen removal capability of SRB and MA. 
Other compounds that exhibited similar removal with and without inhibition of SRB or MA, 
but lower removal with simultaneous inhibition of SRB and MA are shown in Figure 5-8. 
Previously, only five of these compounds were shown to transform in sulfate-reducing 
environment, i.e. carbamazepine (20% transformation by sulfate-reducing digested 
sludge),118 2,4-D (mineralised in aquifer slurries, however contribution of SRB is 
ambiguous),119 venlafaxine, sulfamethoxazole and acetaminophen (all >80% during 
anaerobic post-treatment of activated sludge).115 Under methanogenic conditions, 
previously reported transformations of acetaminophen (80%), diclofenac (20-60%), 
trimethoprim (70-90%), ibuprofen (20-40%) and gemfibrozil (<16%) are in accordance with 
the removal efficiency by MA in this study.52–55,57,116 In contrast, MA in this study exhibited 
lower removal efficiencies than reported during anaerobic treatment of carbamazepine 
(40%), roxithromycin (20-95%), sulfamethoxazole (80-100%)52–55,116 and venlafaxine (50%), 
while the reportedly persistent diuron and tramadol were removed by >30% by MA in this 
study.115 
Significantly decreased removal efficiencies of caffeine and 2,4-D after simultaneous 
inhibition of SRB and MA compared to removal by uninhibited RM are in accordance with 
the reported high removal of these compounds under anaerobic conditions (90-
100%).54,119,120 In the case of 2,4-D, significantly lower removal after inhibition of either SRB 
or MA compared to uninhibited biofilm suggests the transformation of caffeine and 2,4-D via 
different pathways, with the overall removal being cumulative. On the other hand, similar 
removal efficiencies of caffeine after inhibition of SRB, MA and SRB and MA simultaneously 
indicate a severe loss of caffeine transformation when either of the communities is inactive. 
Possibly, the transformation of caffeine in RM occurs due to the syntrophic relationship of 
SRB and MA. MA have previously been reported to transform caffeine into methane under 
anaerobic conditions,121 but depend on other microbial communities for the provision of 
H2,56,122,123 which may be limited after the inhibition of SRB. However, the data obtained 
during this study does not allow for the unambiguous explanation of caffeine removal by 
SRB and MA. 
Biotransformation of micropollutants in sewers –Results | 63  
 
Figure 5-8: Removal of investigated compounds by RM without inhibition (dark grey bars), 
with inhibition of MA (green, hatched), SRB (red) and MA and SRB simultaneously (white, 
dotted). Compounds are removed by SRB and MA to similar extent. The asterisk (*) 
indicates significantly lower removal compared to uninhibited RM. P-value for 
acetaminophen after simultaneous inhibition of SRB and MA was 0.051. Other p-values 
were >0.1. 
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5.2.4 Potential mechanisms behind PhAC and pesticide removal by SRB and MA 
With the exception of sulfamethoxazole, all investigated PhACs and pesticides were 
transformed by SRB or MA or both microbial communities. The investigated compounds 
differ in molecular structures and properties, however their degradability by SRB or MA was 
not influenced by the compounds molecular weight (MW), charge at experimental pH 8, 
LogKOW, LogD (at pH 8), number of halogens (chloride, iodide) or degree of unsaturation 
(expressed as ring double bond equivalents, RDBE) (Figure 5-9).  
 
Figure 5-9: Molecular properties of the investigated PhACs and pesticides. Coloured 
symbols indicate compounds that were preferably transformed by SRB (red), MA (green) or 
both (white). Contribution of other microbial communities to transformation is indicated with 
grey symbols.  
 
Although reports about exclusively SRB-driven biotransformation of the investigated 
compounds are scarce, SRB were previously shown to transform a variety of persistent 
chemicals. Aromatic compounds, such as phenol, catechol and phloroglucinol were 
previously reported to be degraded by various genera of SRB in pure cultures, aquifer 
slurries, freshwater and marine sediments, soil and sewage sludge.109,110 Possibly, the RM 
biofilm SRB community in this study contributed to removal of the investigated compounds 
by transforming the homocyclic structures contained in many compounds, such as the 
radiocontrast agent iopromide, the analgesics acetaminophen, ibuprofen, tramadol and 
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diclofenac, the insect repellent DEET or the pesticides metolachlor, 2,4-D and diuron (list 
not exhaustive; all structures are listed, Table 8-1). SRB in pure cultures and mixed cultures 
were also shown to degrade O- and N-substituted heterocyclic, as well as polycyclic 
structures, such as indole, quinolone and pyridine.110–112 However, no references were 
found for the SRB-driven degradation of benzothiadiazide (as contained in 
hydrochlorothiazide), isoxazole (sulfamethoxazole) or pyrimidine (trimethoprim, 
sulfadiazine). Apart from the degradation of cyclic structures, SRB were shown to degrade 
chlorinated and brominated compounds in aquifer slurries by reductive 
dehalogenation.56,124,125 Possibly, the chlorinated compounds in this study, i.e. diclofenac, 
hydrochlorothiazide, metolachlor, 2,4-D or diuron, were transformed by dehalogenation. In 
soil, SRB were able to deiodinate the aerobically persistent radiocontrast agent diatrizoate,69 
hence other iodinated structures, such as iopromide, may be deiodinated as well. 
Furthermore, SRB are capable to transform compounds by demethylation under sulfate-
reducing conditions, as shown for the pesticide dicamba in anaerobic soil and sand.126 
However, without a comprehensive analysis of transformation products and pathways, it is 
impossible to confirm the occurrence of these reactions in RM sewers. Nevertheless, the 
transformation of the majority of the compounds in this study (n=21), with four compounds 
being exclusively transformed by SRB, strongly recommends to further investigate the 
capability of SRB to transform micropollutants.  
Methanogenic environments were previously acknowledged as advantageous for the 
biotransformation of selected micropollutants that are persistent to aerobic 
biotransformation, including trimethoprim, sulfamethoxazole, carbamazepine or 
diclofenac.56 Similarly to SRB, MA were shown to transform homocyclic structures, such as 
benzene, phenol and toluene via multiple pathways,109,127,128 as found in atenolol. Reductive 
dehalogenation of chlorinated and iodinated compounds was reported to occur under 
methanogenic conditions, such as radiocontrast agents,129 and chlorphenols.56 While MA 
were shown to transform heterocyclic and polycyclic structures, such as indole, uracil and 
tryptophan,127 their advantage over SRB is the capability to transform pyrimidines, as found 
in trimethoprim.130  
In summary, the functional groups of a micropollutant may be the determining factor for the 
preferred transformation by SRB or MA. While the detailed analysis of transformation 
products and pathways of all investigated compounds was beyond the scope of this 
objective, previously reported transformation reactions of substances with similar functional 
groups are promising.56 Further investigations should focus on primary substrate availability, 
utilisation of micropollutants as primary substrate and substrate competition by SRB and MA 
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during the in-sewer transformation of micropollutants. Finally, the spatial advantage of SRB 
over MA due to the stratified structure of biofilms requires further attention with regard to the 
transformation of micropollutants. 
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5.3 Formation of anaerobic TPs of the antibiotics trimethoprim and roxithromycin 
In the previous chapters biotransformation was identified as the major in-sewer removal 
mechanism for micropollutants. Moreover, the contributing microbial communities during in-
sewer biotransformation were SRB and MA, which are the predominant communities in 
anaerobic sewer biofilms. The biochemical in-sewer removal of micropollutants implies the 
formation of other substances. Thus, unless the micropollutants are mineralised into CO2, 
CH4, H2O and inorganic nitrogen species, the removal of micropollutants form the bulk water 
phase should coincide with the formation of transformation products (TPs).  
During 13-day batch experiments in synthetic wastewater, the TP formation from the 
antibiotics trimethoprim and roxithromycin by RM biofilm was investigated. 
5.3.1 Activity of anaerobic rising main sewer biofilm prior to and after TP elucidation 
experiments 
Analyses of the biofilm activity demonstrated that anaerobic sewer biofilm reactors mimicked 
the substrate conversion processes in sewers well, as described in more detail in chapter 
5.1.1. Despite the high initial concentration of the antibiotics roxithromycin (ROX) and 
trimethoprim (TMP) applied for the elucidation of their biotransformation pathway (i.e., 
13 mg L-1), the biofilm activity was only slightly inhibited.  
In the reactor spiked with ROX, methane and sulfide production decreased from 
6 mg L- 1 h- 1 to 4 mg L-1 h-1 and 4 mgS-S2- L-1 h-1 to 1 mgS-S2- L-1 h-1, respectively, when 
changing to synthetic wastewater feed, which indicates a partial suppression of biofilm 
activity. Methane and sulfide production rates coincided with the rates observed in the 
control experiment without spiked antibiotic, hence the decreased activity can be attributed 
to the changed medium (Figure 5-10). Analogously, VFA conversion (i.e. acetate and 
propionate) did not differ significantly in reactors spiked with ROX and reactors without 
spiked antibiotic (Figure 5-11 A and B, respectively). 
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Figure 5-10: Conversion of sulfate-S (white, hatched), production of sulfide-S (white) and 
dissolved methane (grey) prior to TP elucidation experiments and after 13-day TP 
elucidation batch experiments in reactors without spiked antibiotic or spiked with 13 mg L-1 
ROX or TMP, respectively. 
 
Analogously to the experiments with ROX, methane production rate was reduced to 
4 mg L- 1 h-1 during TMP TP elucidation experiments in synthetic wastewater at prolonged 
exposure (i.e. 13 days) of TMP at high concentrations (i.e. 13 mg L-1). Similar decrease of 
methanogenic activity in control experiment without spiked antibiotic suggests that the 
decreased activity is due to the changed medium (Figure 5-10). On the other hand, sulfide 
production rates increased to 6 mgS-S2- L-1 h-1 (from 4 mgS-S2- L-1 h-1), as opposed to the 
decrease of sulfidogenic activity in the control without antibiotic (i.e. 2 mgS-S2- L-1 h-1). 
Additionally, higher propionate consumption was observed after dosing TMP compared to 
biofilm without spiked antibiotic (Figure 5-11 B). High dose of TMP may have promoted 
propionate-driven sulfide production by inhibiting the competing microorganisms, such as 
fermenting bacteria. Previously, propionate-consuming SRB yielded higher sulfidogenic 
activity than aceticlastic SRB in anaerobic sludge.134,135 Thus, the increased sulfide 
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production may be attributed to propionate-consuming SRB in RM sewers as well. Overall, 
the biofilm activity was not inhibited by the high dose of antibiotic. 
 
Figure 5-11: Concentration ratio of VFAs: A) acetate and B) propionate prior to TP 
elucidation experiments (▲) and after TP elucidation experiments in reactors spiked with 
ROX (●), TMP (●) or without spiking of antibiotic (○). 
 
5.3.2 Structural elucidation of biotransformation products of ROX and their pathways 
When spiked at high initial concentration (i.e. 13 mg L-1), 50% of ROX was removed after 
13 days (Figure 8-19 A), at similar first-order rate constant compared to biotransformation 
experiments at 50 µg L-1, i.e. 48.14±6.08x10-2 h-1 and 39.12±4.72 x 10- 2 h- 1, respectively 
(p>0.05). In parallel with the disappearance of ROX, continuous formation of four new 
anaerobic in-sewer TP was observed: TP822, TP916, TP854 and TP575 (Figure 5-12). 
These products were not detected in the control experiments without biofilm, excluding the 
abiotic formation route (i.e., hydrolysis). The evolution of intensity of the proposed ROX TPs 
is depicted in Figure 5-13. Identification of TPs was conducted based on the full scan, data-
dependent and MS/MS experiments conducted at quadrupole-Orbitrap MS. Table 8-4 in the 
appendix summarises the observed retention times of ROX TPs, exact and measured 
masses of their molecular and fragment ions, relative errors and ring double bond 
equivalents. The proposed fragmentation pathways of ROX TPs and their description are 
shown in Figure 8-20 - Figure 8-24. 
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Figure 5-12: Biotransformation pathway of ROX in anaerobic biofilm reactor mimicking 
pressurized sewer. 
 
Product ion spectrum of ROX molecular ion m/z 837.5319 revealed characteristic fragment 
ions at m/z 679.4376, m/z 558.3637 and m/z 398.2537, which corresponds to the cleavage 
of cladinose (C3-atom), simultaneous cleavage of desosamine (C5-atom) and the N-oxime 
side chain and the lactone ring (Figure 8-20).  
Mass spectrum of TP822 (m/z 823.5162) revealed characteristic fragment ions m/z 
665.4219, m/z 647.4113 and m/z 508.3116, with masses shifted downward by 14 Da 
relative to the analogous fragment ions in the mass spectrum of ROX (i.e., m/z 679.4376, 
m/z 661.4270 and m/z 522.3273, respectively) (Figure 8-21). This suggested that TP822 
was formed by O-demethylation at the N-oxime chain. TP822 and the O-demethylation at 
the N-oxime chain have previously been reported for human metabolites,136 however O-
demethylations have also been shown to occur in anaerobic methanogenic and sulfate-
reducing environments, e.g. soil and fresh water sediments, subsurface flow constructed 
wetlands and anaerobic sludge, e.g. for the pharmaceuticals tramadol or naproxen.126,137–
139
 Previous studies conducted with the anaerobic bacteria Acetobacterium dehalogenans, 
Desulfitobacterium spp., Clostridium thermoaceticum and Holophaga foetida suggested 
methylether cleavage by the enzyme O-demethylase as catalyst for tetrahydrofolate 
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production.140–144 Possibly, the methanogenic or sulfate-reducing microorganisms in sewer 
biofilms demethylated ROX using O-demethylase as well.  
TP916 was detected as both protonated species with m/z 917.4982 and sodium adduct with 
m/z 939.4801, intensity of the latter was significantly higher and was thus further 
fragmentised to obtain mass spectra information. Exact mass measurement of the molecular 
ion m/z 917.4982 (TP916) indicated an incorporation of a phosphoryl group (-PO(OH)2) in 
ROX molecule. Mass spectrum of TP916 revealed sodiated fragment ions m/z 702.4035 
and m/z 544.3092, analogous to the fragment ions m/z 679.4376 (cleavage of cladinose) 
and m/z 522.3273 (cleavage of cladinose and desosamine) in the fragmentation pattern of 
ROX (Figure 8-22). The key fragment ion for placing the phosphoryl group at the 
desosamine moiety was m/z 781.3858 (cleavage of cladinose). Previously, phosphorylation 
of sugars was shown to be facilitated by the enzyme phosphatase and to preferably occur 
at alcohols, such as the 2’-OH in the ROX desosamine moiety.145 The modification of the 2’-
OH at the desosamine moiety, in particular its phosphorylation, prevents hydrogen bonding 
with the target sites in peptidyl transferase,146,147 and thus inhibits the antibiotic activity of 
ROX. Phosphorylation of the 2’-OH group has been reported to occur in aerobic sludge 
communities in MBR.148,149 Moreover, enzymatically induced phosphorylation may also 
occur in anaerobic environments, as indicated by phosphatase activity in anaerobic sludge 
systems containing bacteria and archaea, such as upflow anaerobic sludge blankets.150,151 
TP916 was previously detected as the protonated molecular ion by Terzic at al.,149 instead 
of its sodiated form. The abundance of sodium ions was likely reduced due to the sample 
preparation using solid phase extraction, which could not be realised in this study due to the 
small sample volume. Difficulties to obtain fragmentation spectra of the protonated 
molecular ions and preferred fragmentation of sodium adducts were previously reported for 
the macrolide SDZ RAD,152 however it is unclear why TP916 was the only compound in this 
study that exhibited this behaviour, but it may be due to interactions between the phosphoryl 
group and the sodium ions. 
The exact mass of the molecular ion of biotransformation product TP854 (m/z 855.5424) 
and fragment ions m/z 697.4481 and m/z 576.3742 were shifted upward for 18 Da relative 
to the m/z 679.4376 and m/z 558.3637 fragment ions of ROX, suggesting that TP854 was 
formed by hydrolysis of ROX (Figure 8-23). In addition, absence of an analogue fragment 
ion to m/z 398.2537 in ROX (lactone ring) further suggests the hydrolytic cleavage of the 
lactone ring. Although the exact position of the -OH group could not be deduced based on 
the fragmentation pattern of P854, hydrolysis likely occurred at the ester bond at the C13-
atom. Lactone ester bond hydrolysis in macrolides was previously observed for erythromycin 
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by cultivated anaerobes E. coli and S. aureus due to host-specific esterase enzymes.153,154 
Moreover, the macrolide spiramycin I was previously shown to undergo lactone ring opening 
by hydrolysis at the ester bond during anaerobic digestion.155,156 Hydrolysis of the lactone 
ring in macrolides inactivates their antibiotic activity due to the decrease of hydrogen 
bonding with the macrolide target sites in peptidyl transferase.146,147 Thus, TP854 is not 
expected to exert residual antibiotic activity.  
Product TP575 was formed by the cleavage of the lactone ring at the C13-atom in ROX 
molecule and loss of the desosamine and N-oxime moiety. The exact mass of TP575 
molecular ion (m/z 576.3742) coincided with the exact mass of a fragment ion in the 
spectrum of TP854, which suggests structural similarities between both TPs (Figure 8-24). 
In addition, the lack of fragment ions of TP575 analogous to ROX indicates the scission of 
the lactone ring. Fragment ions with m/z 558.3637, m/z 500.3218 and m/z 325.2010 
represent gradual scission of the cleaved lactone ring by the loss of water, cleavage of a 
keto group (-C3H4O) and further cleavage of residual lactone chain (-C11H23NO5) with 
respect to the molecular ion (Figure 8-24). The capability of anaerobic microbial 
communities to hydrolyse ester bonds was previously discussed with regard to TP854. The 
desosamine moiety and the N-Oxime chain in TP575 were likely removed through hydrolysis 
as well, as has been demonstrated for aromatic ethers and oxime pesticides during 
anaerobic digestion or in anaerobic soils.157–159 
 
Figure 5-13: Peak intensities (XIC) of anaerobic in-sewer TPs of ROX during 13-day batch 
experiments. High intensity product (left Y-axis): TP854 (♦). Low intensity products (right Y-
axis): TP916 (○), TP575 (●) and TP822 (▲).  
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5.3.3 Structural elucidation of biotransformation products of TMP and their pathways 
When spiked at high initial concentration (i.e. 13 mg L-1), 91% TMP was removed after 13 
days (Figure 8-19 B), yielding a first-order kinetic rate constant of 18.03±0.04x10-2 h-1, which 
was significantly lower compared to experiments at lower initial concentration (i.e. 50 ppb; 
54.05±3.91x10-2 h-1). Decreased transformation rates of pharmaceuticals have been 
previously linked with a decreased biomass to analyte ratio for TMP or ibuprofen in activated 
sludge,108,160 possibly due to mass transfer limitations between the bulk liquid and the 
biomass.  
In parallel with the disappearance of TMP, continuous formation of four TPs was observed 
(Figure 5-14): TP276A, TP276B, TP304 and TP238. The early detection of all four 
transformation products suggests their instant transformation from TMP (Figure 5-15). No 
significant changes in TMP concentrations were recorded in control experiments without 
biofilm (data not shown). Table 8-5 summarizes the retention times of TMP TPs, exact and 
measured masses of their molecular ions, relative errors and ring double bond equivalents, 
and the proposed compound structures. Figure 8-25 to Figure 8-29 represent the proposed 
fragmentation patterns of TMP TPs. 
 
Figure 5-14: Proposed transformation pathway for TMP in anaerobic sewer biofilm reactors. 
Based on the early detection of TPs, it is proposed that they form from TMP directly. 
 
The product ion spectrum of TMP (m/z 291.1452) revealed characteristic fragment ions 
m/z 123.0665 (charged diamino pyrimidine moiety), m/z 181.0860 (charged trimethoxy 
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benzene moiety), and m/z 261.0982 formed by the loss of two methyl groups at the 
trimethoxy benzene moiety (Figure 8-25).  
Two peaks eluted at retention times 2.14 min and 2.77 min with the exact mass of the 
molecular ions of m/z 277.1295, and were marked as TP276A and TP276B. Both products 
had identical mass spectra, with several fragment ions analogous to the mass spectrum of 
TMP. For example, fragment ions m/z 167.0703 and m/z 233.1033 were shifted downward 
by 14 Da relative to TMP fragment ions m/z 181.0860 and m/z 247.1190, suggesting the 
loss of a methyl group at the trimethoxy benzene moiety through O-demethylation, while the 
diamino pyrimidine moiety was preserved (m/z 123.0665) (Figure 8-26 and Figure 8-27). 
Based on their order of elution in LC, TP276A and TP276B are deduced to be more polar 
than TMP, likely due to increased hydrogen bonding with the liberated -OH group at the 
trimethoxy benzene moiety compared to the ether bond in the parent compound. The exact 
location of C-O bond scission could not be determined using LTQ-Orbitrap, however, 
different conformers of dimethoxylated phenols were previously shown to differ in their 
solubility in water, as indicated by their boiling points. For instance, with a boiling point of 
261°C, solubility of 2,6-dimethoxyphenol with both methoxy groups in ortho-position to the -
OH group (analogous to the demethylation of TMP at the C4’-methoxy group) is higher 
compared to 2,3-dimethoxyphenol, which has a boiling point of 233°C and one methoxy 
group each at the ortho- and meta-position (demethylation of TMP at the C3’- or C5’-methoxy 
group). O-demethylation of TMP was previously observed during human phase I metabolism 
and yielded 4-desmethyl- and 3-desmethyl-TMP, which resemble the proposed structures 
of TP276A and TP276B, respectively.161 However, carry-over of human metabolites from 
sewage in these experiments can be excluded, due to the usage of synthetic wastewater. 
Microbially mediated O-demethylation of TMP yielded 4-desmethyl-TMP in aerobic 
sequencing batch reactors.108 Although O-demethylation of TMP was previously not 
observed in anaerobic environments, the pesticide dicamba,126 and the PhACs venlafaxine, 
tramadol and naproxen underwent O-demethylation under methanogenic and sulfate-
reducing in soil and anaerobic sludge. 126,137–139 
The molecular ion of TP304, m/z 305.1608, was shifted upward by 14 Da relative to the 
molecular ion of TMP, which suggests its methylation. With a preserved diamino pyrimidine 
moiety (m/z 123.0665), the methylation likely occured at the trimethoxy benzene moiety. 
However, a hypothetical fragment ion with m/z 195.1016 (methylated trimethoxy benzene 
moiety) was not detected. Instead fragment ions with m/z 275.1139 (desmethyl-TMP) and 
m/z 167.0703 (demethylated trimethoxy benzene moiety) indicate the loss of an alkyl group 
at the trimethoxy benzene moiety (Figure 8-28). The methylation thus has likely occurred at 
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one of the methoxy groups to form an ethoxy ether, which was cleaved at the ether bond 
during fragmentation. Although the exact location of methylation could not be detected, the 
delayed retention time of TP304 with respect to the parent compound TMP (i.e. 3.75 min vs 
3.29 min) suggest the methylation at one of the methoxy group instead of the methylene 
bridge at the C7-atom. Previously, the reductive methylation of pyrimidines and benzene 
rings, as in TP304, was observed under methanogenic and sulfate-reducing 
conditions,162,163 which dominates in anaerobic sewers as well. 
As far as TP238 is concerned, the molecular ion (m/z 239.1390) was likely the result of TMP 
O-demethylation and ring reduction at the trimethoxy benzene moiety and deamination at 
the diamino pyrimidine moiety, which yielded a lowered mass by 52 Da with respect to TMP. 
Due to modifications of both major moieties, MS2 spectrum of TP238 did not yield identical 
fragment ions to those of TMP. Fragment ions with m/z 221.1285 (loss of water) and m/z 
175.1230 (further loss of methoxy group) indicate the gradual reduction of the cyclohexane 
rest of the trimethoxy benzene moiety (Figure 8-29). Further dehydration and dealkylation 
of the cyclohexane ring were obtained after ring scission (i.e. m/z 211.1441, m/z 193.1335, 
m/z 139.1230). Only one of the three methoxy groups in TMP was preserved in TP238, 
however the location could not be identified using LTQ-Orbitrap. The proposed 
transformations of TMP to yield TP238 were previously reported in other studies using 
anaerobic cultures. In addition to O-demethylations, which were discussed in the previous 
sections of this chapter (see ROX TP822, TMP TP276A and TP276B), anaerobic ring-
reductions have been reported for many benzene based chemicals and microorganisms, 
e.g. methanogens109,164 and pseudomonas sp.165 Reductive deamination of the diamino 
pyrimidine moiety, was previously reported to occur for the pyrimidine cytosine through 
hydrolysis with further scission of the pyrimidine ring,166 and aniline after initial carboxylation 
and hydrogenation.167 While TP238 was not detected during abiotic experiments, a steady 
increase of TP238 was observed during experiments without spiked antibiotic ( 
Figure 8-30). This may be due to three reasons: i) TP238 may have previously sorbed to 
the RM biofilm and desorbed during the experiment. Since the reactors were maintained 
with collected raw sewage prior to the experiment the prior sorption of in-sewer TPs to the 
biofilm cannot be excluded. With two liberated -OH groups and cleaved primary amines, 
TP238 and TMP may have similar partitioning behaviour. However, the prior sorption and 
desorption should be visible in the reactor spiked with TMP as well and is therefore unlikely 
to have occurred; ii) Possibly, TP238 is not a TMP TP, but an in-sewer metabolisation 
product of a substrate. A search in an online database yielded three substances with an 
identical molecular formula, however significantly different structure,168 which are unlikely to 
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match the obtained fragment ions of TP238. In addition, TP238 is unlikely an in-sewer 
metabolisation product, due to the significantly different evolution of intensity during the 
experiments in reactors without antibiotic and with spiked TMP; and iii) The signals may 
belong to different isomers with similar hydrophilicity, which may lead to similar elution times 
in the LC. For instance, the evolution of TP238 in the reactor spiked with TMP may depict 
the sum of intensities of the proposed TMP TP and an unknown metabolisation product, 
while the reactor without spiked TMP accumulates the metabolisation product only. In order 
to fully elucidate the origin of TP238 in RM sewer environments, the in-sewer transformation 
of TMP requires further attention in future research. Spiking of an isotopically labelled 
standard of TMP is recommended to distinguish between TMP TPs and other non-related 
compounds. 
 
Figure 5-15: Peak intensities (XIC) of anaerobic in-sewer TPs of TMP during 13-day batch 
experiments. High intensity products (left Y-axis): TP276A (●), TP276B (♦) and TP238 (▲). 
Low intensity product (right Y-axis): TP304 (○).  
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5.3.4 Implications 
The observed in-sewer biotransformation of ROX and TMP and the identification of 8 TPs, 
which were previously not reported to form in anaerobic sewers, demonstrate the 
underestimated ability of anaerobic sewer biofilms to transform micropollutants.  
The inactivation of macrolides through hydrolysis of the lactone ring at the ester bond, as in 
TP854 and TP573, has been reported as effect of microbial resistance towards 
macrolides,147,153,169 by preventing hydrogen bonding with the target, i.e. peptidyl 
transferase.146,147 The same applies to the demethylation of the oxime chain (TP822) and 
the phosphorylation of the desosamine (TP916), hence the proposed TPs of ROX are not 
expected to exert comparable antibiotic activity to ROX. Although these TPs are unlikely to 
exhibit further antibiotic activity,146,147 the capability of the RM microbial communities to 
inactivate antibiotics supports previous reports that sewers are a reservoir for antibiotic 
resistance.75  
TMP is a dihydrofolate reductase (DHFR) inhibitor, which binds to the active site of the 
DHFR enzyme with its diamino pyrimidine moiety. The proposed structures of TP276A, 
TP276B and TP304 indicate a preserved diamino pyrimidine moiety, hence these TPs may 
exert the antibiotic activity of TMP after transformation. This gains importance in connection 
with integrated approaches to monitor and control antibiotic resistance and its spread in 
aquatic environments.  
Although three TPs were previously identified as human metabolites (i.e. ROX TP822, TMP 
TP276A and TP276B), the carry-over of the proposed in-sewer TPs of ROX and TMP from 
sewage can be excluded due the usage of synthetic wastewater and due to their increasing 
intensities during the batch experiments. Furthermore, TP916 was previously observed to 
form during aerobic CAS treatment. Possibly, the anaerobic transformation of ROX and TMP 
requires the activity of enzymes, such as demethylases, phosphorylases or esterases, which 
have been detected in other anaerobic microbial communities previously.140–144,150,151,155,156 
Enzymes with the ability to phosphorylate or hydrolyse substrates are also known to occur 
in aerobic environments, i.e. CAS, or during human metabolism and may facilitate the 
production of corresponding TPs.23,170–172 
Overall, this study demonstrates the widely neglected ability of anaerobic sewer biofilms to 
not only remove antibiotics, but also transform them into unknown, but potentially hazardous 
TPs. Further research should focus on the occurrence of the proposed TPs during full-scale 
RM sewer passage. 
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5.4 Demonstrating in-sewer biotransformation of micropollutants in full-scale sewer 
pipes 
After the comprehensive analysis of in-sewer removal mechanisms, contributing microbial 
communities and formation of in-sewer TPs, the capability of sewer biofilms in a full-scale 
sewer pilot to remove micropollutants was investigated. This chapter summarised and 
discusses the results obtained during pilot experiments in full-scale RM and GS sewer pipes. 
 
5.4.1 Biotransformation of micropollutants in full-scale RM sewer pipes 
In-sewer transformations of selected micropollutants and growth substrates were monitored 
in a full-scale RM pilot sewer during two sets of experiments. The difference between the 
experimental setups was the sewage slug, which is the monitored volume of sewage along 
the sewer pipe’s length that is replaced with each pump event. 
During the first set of experiments, the monitored sewage slug expanded over 30 m and 
progressed within the pipe during eight hourly pump events (1 min each, flow rate 
237 L min- 1, total HRT=8 h). The sewage slug during the second set covered the entire pipe 
length and was monitored at three locations (#1: 15 m; #4: 105 m; #B7: 210 m). With the 
pump events as major source of agitation of the sewage, higher transformation rates of 
substrates and PhACs are expected in experiments with pump events than without.  
 
5.4.1.1 Biofilm activity in RM 
Biofilms in the RM sewer pipe were mature and active, as indicated by the in-sewer 
production of sulfide and methane by SRB and MA, respectively, and the conversion of 
VFAs. SRB and MA activity decreased with increasing distance from the feed, as suggested 
by a drop in sulfide and methane production rates between different sampling locations in 
experiments without pump events. The maximum sulfide and methane production rates 
decreased significantly with increasing distance from the feed (2.8±0.1 mgS2--S L-1 at #1 to 
1.1±0.1 mgS2--S L-1 at #B7; 3.1±0.3 mgCOD L-1 at #1 to 1.6±0.4 mgCOD L-1 at #B7; p<0.05) 
(Figure 5-16). With the same initial concentrations of sulfate and VFAs provided in all pipe 
sections (concentration profiles shown in Figure 8-31), drops in sulfide and methane 
productions indicate a decreasing capability of SRB and MA to transform substrates at more 
downstream pipe sections compared to more upstream sections. This is supported by the 
decreased conversion of acetate, propionate, butyrate and valerate between sampling 
location #1 and #B7 (Figure 5-16).  
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During experiments with hourly pump events, sulfide and methane production rates did not 
differ significantly between pump events (between 0.8±0.5 and 2.4±0.8 mgS2--S L-1; 
between 0.1±1.2 and 5.4±1.3 mgCOD L-1; Figure 8-32). Sulfide and methane production 
depends on the biofilm activity and on the initial substrate concentrations in sewage, which 
ranged from 14 to 40 mgS L-1 for sulfate-S, 63 to 98 mgCOD L-1 for actetate and 5 to 
18 mgCOD L-1 for propionate (concentration profiles in Figure 8-33). The variance in initial 
substrate concentration likely led to dissimilar sulfide and methane production rates during 
each replicate experiment, resulting in large errors during linear regression and leading to 
insignificant differences between datasets. For further comparison, the maximum sulfide 
and methane production rates were obtained during the first hour (i.e. 2.4±0.8 mgS2--S L-1 
and 3.1±0.5 mgCOD L-1), when sulfate, acetate and propionate were most abundant. 
 
Figure 5-16: Production rates of sulfur species, methane and VFA indicate active biofilm 
microbial community in RM. Results from the experiments without pump events are 
displayed for the three sampling locations, i.e. location #1 at 15 m (white), location #4 at 105 
m (white, dotted) and location #B7 at 210 m (white, hatched). Production rates during 
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experiment with hourly pump events are displayed in dark grey. Methane production and 
acetate consumption were significantly higher in RM with pump events than without 
(p<0.05). 
 
In comparison to the laboratory-based sulfide and methane production in RM biofilm 
reactors (see chapter 5.1.1), the full-scale pilot RM yielded lower biofilm activity, as indicated 
by their lower production rates (normalised to the ratio of biofilm surface to sewage volume, 
A/V). Conversion rates of sulfur species were tripled in the RM reactor with the lowest A/V 
(i.e. 33 m2 m- 3) compared to those in full-scale RM (A/V of 33 m2 m-3) (Figure 5-17). While 
this difference was not statistically significant, it may be attributed to continuous mixing in 
the laboratory RM. On the other hand, methane production occurred at significantly higher 
rates in both RM reactors than in the full-scale RM, i.e. approximately 700 mgCOD L-1 h-1 
and 78.7±12.6 mgCOD L-1 h-1, respectively, suggesting a significantly more active MA 
biofilm community in the laboratory-scale setups. Possibly, the more consistent provision of 
sewage in the laboratory setup facilitated the activity of MA, such as absence of dissolved 
oxygen, utilisation of the same sewage batch for one week or regular activity assessment to 
ensure consistent methane production. In the full-scale RM, the sewage varied, as it was 
fed from the STP influent.  
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Figure 5-17: Comparison of sulfur species, methane and VFA production rate during 
experiments in full-scale RM without pump events (location #1 at 15 m (white), location #4 
at 105 m (white, dotted) and location #B7 at 210 m (white, hatched)), with hourly pump 
events (dark grey) and laboratory-based RM experiments in reactors with A/V of 55 m2 m-3 
(yellow) and A/V of 33 m2 m-3 (orange). All production rates are normalised by A/V. 
 
5.4.1.2 Removal of micropollutants in RM 
The removal of all target micropollutants was similar in RM with and without pump events 
(i.e. p>0.05), which may be due to two reasons: Firstly, the measured concentrations vary 
between experimental replicates, which results in larger errors associated with removal 
(Table 8-6). The initial concentrations varied by up to one order of magnitude (sulfasalazine), 
however were <50% for the majority of compounds. Apart from errors due to fluctuations of 
concentrations, similar removals during experiments with and without pump events suggest 
that the capability of the RM biofilm to transform micropollutants did not differ significantly 
across a RM pipe with a length of 300 m during these experiments. However, further 
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investigation is required to confirm similar micropollutant removal at different pipe locations 
despite significant differences in biofilm activity. Due to the similarity of micropollutant 
removal during both experiments in RM, all further discussion of PhAC removal in RM is 
restricted to the experiments with hourly pump events. An overview of the micropollutant 
removal efficiencies during the RM experiments without pump events, as well as the 
concentration profiles of spiked and benchmarking compounds can be found in the appendix 
(Figure 8-35 to Figure 8-38). A summary of first order kinetic rate constant for all experiments 
can be found in Table 8-6. 
During experiments in RM with hourly pump events and an HRT of 8 h, the removal of 13 
compounds exceeded 10%. The highest removal was observed for the antibiotics 
sulfasalazine and cephalexin, and the analgesic acetaminophen, i.e. 100±21%, 51±19% and 
59±6%, respectively. While the dominant removal mechanism for sulfasalazine in 
laboratory-scale RM was sorption (see chapter 5.1.2), it was previously reported to 
transform rapidly under anaerobic conditions, such as in the human colon.173 Cephalexin 
was previously shown to degrade rapidly during conventional activated sludge treatment in 
STPs30 and by up to 78% in an anaerobic granule reactor.174 Thus, high removal efficiencies 
of sulfasalazine and cephalexin during RM sewer passage are realistic. With acetaminophen 
known to be readily biochemically removed, its high removal in RM is not surprising, however 
significantly lower than previously observed during laboratory-based experiments (i.e. 
>90%)14,88 (see chapter 5.1.3). Possibly, the low removal efficiencies obtained during full-
scale experiments are influenced by the limitation of micropollutant distribution within the 
pipe without mixing, while sewage during laboratory-based studies is usually stirred 
continuously. Nevertheless, the removal efficiency of acetaminophen in RM was the second 
highest of all investigated compounds, thus it can be considered a benchmarking compound 
for readily transformed compounds under RM conditions. In contrast, carbamazepine was 
removed by 15±3%, although it is considered persistent to biotic removal. Previously, Jelić 
et al. report negative removal of carbamazepine (~-15%),18 possibly due to deconjugation 
from human metabolites, as previously observed during wastewater treatment.30 In 
laboratory-scale experiments, however, carbamazepine removal exceeded 38% (see 
chapter 5.1.3), which demonstrates the capability of RM biofilm to transform carbamazepine. 
The spiked compounds trimethoprim and N4-acetyl-sulfamethoxazole-d4 were removed by 
21±5% and 31±5%, respectively. The fate of this compound will be further discussed in the 
next section with regard to the formation of in-sewer TPs (see chapter 5.4.1.3). 
Negligible removal (i.e. <10%) was observed for 10 compounds, including roxithromycin and 
sulfamethoxazole (i.e. - 3±8% and -3±6%, respectively) (Figure 5-18). Higher negative 
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removal of sulfamethoxazole, i.e. -66%, was previously observed in full-scale RM.18 
Furthermore, the same study reported the negative removal of erythromycin (-30%), a 
macrolide antibiotic with almost identical molecular structure to roxithromycin. Both 
compounds are mostly excreted via the faeces and are likely released into the bulk sewage 
during the decomposition of faecal matter.30 Although removal efficiencies for macrolide 
antibiotics and sulfamethoxazole were reported negative during full-scale studies, 
laboratory-based studies at different initial concentrations demonstrated the capability of RM 
biofilm to remove these compounds by 55±5% and 28±6%, respectively (see chapter 5.1.3). 
Thus, the in-sewer removal of roxithromycin and sulfamethoxazole possibly occurs in 
parallel with their formation from different compounds or the release from particles. 
Tramadol and diclofenac are considered persistent to biotic removal and were removed by 
4±4% and - 3±2%, respectively (Figure 5-18). Jelić et al. observed low negative removal of 
diclofenac in full-scale RM (~-10%), which is in accordance with this study. The persistence 
of tramadol to in-sewer transformation was previously demonstrated during laboratory tests 
using collected sewer biofilm from a full-scale pipe, however only in GS conditions.88 
Nevertheless, tramadol was the least susceptible benchmarking compound to 
biotransformation in RM during this study. These removal efficiencies in full-scale RM were 
significantly exceeded during laboratory experiments, yielding 34-39% removal (see chapter 
5.1.3). The concentration profiles during experiments in RM with hourly pump events can be 
found in the appendix, Figure 8-39. 
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Figure 5-18: Removal [%] of selected micropollutants in RM with hourly pump events during 
a HRT of 8 h. The removal of ranitidine was -136±30%. 
 
Negative removal efficiencies were observed for 12 compounds and the highest for the 
antihistamines ranitidine and doxylamine (Figure 5-18). The fate of doxylamine during sewer 
passage has not been reported previously, while ranitidine was removed by ~-20% in a full-
scale RM study with an HRT of 21 h.18 During laboratory-based experiments in RM, the 
removal of ranitidine was dominated by sorption (see chapter 5.1.2). Possibly, the 
introduction of ranitidine indicates its release from decomposed particulate matter, similarly 
to previously reported for macrolide antibiotics.30 Only a low fraction of doxylamine was 
removed by sorption, i.e. ~33% (see chapter 5.1.2), therefore another mechanism is 
responsible for its introduction. Negative removal of the cardiovascular drugs metoprolol is 
in accordance with previously reported removal of ~-20% in full-scale RM.18 Contrarily, 
propanolol was reported to be removed by ~20% in the same study, while our results 
indicate a negative removal of -13±3%. Similarly to removal of ranitidine, propranolol’s 
dominant removal mechanism was shown to be sorption (see chapter 5.1.2), thus other 
introducing mechanisms than biotransformation may apply.  
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5.4.1.3 Formation of in-sewer biotransformation products 
Increasing concentrations of 3-desmethyl-trimethoprim (3-OH-TMP) and sulfamethoxazole-
d4 in parallel with the removal of trimethoprim and N4-acetyl-sulfamethoxazole-d4, 
respectively, confirm the in-sewer biotransformation of these compounds during RM 
experiments with hourly pump events. The removal of trimethoprim and the production of 3-
OH-TMP occurred with rate constants of 2.9±0.9 x 10-2 h-1 (trimethoprim) and 
- 3.2±1.0 x 10- 2 h-1 (3-OH-TMP) (Figure 5-19 A). After an HRT of 8 h, approximately 3.5% 
of trimethoprim were converted into 3-OH-TMP. As opposed to 3-OH-TMP, 4-desmethyl-
trimethoprim (4-OH-TMP) did not exhibit increasing concentrations and thus was not formed 
during the experiments. While structures for four TPs of trimethoprim have been suggested 
(see chapter 5.3.3), only two TPs were available as analytical standards, i.e. 3-OH-TMP and 
4-OH-TMP, as their structures have been previously identified as human metabolites of 
trimethoprim. While the occurrence of 3-OH-TMP and 4-OH-TMP in raw sewage is expected 
in the presence of trimethoprim, the increase of 3-OH-TMP suggests its formation during the 
experiments. However, the low ratio of trimethoprim conversion into 3-OH-TMP strongly 
suggest the production of further in-sewer TPs of trimethoprim.  
Approximately 48% of the removed N4-acetyl-sulfamethoxazole-d4 transformed into 
sulfamethoxazole-d4 at rates of 4.6±1.0 x 10-2 h-1 and -7.3±1.6 h-1, respectively (Figure 5-19 
B). The isotopically labelled compounds N4-acetyl-sulfamethoxazole-d4 and 
sulfamethoxazole-d4 do not occur in sewage naturally, thus the decreasing concentration of 
N4-acetyl-sulfamethoxazole-d4 is unambiguously the origin of sylfamethoxazole-d4. The 
conversion of N4-acetyl-sulfamethoxazole into sulfamethoxazole was previously suggested 
due to 66% increase of sulfamethoxazole during full-scale RM sewer passage with a HRT 
of 21 h.18 This corresponds well with the high conversion of the acetylated metabolite into 
the parent compound sulfamethoxazole during this study. However, with approximately 48% 
of the removed N4-acetyl-sulfamethoxazole-d4 transforming into the parent compound, 
approximately 52% transform into other and previously not reported TPs of N4-acetyl-
sulfamethoxazole-d4. 
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Figure 5-19: In-sewer biotransformation of PhACs during RM experiments with hourly pump 
events. The lines indicate the model fit (first order). A: Evolution of 3-OH-TMP (▲, dashed 
line) and 4-OH-TMP (○, dash-dotted line) concentrations in parallel with TMP (●, solid line) 
removal. B: Evolution of sulfamethoxazole-d4 (●, dashed line) concentrations in parallel with 
N4-acetyl-sulfamethoxazole-d4 (▲, solid line) removal. The slopes of all displayed curves 
are significant, i.e. p<0.05, except for 4-OH-TMP. 
 
The transformations of trimethoprim into 3-OH-TMP or 4-OH-TMP were not observed during 
experiments in RM without pump events. On the contrary, both compound were removed 
by 15-35% and 30-45%, respectively at the three sampling locations (Figure 8-40). With 
trimethoprim removal between 21 and 45%, the formation of TPs would be expected. The 
conversion of N4-acetyl-sulfamethoxazole-d4 into sulfamethoxazole-d4 was not monitored 
during RM experiments without pump events, due to low availability of the deuterated 
standard for spiking. Instead, concentration profiles of N4-acetyl-sulfamethoxazole and 
sulfamethoxazole (both not deuterated) show the removal of both compounds by 34-48% 
and 13-20%, respectively (Figure 8-41). Thus, the transformation of N4-acetyl-
sulfamethoxazole into sulfamethoxazole is likely, however cannot be confirmed 
unambiguously.  
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5.4.2 Biotransformation of micropollutants in full-scale GS sewer pipes 
In-sewer transformation of growth substrates and selected micropollutants were monitored 
in a full-scale GS pilot sewer during experiments with recirculated sewage (flow rate of 125 
L min-1, HRT of 5 h). Monitoring of the spiked flow trace rhodamine indicated that the spiking 
solution, containing rhodamine and selected micropollutants, was evenly distributed across 
the GS pipe at t=1.5 h after spiking. 
 
5.4.2.1 Biofilm activity in GS 
As opposed to the full-scale RM, sulfide and methane production was negative during GS 
experiments and indicate inactive SRB and MA (Figure 5-20). The removal of sulfide and 
methane likely occurred via biotransformation by other microbial communities and 
volatilisation. Due to the recirculation of the partly filled gravity pipe, sulfide and methane 
have a sufficiently large water surface area to partition into the gas-phase. However, sulfide 
removal also occurs due to its oxidation or biotransformation, as indicated by the production 
of sulfate-S (Figure 5-20). Furthermore, the rapid conversion of VFAs acetate, propionate, 
butyrate and valerate indicate the activity of heterotrophic microbial communities in the GS 
pipes, such as sulfide-oxidising bacteria. 
The GS biofilm activity in full-scale differed significantly from the laboratory-scale (see 
chapter 5.1.1), likely due the continuous flow and reduced contact time of the sewage with 
the biofilm in full-scale. The impact of contact time has been previously highlighted by McCall 
et al.86 Although the substrate conversion rates in the laboratory-scale reactor were in 
accordance with reported values in literature (see chapter 5.1.1), the significantly different 
substrate conversion rates for sulfide to those in the full-scale GS suggest the population of 
different microbial communities in both setups.  
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Figure 5-20: Production rates of sulfur species, methane and VFAs in full-scale GS.  
 
5.4.2.2 Micropollutant removal during recirculation in gravity sewer pipe 
Twenty out of thirty-three compounds exhibited positive removal in GS, including the spiked 
compounds trimethoprim and sulfamethoxazole, which were removed by 48±9%and 
23±7%, respectively (Figure 5-21). During CAS treatment, significantly higher removal 
efficiencies up to 80% and 100%, respectively, were reported.30 Furthermore, the removal 
of 3-OH-TMP was observed as opposed to its production in RM with hourly pump events 
(i.e. 2±7% vs -29±6%, p<0.05), which indicates the removal of trimethoprim via a different 
removal mechanism or transformation pathway than in RM. The removal of N4-acetyl-
sulfamethoxazole during recirculation in GS occurs in parallel with removal of the parent 
compound sulfamethoxazole. Previously, N4-acetyl-sulfamethoxazole was suggested to 
transform into sulfamethoxazole during CAS treatment and in RM sewers.18,30 However, the 
high removal efficiency of both, N4-acetyl-sulfamethoxazole and sulfamethoxazole during 
this study rather suggests the removal of N4-acetyl-sulfamethoxazole to occur via a different 
pathway. Carbamazepine is considered persistent to biotic removal (<10%),88, however was 
removed by 34±11% in GS. The removal of caffeine and acetaminophen was 35±6% and 
71±9%, respectively. While higher removal efficiencies have been reported during CAS 
treatment for both compounds, i.e. >80%,30,175 acetaminophen may serve as benchmarking 
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substance for easily degradable compounds. Concentration profiles of spiked and 
benchmarking compounds during experiments in GS can be found in the appendix, Figure 
8-42. 
Negligible removal was observed for 9 compounds, including the spiked macrolide antibiotic 
roxithromycin (i.e. 3±14%). While negligible removal may indicate this compounds 
persistence during passage of GS, it may also suggest the removal of roxithromycin by the 
GS biofilm and its introduction from decomposed faecal matter in the sewage. During 
laboratory-based experiments, roxithromycin exhibited removal of 28% (see chapter 5.1.3), 
suggesting low removal capability of the GS biofilm. The more persistent benchmarking 
substances diclofenac and tramadol were removed in full-scale GS by 3±9% and 6±7%, 
which confirms their persistence during recirculation in GS (Figure 5-21). Their removal by 
other full-scale GS biofilm was previously reported to be <25%,88 which is similar the removal 
efficiencies in this study and previous laboratory-based experiments (see chapter 5.1.3). 
Furthermore, removal efficiencies of cardiovascular drugs (except perindopril) and 
venlafaxine were negligible, which suggests their persistence to transformation in GS 
conditions. 
Analogously to removal efficiencies in RM, negative removal (>-10%) was observed for 
ranitidine and doxylamine, i.e. -143±40% and -53±10%, possibly due to desorption or 
release from decomposed particulate matter (Figure 5-21). Negative removal of sulfadiazine 
has previously been observed during moving bed biofilm treatment and attributed to the 
deconjugation of human metabolites.176 
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Figure 5-21: Removal [%] of selected micropollutants in GS during recirculation. The 
removal efficiencies were extrapolated to a HRT of 8 h. The removal of ranitidine was -
143±40%. Sulfamethoxazole-d4 and N4-acetyl-sulfamethoxazole-d4 were not monitored in 
GS. 
 
The removal of the target PhACs during GS recirculation experiments exceeded the removal 
efficiencies obtained from RM experiments for the majority of compounds (Figure 8-43). 
Higher removal in GS than in RM is in contrast to previous laboratory-based experiments 
(see chapter 5.1.3) and may be due to four reasons: Firstly, due to the uneven distribution 
of the spiking solution during the initial 1.5 h after spiking, samples collected prior to even 
distribution might not be representative. However, uneven distribution is unlikely the issue, 
due to the normalisation of the spiked compound concentration with the proportion of 
rhodamine in the samples. Second, mixing and a sewer atmosphere in the GS reactor allow 
for additional removal mechanism to biotransformation by the biofilm and sorption, such as 
oxidation by aerobic communities above the sewage surface. The turbulence also facilitates 
the contact between micropollutants and the biofilm surface area, which may lead to higher 
removal due to improved availability of micropollutant in comparison with RM. Third, the 
experiments were conducted with an HRT of 5 h. However, in order to yield comparable 
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results to RM with an HRT of 8 h, the removal after 8 h was extrapolated using the fitted 
kinetic model. Since the experiments were designed to exclude these sources of error, 
higher removal in GS than is RM is likely the results of higher removal capability of the biofilm 
in GS. Finally, the overall positive removal of micropollutants may indicate the predominantly 
physico-chemical removal of micropollutants from the bulk water phase, such as by 
adsorption.  
The role of micropollutants as substrates during their in-sewer transformation is yet to be 
confirmed. In the case of co-metabolic removal, a carbon and electron source is required for 
microbial metabolism. However, the largest proportion of substrates, except acetate, is 
depleted in GS after 1.5 h, suggesting that further metabolism depends on the consumption 
of acetate or possibly micropollutants as electron and carbon donor. While the specific 
mechanisms for higher removal in GS than in RM cannot be confirmed during this study, the 
high removal efficiencies obtained in GS are possibly influenced by the microbial community 
or the hydraulic conditions.  
 
5.4.3 Implications 
The removal of common PhACs and pesticides in full-scale RM and GS sewer pipes offered 
first insights into PhAC removal kinetics in realistic operational conditions. So far, only limited 
information was published about the fate and behaviour of PhACs in RM and GS conditions 
and is almost completely restricted to laboratory-based research.  
A comparison of the full-scale biofilms in this study and previously utilised laboratory-scale 
biofilm reactors demonstrate significant differences with regard to micropollutant removal 
due to differences in sewage flow rate, mixing conditions, sulfide and methane production 
rates and PhAC removal efficiency. Hence, the fate and behaviour of micropollutants in 
sewers is impacted by the activity of the biofilm, its capability to transform micropollutants 
and the operational conditions in the sewer pipe. Presumably this underestimated 
complexity of the in-sewer biotransformation of micropollutants is the reason for the 
scarceness of literature in this field of research. 
Nevertheless, the in-sewer transformation of trimethoprim, sulfamethoxazole and their 
metabolites confirm the capability of RM sewer biofilms to transform PhACs and their human 
metabolites, with transformation kinetics obtained in a realistic full-scale environment. The 
full-scale pilot sewer setup offered the rare opportunity to control all relevant operational 
parameters and allowed for sampling at multiple locations along the RM pipe.  
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Further research questions to address based on this study are i) identifying the mechanisms 
behind the negative removal of compounds, such as ranitidine. Possible mechanisms may 
be desorption of previously sorbed compound from the biofilm or particulate matter, release 
due to decomposition of particulate matter or the transformation of structurally similar 
compounds, such as metabolites, into the parent compound. Spiking of isotopically labelled 
compounds is recommended for the experimental work. ii) Elucidation of further in-sewer 
TPs and pathways in full-scale. iii) Correlation of in-sewer removal with the microbial 
community and its specific properties, i.e. phylogenetic analysis, expression of functional 
genes during PhAC transformation or the adaptation to the presence of toxic compounds by 
developing resistances.  
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6 Summary and conclusion 
This thesis describes the in-sewer removal of 30 PhACs from various therapeutic groups 
and 4 pesticides by RM and GS sewer biofilms. The investigations included the identification 
of removal mechanisms and involved functional organisms and the elucidation of anaerobic 
transformation products for two antibiotics. Furthermore, the in-sewer transformation of the 
investigated compounds was studied during laboratory-based and pilot full-scale sewer 
experiments. The main conclusions are: 
 
I. Removal under RM conditions: 
• Biotransformation is the dominant removal mechanism during in-sewer removal of 
PhACs and pesticides. Abiotic removal mechanisms, such as sorption, hydrolysis and 
interactions with particles in sewage did not contribute significantly to overall removal, 
with the exception of eight primarily sorbed compounds. 
• Eight cationised and/or lipophilic compounds were sorbed to RM biofilm by 80-100%, 
likely due to surface charge interactions with the biofilm. The remaining investigated 
micropollutants exhibited low sorption (median: 35%). The potential desorption of 
initially sorbed compounds requires further attention. 
• In-sewer micropollutant biotransformation in RM is driven by the predominant 
microbial biofilm communities, i.e. SRB and MA. Only 3 out of 24 compounds were 
removed with the partly contribution of other microbial communities. Furthermore, the 
removal of two other compounds (i.e. sulfamethoxazole and sulfadiazine) was driven 
by other microbial communities, which have yet to be identified.  
• SRB and MA in RM are capable to remove 16 out of 24 compounds to similar extends. 
Competition for substrate by SRB and MA possibly lowers the potential overall 
removal of micropollutants and requires further investigation. 
• Trimethoprim and atenolol were exclusively transformed by MA, while atrazine, 
iopromide, DEET and metolachlor were exclusively transformed by SRB. Low 
abundance or activity of MA and SRB are expected to yield lower removal of these 
compounds. 
• Trimethoprim was transformed into 4 anaerobic transformation products. O-
Demethylation at the C4 and C3 methoxy group yielded TP276A and TP276B, 
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respectively, which structures were previously reported for human metabolites. The 
previously not reported methylation of trimethoprim at the trimethoxy benzene moiety 
produced TP305. TP238 resulted from deamination, ring reduction and O-
demethylation at multiple locations. Except TP238, all transformation products had 
their active antibiotic site (diamino pyrimidine moiety) and possibly their antibiotic 
activities preserved. 
• Roxithromycin was transformed into 4 anaerobic transformation products, i.e. the 
previously reported O-demethylated TP822 and phosphorylated TP916. The 
previously not reported TP854 and TP575 are the results of lactone ring hydrolysis 
and subsequent transformation of the desosamine moiety and N-oxime chain. The 
hydrolysis of lactone rings and phosphorylation of macrolide antibiotics were 
previously linked with microbial antibiotic resistance mechanisms. The potential 
occurrence of the involved antibiotic resistance genes require further investigation. 
• Biotransformation of micropollutants was confirmed in full-scale by the transformation 
of trimethoprim into TP276B, and the production of sulfamethoxazole from its major 
human metabolite N4-acetyl-sulfamethoxazole. These compounds were only partly 
transformed into the monitored transformation products, which strongly suggests the 
occurrence of further unknown TPs. 
• In full-scale RM, the dispersion and dilution of sewage during pump events may 
contribute to overestimation of micropollutant removal without monitoring of a tracer. 
Rhodamine was diluted to ~60% of the initial concentration after eight pump events. 
No significant dilution of rhodamine was observed between pump events. 
• Reduced mixing of sewage in full-scale RM led to lower removal of many investigated 
compounds than observed in laboratory-scale, where continuous mixing was 
provided.  
• Negative removals of micropollutants in full-scale RM indicate the biotransformation 
of human metabolites into the parent compounds or the release of faeces-bound 
compounds during sewer passage.  
 
I. Removal under GS conditions: 
• Laboratory-based GS biofilm yielded lower removal efficiencies than RM for the 
majority of 34 investigated compounds (median: 31% and 41%, respectively) and 
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suggests disadvantages of GS over RM during the reductive dehalogenation of 
chlorinated and iodinated compounds or the strictly anaerobic transformation of 
trimethoprim. 
• In pilot-scale recirculation experiments, the even distribution of spiked compounds 
only occurred after 1.5 h. Spiking of a flow tracer is therefore strongly recommended 
during GS sampling in real sewers.  
• Higher positive removal of the investigated micropollutants during full-scale 
experiments in GS than in RM contradicts the laboratory-based results and is 
attributed two factors: 1) The continuous mixing of sewage, which supports the 
contact between biofilm surface and micropollutant in the bulk sewage. And 2) 
possibly different microbial communities in full-scale and laboratory-scale GS 
biofilms. 
 
Recommendations for future research 
Considering the demonstrated ability of sewer biofilms to remove and transform 
micropollutants from the bulk water phase, further pursuit of this field of research is highly 
recommended and could cover the research questions presented below. 
 
• The removal of micropollutants via physico-chemical mechanisms should be further 
studied in order to differentiate between their adsorption, absorption and 
bioaccumulation. Furthermore, desorption of previously sorbed micropollutants 
requires further investigation, as it has not previously been reported. 
• Non-target analysis of micropollutants may be an effective tool for monitoring the 
occurrence or absence of a broad range of micropollutants and their TPs. The 
analysis of changes in the wastewater composition with regard to micropollutants 
may be beneficial for an initial prioritisation of targeted compounds. 
• In context of the increasing concern about the spread of antibiotic resistance, sewer 
biofilms have been previously identified as reservoir for antibiotic resistance genes.75 
Future research should combine the structural elucidation of further in-sewer TPs and 
their correlation with increasing antibiotic resistance. 
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• Continued monitoring of the fate and behaviour of micropollutants in full-scale RM 
and GS pilot sewer pipes can facilitate the investigation of a broader range of 
scenarios. In particular, the impact on micropollutant removal of HRT, HRT between 
pump events in RM, flow rates and velocities, sewage composition and 
corresponding methane and sulfide production rates still require further attention in 
order to fully elucidate the capacity of sewer biofilms to remove micropollutants. 
Furthermore, pipe diameter and corresponding biofilm surface to sewage volume 
ratios are likely to have an impact on the micropollutant removal rates, as previously 
suggested by McCall et al.86 
• A comprehensive model, containing in-sewer transformation and sorption rates, will 
be highly beneficial for the integrated monitoring and management of micropollutants 
in the urban water cycle from consumer to emission into the aquatic environment. 
The model could allow for the prediction of incoming micropollutant loads at a 
downstream STP inlet and facilitate the optimisation of dedicated treatment steps for 
the removal of micropollutants. Ultimately, an integrated monitoring approach using 
mathematical models may facilitate the reduction of the micropollutant load that is 
emitted into the aquatic environment. 
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8 Appendices 
8.1 Methods: Micropollutant properties and analytical parameters 
Supply information, structures and properties of studied micropollutants. All substances were purchased as analytical standard grade or 
>98 % except erythromycin (95 %) and roxithromycin (90 %). The table below displays their chemical structures and sum formulae arranged 
by therapeutic groups. pKa, charge and LogD values at pH 8 estimated using ChemAxon Marvin Sketch 16.10.31; LogKOW cited in or 
calculated using EPIsuite Kowwin v1.68. Henry’s law volatility constant kHpc calculated using EPIsuite Henrywin v3.20. CAS: Chemical 
Abstracts Services; n.a.: not available. 
Table 8-1: Supply information, structures and properties of studied micropollutants. 
 
Substance (CAS 
number, supplier) 
MW  
[g mol-
1] 
Sum formula Structure pKa charge at pH 8 LogKOW 
LogD 
(pH 8) 
kHpc 
[m3 Pa mol-1] 
A
n
a
l
g
e
s
i
c
s
 
Acetaminophen (103-
90-2, Sigma-Aldrich) 151.16 C8H9NO2 
 
9.45 neutral; 3.3% neg. 
0.27; 
0.46 0.89 6.67 x 10
-8
 
Ibuprofen (15687-27-1, 
Sigma-Aldrich) 206.28 C13H18O2 
 
4.85 100% 
neg. 
3.79; 
3.97 0.85 1.52 x 10
-2
 
Indomethacin (53-86-
1, Sigma-Aldrich) 357.78 C19H16ClNO4 
 
3.8 100% 
neg. 
4.23; 
4.27 0.26 3.18 x 10
-9
 
CH3
O
N
O
Cl
CH3
OH
O
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Substance (CAS 
number, supplier) 
MW  
[g mol-
1] 
Sum formula Structure pKa charge at pH 8 LogKOW 
LogD 
(pH 8) 
kHpc 
[m3 Pa mol-1] 
Diclofenac (15307-86-
5, Sigma-Aldrich), 
sodium salt 
296.14 C14H11Cl2NO2 
 
4.0 100% 
neg. 
4.02; 
4.51 1.10 4.80 x 10
-7
 
Tramadol (27203-92-5, 
Sigma-Aldrich), HCl 263.37 C16H25NO2 
 
9.2; 
13.8 94% pos. 
3.01; 
2.51 1.20 1.56 x 10
-6
 
A
n
t
i
b
i
o
t
i
c
s
 
(
f
l
u
o
r
o
q
u
i
n
o
l
o
n
e
s
)
 
Enrofloxacin (93106-
60-6, Fluka Analytical) 359.39 C19H22FN3O3 
 
5.75; 
6.65 
95% neg.; 
5% 
zwitterioni
c 
0.7 0.06 1.50 x 10-13 
Norfloxacin (70458-96-
7, Riedel-de-Häen) 319.33 C16H18FN3O3 
 
5.75; 
8.65 
82% 
zwitterioni
c; 17% 
neg. 
-0.31; -
1.03 -0.97 8.82 x 10
-14
 
A
n
t
i
b
i
o
t
i
c
s
 
(
s
u
l
f
o
n
a
m
i
d
e
s
 
a
n
d
 
t
r
i
m
e
t
h
o
p
r
i
m
;
 
f
o
l
i
c
 
a
c
i
d
 
i
n
h
i
b
i
t
o
r
)
 
Sulfamethoxazole 
(723-46-6, Fluka 
Analytical) 
253.27 C10H11N3O3S 
 
1.95; 
6.15 99% neg. 
0.48; 
0.89 -0.11 6.67 x 10
-8
 
Sulfadiazine (68-35-9, 
Riedel-de-Häen) 250.27 C10H10N4O2S 
 
2.0; 7.0 91% neg. -0.34; -0.09 -0.33 1.60 x 10
-5
 
Sulfasalazine (599-79-
1, Sigma-Aldrich) 398.39 C18H14N4O5S 
 
3.2; 
6.8;11.8 
100% 
neg.; 
(95% 
divalent) 
3.81 -0.05 2.22 x 10-13 
Trimethoprim (738-70-
5, Fluka Analytical) 290.31 C14H18N4O3 
 
7.2 Neutral; 12% pos. 
0.73; 
0.91 1.23 2.44 x 10
-9
 
114 | 
 
Substance (CAS 
number, supplier) 
MW  
[g mol-
1] 
Sum formula Structure pKa charge at pH 8 LogKOW 
LogD 
(pH 8) 
kHpc 
[m3 Pa mol-1] 
A
n
t
i
b
i
o
t
i
c
s
 
(
m
a
c
r
o
l
i
d
e
s
)
 Erythromycin (114-07-
8, Fluka Analytical) 733.92 C37H67NO13 
 
8,4 71% pos. 2.48; 3.06 2.06 5.49 x 10
-24
 
Roxithromycin (80214-
83-1, Sigma-Aldrich) 837.04 C41H76N2O15 
 
2.3; 9.1 92% pos. 2.75 1.89 5.03 x 10-26 
A
n
t
i
b
i
o
t
i
c
s
 
(
l
i
n
c
o
s
a
m
i
d
e
)
 
Lincomycin (154-21-2, 
Fluka Analytical), HCl 406.53 C18H34N2O6S 
 
8.0 48% pos. 0.29; 0.20 -0.60 3.03 x 10
-18
 
A
n
t
i
b
i
o
t
i
c
s
 
(
b
e
t
a
-
l
a
c
t
a
m
)
 
Cephalexin (15686-71-
2, Sigma-Aldrich), 
H2O 
347.38 C16H17N3O4S 
 
3.5; 7.2 
86% neg.; 
14% 
zwitter-
ionic 
0.40; 
0.65 -2.49 2.80 x 10
-12
 
A
n
t
i
m
a
l
a
r
i
a
l
 Dapson (80-08-0, 
Riedel-de-Häen) 248.3 C12H12N2O2S 
 
1.5; 2.4 100% 
neutral 
0.77; 
0.97 1.27 3.15 x 10
-9
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Substance (CAS 
number, supplier) 
MW  
[g mol-
1] 
Sum formula Structure pKa charge at pH 8 LogKOW 
LogD 
(pH 8) 
kHpc 
[m3 Pa mol-1] 
C
a
r
d
i
o
v
a
s
c
u
l
a
r
 
d
r
u
g
s
 
Gemfibrozil (25812-30-
0, Sigma-Aldrich) 250.33 C15H22O3 
 
4.4 100% 
neg. 4.77 1.51 1.21 x 10
-3
 
Atenolol (29122-68-7, 
Sigma-Aldrich) 266.33 C14H22N2O3 
 
9.7 98% pos. -0.03; 0.16 -1.24 1.39 x 10
-13
 
Metoprolol (37350-58-
6, Sigma-Aldrich), 
tartrate 
684.81 C15H25NO3 
 
9.7 98% pos. 1.69; 1.88 -0.47 1.42 x 10
-8
 
Propanolol (525-66-6, 
Sigma-Aldrich), HCl 259.34 C16H21NO2 
 
9.7 98% pos. 0.74 0.92 8.09 x 10-8 
Hydrochlorothiazide 
(58-93-5, Sigma-
Aldrich) 
297.73 C7H8ClN3O4S2 
 
9.0; 
11.4 
92% 
neutral; 
8% neg. 
-0.10; -
0.07 -0.58 4.45 x 10
-7
 
Perindopril (82834-16-
0, Sigma-Aldrich), 
erbumine 
268.46 C19H32N2O5 
 
3.8; 5.5 100% 
neg. 2.59 -1.04 7.61 x 10
-10
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Substance (CAS 
number, supplier) 
MW  
[g mol-
1] 
Sum formula Structure pKa charge at pH 8 LogKOW 
LogD 
(pH 8) 
kHpc 
[m3 Pa mol-1] 
A
n
t
i
h
i
s
t
a
m
i
n
e
s
 Doxylamine (469-21-6, 
Sigma-Aldrich), 
succinate 
270.36 C17H22N2O 
 
3.2; 8.9 
88% pos.; 
12% 
neutral 
2.37 2.04 6.51 x 10-7 
Ranitidine (66357-35-
5, Sigma-Aldrich), HCl 314.4 C13H22N4O3S 
 
8.0 
61%neutr
al; 38% 
pos. 
0.29; 
0.27 0.78 3.46 x 10
-10
 
A
n
t
i
e
p
i
l
e
p
t
i
c
s
 
Carbamazepine (298-
46-4, Sigma-Aldrich) 236.26 C15H12N2O 
 
n.a. neutral 2.25; 2.45 2.77 1.11 x 10
-5
 
Phenytoin (57-41-0, 
Sigma-Aldrich) 252.26 C15H12N2O2 
 
8.5 neutral; 24% neg. 
2.16; 
2.47 2.03 1.03 x 10
-6
 
A
n
t
i
d
e
p
r
e
s
s
a
n
t
s
 
Fluoxetine (2-84-9, 
Sigma-Aldrich), HCl 309.32 C17H18F3NO 
 
9.8 99% pos. 4.65; 4.05 2.38 9.02 x 10
-3
 
Sertraline (79617-96-
2, Sigma-Aldrich), HCl 306.22 C17H17Cl2N 
 
9.5 97% pos. 5.29 3.58 5.17 x 10-3 
O
N
N
H
3
C
CH
3
CH
3
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Substance (CAS 
number, supplier) 
MW  
[g mol-
1] 
Sum formula Structure pKa charge at pH 8 LogKOW 
LogD 
(pH 8) 
kHpc 
[m3 Pa mol-1] 
Venlafaxine (93413-
69-5, Sigma-Aldrich), 
HCl 
277.4 C17H27NO2 
 
8.9 89% pos. 3.28 1.78 2.07 x 10-6 
Citalopram (59729-33-
8, Toronto Research 
Chemicals), HBr 
324.39 C20H21FN2O 
 
9.8 98% pos. 3.74 1.41 2.73 x 10-6 
P
s
y
c
h
o
-
s
t
i
m
u
l
a
n
t
 
Caffeine (58-08-2, 
Sigma-Aldrich) 194.19 C8H10N4O2 
 
n.a. 
100% 
neutral 
0.16; -
0.07 -0.55 1.11 x 10
-6
 
R
a
d
i
o
c
o
n
t
r
a
s
t
 
a
g
e
n
t
 
Iopromide (73334-07-
3, USP) 791.11 C18H24I3N3O8 
 
n.a. 
100% 
neutral 
-2.49; -
2.05 -2.12 1.02 x 10
-23
 
I
n
s
e
c
t
 
r
e
p
e
l
l
e
n
t
 
DEET (134-62-3, 
Fluka Analytical) 191.13 C12H17NO 
 
n.a. 
100% 
neutral 
2.26; 
2.18 2.50 2.13 x 10
-3
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Substance (CAS 
number, supplier) 
MW  
[g mol-
1] 
Sum formula Structure pKa charge at pH 8 LogKOW 
LogD 
(pH 8) 
kHpc 
[m3 Pa mol-1] 
P
e
s
t
i
c
i
d
e
s
 
(
I
n
s
e
c
t
i
c
i
d
e
s
)
 
Metolachlor (51218-
45-2, Fluka Analytical) 283.79 C15H22ClNO2 
 
n.a. 
100% 
neutral 
3.24; 
3.13 3.45 9.09 x 10
-4
 
2, 4-Dichlorophenoxy-
acetic acid (94-75-7, 
Toronto Research 
Chemicals) 
221.03 C8H6Cl2O3 
 
2.8 100% 
neg. 
2.62; 
2.81 -0.1.02 2.00 x 10
-5
 
Atrazine (1912-24-9, 
Fluka Analytical) 215.68 C8H14ClN5 
 
3.2 100% 
neutral 
2.82; 
2.61 2.2 2.86 x 10
-4
 
Diuron (330-54-1, 
Sigma-Aldrich) 233.09 C9H10Cl2N2O 
 
13.2 100% 
neutral 
2.67; 
2.68 2.53 5.00 x 10
-5
 
 
 
O
OH
O
Cl
Cl
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Table 8-2: MS parameters of studied PhACs and pesticides in 4000qTRAP. tR: retention time; CE: collison energy, DP: declustering 
potential, CXP: collision cell exit potential; all in Volt; Entrance potential was set to 10 V. Compounds marked with and asterisk (*) were 
analysed during the pilot experiments (objective 4), only. 
Standard Internal standard 
Substance tR [min] 
Precursor 
ion 
Q1 
MRM1/ 
MRM2 
CE-DP-CXP: 
MRM1/ MRM2 
Substance (CAS 
number) 
Q1 
MRM1/ 
MRM2 
CE-DP-CXP: 
MRM1/ MRM2 
Acetaminophen 5.7 [M-H]- 150  106/107 
60-26-7/ 60-22-
5 
Acetaminophen-d4 
(64315-36-2) 
155  
111/121 60-26-7/ 60-42-5 
Ibuprofen 7.9 [M-H]- 205  161 52-11.5-10 rac. Ibuprofen-d3 (121662-14-4) 
209  
164/161 45-10-11/ 45-10-5 
Indomethacin 11.1 [M-H]+ 358  139/111 
91-27-12/ 91-
71-8 
Indomethacin-d4 
(87377-08-0) 
362  
143/115 81-29-10/ 81-77-18 
Diclofenac 6.8 [M-H]- 193  250/214 
40-16-1/ 40-30-
15 
Diclofenac-d4 (153466-
65-0) 
298  
253/216 60-16-1/ 60-30-12 
Tramadol 6.7 [M-H]+ 264  58/42 
45-44-8/ 45-
125-3 Tramadol-d6 (n.a.), HCl 
270  
64/45 61-39-2/ 61-113-8 
Enrofloxacin 6.3 [M-H]+ 360  316/245 
81-29-12/ 81-
39-20 
Enrofloxacin-d5 
(1173021-92-5) 
365  
321/245 86-33-18/ 86-35-22 
Norfloxacin 6.2 [M-H]+ 320  276/233 
70-26-14/ 70-
35-14 
Enrofloxacin-d5 
(1173021-92-5) 
365  
321/245 86-33-18/ 86-35-22 
Sulfamethoxazole 7.4 [M-H]+ 254  92/156 
51-38-8/ 51-23-
8 
Sulfamethoxazole-d4 
(1020719-86-1) 
258  
96/112 76-37-8/ 76-39-6 
*N4-acetyl-
sulfamethoxazole 7.4 [M-H]+ 
296  
134/65 
66-35-6/ 66-63-
10 
Sulfadiazine-d4 
(1020719-78-1) 
255 
160/96 71-23-12/ 71-39-6 
*N4-acetyl-
sulfamethoxazole-
d4 
7.4 [M-H]+ 301  139/68 
76-35-8/ 76-69-
12 
Sulfadiazine-d4 
(1020719-78-1) 
255 
160/96 71-23-12/ 71-39-6 
*Sulfamethoxazole-
d4 7.4 [M-H]+ 
258  
96/112 
76-37-8/ 76-39-
6 
Sulfadiazine-d4 
(1020719-78-1) 
255 
160/96 71-23-12/ 71-39-6 
Sulfadiazine 6.3 [M-H]+ 251 92/65 
66-39-6/ 66-63-
4 
Sulfadiazine-d4 
(1020719-78-1) 
255 
160/96 71-23-12/ 71-39-6 
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Standard Internal standard 
Substance tR [min] 
Precursor 
ion 
Q1 
MRM1/ 
MRM2 
CE-DP-CXP: 
MRM1/ MRM2 
Substance (CAS 
number) 
Q1 
MRM1/ 
MRM2 
CE-DP-CXP: 
MRM1/ MRM2 
Sulfasalazine 8.1 [M-H]+ 399  223/119 
30-43-11/ 30-
63-7 
Sulfasalazine-d4 
(13446606-50-5) 
403  
385/119 76-27-14/ 76-61-8 
Trimethoprim 6.1 [M-H]+ 291  230/261 
86-33-4/ 86-37-
6 
Trimethoprim-13C2 
(1189970-95-3) 
294  
126/233 96-34-9/ 96-33-12 
*3-desmethyl-
trimethoprim 5.5 [M-H]+ 
277  
261/262 
86-37-14/ 86-
49-6 
Trimethoprim-13C2 
(1189970-95-3) 
294  
126/233 96-34-9/ 96-33-12 
*4-desmethyl-
trimethoprim 5.7 [M-H]+ 
277  
261/123 
76-35-14/ 76-
27-14 
Trimethoprim-13C2 
(1189970-95-3) 
294  
126/233 96-34-9/ 96-33-12 
Erythromycin 7.5 [M-H]+ 734  158/576 
71-41-8/ 71-35-
8 
Erythromycin-3 C13 d3 
(959119-26-7) 
738  
162/83 76-45-14/ 76-89-6 
Roxithromycin 8.4 [M-H]+ 837  679/158 
96-31-12/ 96-
49-12 Roxithromycin-d7 (n.a.) 
844  
158/83 
101-49-12/ 101-103-
6 
Lincomycin 5.7 [M-H]+ 407  126/359 
91-39-10/ 91-
27-10 Lincomycin-d3 (n.a.) 
410  
129/73 96-39-10/ 96-95-2 
Cephalexin 5.9 [M-H]+ 348  158/106 
41-15-12/ 41-
43-6 
Atenolol-d7 (1202864-
50-3) 
274  
145/79 71-37-12/ 71-33-6 
Dapson 7.1 [M-H]+ 249  108/92 
71-31-8/ 71-35-
6 
Venlafaxine-d6 
(1020720-02-8) 
284  
58/266 61-59-8/ 61-19-20 
Gemfibrozil 9.8 [M-H]- 249  121/127 
85-20-7/ 85-14-
5 
Gemfibrozil-d6 
(1184986-45-5) 
256 
121/133 60-28-7/ 60-14-9 
Atenolol 5.2 [M-H]+ 267  145/190 
71-37-12/ 71-
29-16 
Atenolol-d7 (1202864-
50-3) 
274  
145/79 71-37-12/ 71-33-6 
Propanolol 7.3 [M-H]+ 260  116/183 
76-27-8/ 76-27-
12 
rac. Propanolol-d7 
(98897-23-5) 
267  
123/79 76-27-10/ 76-33-6 
Metoprolol 6.6 [M-H]+ 268  116/121 
76-27-8/ 76-35-
8 
Atenolol-d7 (1202864-
50-3) 
274  
145/79 71-37-12/ 71-33-6 
Hydrochlorothiazide 6.0 [M-H]- 296  268/204 
90-26-13/ 90-
30-17 
Hydrochlorothiazide-
2 C13 d2 (1190006-03-1) 
301  
269/78 90-28-5/ 90-50-3 
Perindopril 7.3 [M-H]+ 369  172/98 
76-29-14/ 76-
49-6 
Perindopril-d4 
(1356929-58-2) 
373  
176/102 76-29-44/ 76-55-8 
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Standard Internal standard 
Substance tR [min] 
Precursor 
ion 
Q1 
MRM1/ 
MRM2 
CE-DP-CXP: 
MRM1/ MRM2 
Substance (CAS 
number) 
Q1 
MRM1/ 
MRM2 
CE-DP-CXP: 
MRM1/ MRM2 
Doxylamine 6.0 [M-H]+ 271  182/167 
40-24-8/ 40-45-
7 
Doxylamine-d5 
(1216840-94-6), 
succinate 
276  
187/171 56-25-12/ 56-47-14 
Ranitidine 5.4 [M-H]+ 315  176/102 
61-25-14/ 61-
51-16 
Ranitidine-d6 (1185514-
83-3) 
321  
176/102 51-25-16/ 51-47-8 
Carbamazepine 8.5 [M-H]+ 237  194/193 
61-27-16/ 61-
47-12 
Carbamazepine-d10 
(132183-78-9) 
247  
202/204 81-50-14/ 81-31-12 
Phenytoin 8.2 [M-H]+ 253  182/104 
61-27-10/ 61-
51-8 
Phenytoin-d10 (65854-
97-9) 
263  
192/109 71-27-14/ 71-51-8 
Fluoxetine 8.3 [M-H]+ 310  44/148 
46-41-6/ 46-13-
12 
Phenytoin-d10 (65854-
97-9) 
263  
192/109 71-27-14/ 71-51-8 
Sertraline 8.6 [M-H]+ 306  159/275 
56-39-12/ 56-
19-18 
Sertraline-d3 (1217741-
83-7) 
309  
159/275 51-35-12/ 51-17-18 
Venlafaxine 7.1 [M-H]+ 278  58/260 
61-41-10/ 61-
19-6 
Venlafaxine-d6 
(1020720-02-8) 
284  
58/266 61-59-8/ 61-19-20 
Citalopram 7.7 [M-H]+ 325  109/262 
70-38-4/ 70-28-
4 
Venlafaxine-d6 
(1020720-02-8) 
284  
58/266 61-59-8/ 61-19-20 
Caffeine 6.3 [M-H]+ 195  138/110 
71-29-8/ 71-32-
8 
Caffeine-3 C13 (78072-
66-9) 
198  
112/140 36-27-12/ 36-29-12 
Iopromide 5.3 [M-H]+ 792  113/572 
120-35-10/ 125-
54-10 
Iopromide-d3 (1189947-
73-6) 
795  
576/562 96-33-16/ 96-41-14 
DEET 9.8 [M-H]+ 192  119/91 
61-25-8/ 61-45-
6 
Carbamazepine-d10 
(132183-78-9) 
247  
202/204 81-50-14/ 81-31-12 
Metolachlor 12.2 [M-H]+ 285  253/177 
61-25-16/ 61-
37-16 
Metolachlor-d6 
(1219803-97-0) 
290  
258/182 61-23-20/ 61-37-14 
2, 4-D 5.1 [M-H]- 218  160/124 
45-18-5/ 45-40-
9 
Acetaminophen-d4 
(64315-36-2) 
155  
111/121 60-26-7/ 60-42-5 
Triclopyr 5.3 [M-H]- 256  198/196 
55-30-5/ 55-30-
5 
Acetaminophen-d4 
(64315-36-2) 
155  
111/121 60-26-7/ 60-42-5 
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Standard Internal standard 
Substance tR [min] 
Precursor 
ion 
Q1 
MRM1/ 
MRM2 
CE-DP-CXP: 
MRM1/ MRM2 
Substance (CAS 
number) 
Q1 
MRM1/ 
MRM2 
CE-DP-CXP: 
MRM1/ MRM2 
Atrazine 9.6 [M-H]+ 216  174/68 
81-27-10/ 81-
53-12 
Indomethacin-d4 
(87377-08-0) 
362  
143/115 81-29-10/ 81-77-18 
Diuron 9.3 [M-H]- 230  185/150 
65-26-15/ 65-
36-9 
Diuron-d6 (1007536-67-
5) 
239  
185/150 75-26-15/ 75-34-11 
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Table 8-3: Initial concentrations of investigated PhACs and pesticides in raw sewage. 
Therapeutic group Substance Initial concentration in raw sewage; Range [µg/L] 
Analgesics 
Acetaminophen 26.28-32.96 
Ibuprofen 0.68-1.91 
Indomethacin 0.02-0.04 
Diclofenac 0.25-1.20 
Tramadol 0.05-0.22 
Antibiotics 
(fluoroquinolones) 
Enrofloxacin 0.02-0.03 
Norfloxacin 0.11-1.36 
Antibiotics (sulfonamides 
and trimethoprim; folic acid 
inhibitor) 
Sulfadiazine 0.92-1.29 
Sulfamethoxazole 0.01-0.02 
Sulfasalazine 0.02-0.03 
Trimethoprim 0.03-0.04 
Antibiotics (macrolides) Erythromycin 0.04-0.09 Roxithromycin 0.40-0.44 
Antibiotics (lincosamide) Lincomycin 0.03-0.06 
Antibiotics (beta-lactam) Cephalexin 0.05-0.09 
Antimalarial Dapsone 0.20-0.23 
Cardiovascular drugs 
Gemfibrozil 0.01-0.02 
Atenolol 1.08-1.46 
Propanolol 0.04-0.08 
HCTZ 0.21-0.81 
Perindopril 0.07-0.11 
Antihistamines Doxylamine 0.04-0.07 Ranitidine 0.00-0.00 
Antiepileptics Carbamazepine 0.14-0.31 Phenytoin 0.05-0.08 
Antidepressants 
Fluoxetine 0.01-0.01 
Sertraline 0.02-0.03 
Venlafaxine 0.39-0.63 
Psycho-stimulant Caffeine 13.44-16.68 
Radiocontrast agent Iopromide 0.09-0.23 
Insect repellent DEET 0.43-1.14 
Pesticides (Insecticides) 
Metolachlor 0.00-0.00 
2,4-D 0.02-0.04 
Atrazin 0.01-0.03 
Triclopyr 0.94-1.28 
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8.2 Methods: Modified reactor setups 
 
Figure 8-1: Modified RM setup for batch experiments conducted at initial concentration of 
5 µg L-1. 
Raw sewage, 
stored at 4°C
Recirculation loop:
No feeding, pump used to 
recirculate 5 L of sewage; 
valves v1 and v2 closed
Feeding: No 
recirculation, valves 
v1 and v2 open
v1 v2
Effluent
Reservoir, 2 L, 
no biofilm
Coil in heated 
water bath, 
40°C 
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Figure 8-2: Modified experimental setup for eludication of TP formation in RM. Analogously 
to the reactor, the reservoir was stirred at 250 rpm. 
 
Reservoir, 2 L, sealed to avoid 
exposure to oxygen
Magnetic stirrer and stirrer bar in 
reactor
Dispenser for 
distribution of 
sewage in reactor
Headspace replaced with 
synthetic wastewater; valve 
closed during operation
Sampling ports
Synthetic wastewater, 
conc. 200x, 
autoclaved, sealed
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Figure 8-3: Experimental procedure during transformation product elucidation experiments.  
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Figure 8-4: Schematic representation of the full-scale pilot RM setup. 
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Figure 8-5: Schematic representation of the full-scale pilot GS setup. 
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8.3 Supporting figures for objective 1: Fate and behaviour of key micropollutants in rising main and gravity sewers 
 
Figure 8-6: A. Removal of investigated PhACs and pesticides (normalised to biofilm surface area to wastewater volume ratio, A/V) with 
initial concentration of 5 µg L-1 and 50 µg L-1 in RM. GS was tested only at 50 µg L-1. B. First-order rate constants (normalised to A/V) for 
RM and GS at 50 µg L-1.  
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Figure 8-7: Evolution of micropollutants concentration during laboratory-based experiments. All data is presented as the mean of triplicate 
experiments with standard error. 
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Figure 8-7 ctd: Evolution of micropollutants concentration during laboratory-based experiments. All data is presented as the mean of 
triplicate experiments with standard error. 
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Figure 8-7 ctd.: Evolution of micropollutants concentration during laboratory-based experiments. All data is presented as the mean of 
triplicate experiments with standard error. 
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Figure 8-8: Time series showing production of sulfide-S (■) and methane (▲) and consumption of sulfate-S (■) and VFAs acetate (●), 
propionate (♦), butyrate (○) and valerate (■) during 8h in RM, GS, and RM with inhibited biofilm and control without  
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Figure 8-9: Time series showing production of sulfide-S (■) and methane (▲) and 
consumption of sulfate-S (■) and VFAs acetate (●), propionate (♦), butyrate (○) and valerate 
(■) during 8h at initial concentration of 5 µg L-1. 8 h values for methane were not 
representative and therefore not included in this graph. 
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Figure 8-10: Extent of removal observed in control reactors without biofilm. 
 
 
Figure 8-11: First-order rate constants obtained in control reactor without biofilm. As 
opposed to rate constants in biofilm reactors, values were not normalised. Standard error of 
trimethoprim was ±15.04 h-1 and error bar cropped for better legibility of other values. 
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Figure 8-12: Comparative assessment between normalised removal rates of micropollutants 
in active (x-axis) and inactive RM sewer biofilms (y-axis). The diagonal line denominates a 
slope of 1, thus representing identical removal by active an inactive biofilm. Error bars have 
been removed to enhance graph legibility. 
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Figure 8-13: Comparative assessment between normalised removal rates of micropollutants 
by GS (x-axis) and RM sewer biofilms (y-axis). The diagonal line denominates a slope of 1, 
thus representing identical removal in RM and GS. Error bars have been removed to 
enhance graph legibility. 
 
Figure 8-14: First-order rate constants obtained in RM at 5 µg L-1 initial concentration. 
Values were normalised by the setups biofilm surface to sewage volume ratio. Standard 
error of acetaminophen was ±0.33 m3 h-1 m-2 and error bar cropped for better legibility of 
other values.
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8.4 Supporting figures for objective 2: Role of microbial communities for in-sewer biotransformation 
 
Figure 8-15: Micropollutant removal by RM biofilm (black) and RM biofilm after inhibition of MA (green, hatched), SRB (red) and SRB and 
MA simultaneously (white, dotted). B. First-order rate constants obtained during micropollutant removal by RM biofilm (X) and RM biofilm 
after inhibition of MA (▲), SRB (●) and SRB and MA simultaneously (□). All PhACs are arranged by therapeutic groups. Results are 
displayed as mean with standard error of triplicate experiments. 
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Figure 8-16: Evolution of micropollutants concentration during laboratory-based experiments. All data is presented as the mean of 
triplicate experiments with standard error. 
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Figure 8-16 ctd: Evolution of micropollutants concentration during laboratory-based experiments. All data is presented as the mean of 
triplicate experiments with standard error. 
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Figure 8-17: Time series showing production of sulfide-S (■) and methane (▲) and consumption of sulfate-S (■) and VFAs acetate (●), 
propionate (♦), butyrate (○) and valerate (■) during 8h in RM after inhibition of SRB, MA or SRB and MA. 
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Figure 8-18: Comparative assessment between removals of micropollutants by nitrite-
inhibited RM biofilm (x-axis) vs. RM biofilm with inhibited SRB and MA community (y-axis). 
The thin solid diagonal line through zero denominates identical removal with partly and 
complete inhibition ±10% difference (dashed lines). Results of linear regression were 
significant and are represented by the thick lines. Error bars that exceed the graph area 
were cropped. Numbers in or next to the symbols refer to the displayed micropollutant: 1-
ibuprofen, 2-phenytoin, 3-atenolol, 4-perindopril, 5-iopromide, 6-DEET, 7-diclofenac, 8-2,4-
D, 9-hydrochlorothiazide, 10-carbamazepine, 11-tramadol, 12-gemfibrozil, 13-caffeine, 14-
atrazin, 15-sulfamethoxazole, 16-venlafaxine, 17-diuron, 18-roxithromycin, 19-dapsone, 20-
doxylamine, 21-metolachlor, 22-trimethoprim. Compounds outside the graph area are 
sulfadiazine (x=-1.49±0.21%; y= 11.73±1.19%) and acetaminophen (x=61.93±3.22%; 
y=52.17±0.28%). 
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8.5 Supporting figures and tables for objective 3: Formation of anaerobic TPs of the 
antibiotics trimethoprim and roxithromycin 
 
 
Figure 8-19: Decrease in concentrations of ROX (A) and TMP (B) in sewer biofilm reactors, 
at high initial concentrations applied for the elucidation of TPs.  
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Figure 8-20: Proposed fragmentation pattern of ROX. 
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Figure 8-21: Proposed fragmentation pattern of TP822. 
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Figure 8-22: Proposed fragmentation pattern of TP916.  
 
Figure 8-23: Proposed fragmentation pattern of TP854.  
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Figure 8-24: Proposed fragmentation pattern of TP575. 
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Figure 8-25: Proposed fragmentation pattern of TMP. 
 
 
 
Figure 8-26: Proposed fragmentation pattern of TP276A. 
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Figure 8-27: Proposed fragmentation pattern of TP276B. 
 
 
Figure 8-28: Proposed fragmentation pattern of TP304. 
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Figure 8-29: Proposed fragmentation pattern of TP238.  
Biotransformation of micropollutants in sewers – Appendices | 151  
 
 
Figure 8-30: Peak intensities for TP238 during TP elucidation experiments in sewer biofilm 
reactor spiked with TMP (empty symbols) and without spiked antibiotic (filled symbols). 
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Table 8-4: Accurate mass measurements of roxithromycin (ROX) and transformation products (TPs) in anaerobic rising main sewer biofilm 
reactors determined by UPLC-ESI (+)-linear ion trap-Orbitrap in MS and MS/MS mode. RDBE-ring double bond equivalent. 
Retention 
time, min Compound 
Elemental 
composition of 
molecular and 
fragment ions 
Exact 
mass, 
m/z 
Measured 
mass, m/z 
Relative 
error, 
ppm 
RDBE Proposed compound structure 
6.01 ROX 
C41H76N2O15Na 
C41H77N2O15 
C33H63N2O12 
C33H61N2O11 
C29H52NO9 
C29H50NO8 
C25H48NO10 
C21H36NO6 
859.5138 
837.5319 
679.4376 
661.4270 
558.3637 
540.3531 
522.3273 
398.2537 
859.5130 
837.6746 
679.4365 
661.4262 
558.3630 
540.3523 
522.3267 
398.2534 
-0.9329 
-0.5658 
-1.5134 
-1.1770 
-1.2223 
-1.4786 
-1.0565 
-0.8973 
4.5 
4.5 
3.5 
4.5 
4.5 
5.5 
2.5 
4.5 
 
O O
O
N
O
OH
O O
O
OH OH
O
NHO
O OH
O
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5.15 TP822 
C40H74N2O15Na 
C40H75N2O15 
C32H61N2O12 
C32H59N2O11 
C29H52NO9 
C29H50NO8 
C29H48NO7 
C24H46N2O10 
C21H36NO6 
845.4981 
823.5162 
665.4219 
647.4113 
558.3637 
540.3531 
522.3425 
508.3116 
398.2537 
845.5005 
823.5143 
665.4208 
647.4106 
558.3631 
540.3522 
522.3416 
508.5817 
398.2534 
2.8490 
-2.3114 
-1.5993 
-1.1638 
-1.0037 
-1.7045 
-0.6674 
-1.8769 
-0.8207 
4.5 
4.5 
3.5 
4.5 
4.5 
5.5 
6.5 
2.5 
4.5 
 
5.39 TP916 
C41H76N2O18PNa 
C41H77N2O18P 
C33H63N2O15PNa 
C33H61NO13Na 
C29H52NO12Na 
C29H49NO8Na 
C25H47NO10Na 
939.4801 
917.4982 
781.3858 
702.4035 
660.3119 
562.3350 
544.3092 
939.4832 
917.4955 
781.3846 
702.4025 
660.3112 
562.3345 
544.3086 
2.0650 
-2.9349 
-1.5923 
1.3209 
-1.0883 
-0.6807 
-1.1463 
4.5 
4.5 
3.5 
2.5 
4.5 
5.5 
2.5 
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5.07 TP854 
C41H78N2O16Na 
C41H79N2O16 
C41H77N2O15 
C37H68NO13 
C33H65N2O13 
C29H54NO10 
877.5244 
855.5424 
837.5319 
734.4685 
697.4481 
576.3742 
877.5257 
855.5443 
837.5291 
734.4671 
697.4470 
576.3731 
1.5614 
2.2219 
-3.3350 
-1.9271 
-1.6573 
-2.0409 
3.5 
3.5 
4.5 
4.5 
2.5 
3.5 
 
5.21 TP575 
C29H53NO10Na 
C29H54NO10 
C29H52NO9 
C26H46NO8 
C18H29O5 
C18H27O4 
598.3562 
576.3742 
558.3637 
500.3218 
325.2010 
307.1904 
598.3750 
576.3750 
558.3622 
500.3205 
325.2002 
307.1897 
0.4168 
1.3477 
-2.5340 
-2.6557 
-2.4160 
-2.3408 
3.5 
3.5 
4.5 
4.5 
4.5 
5.5 
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Table 8-5: Accurate mass measurements of trimethoprim (TMP) and transformation products (TPs) in anaerobic rising main sewer biofilm 
reactors determined by UPLC-ESI (+)-linear ion trap-Orbitrap in MS and MS/MS mode. RDBE-ring double bond equivalent. 
Retention 
time, min Compound 
Elemental 
composition of 
molecular and 
fragment ions 
Exact 
mass, m/z 
Measured 
mass, m/z 
Relative 
error, 
ppm 
RDBE Proposed compound structure 
3.29 TMP 
C14H18N4O3Na 
C14H19N4O3 
C13H16N4O3 
C12H14N4O3 
C12H13N4O3 
C12H15N4O2 
C12H14N4O 
C10H13O3 
C5H7N4 
313.1271 
291.1452 
276.1217 
262.1060 
261.0982 
247.1190 
230.1162 
181.0859 
123.0665 
313.1272 
291.1455 
276.1216 
262.1059 
261.0982 
247.1189 
230.1162 
181.0859 
123.0666 
0.4019 
1.1075 
-0.1768 
-0.4399 
0.0739 
-0.2257 
-0.1399 
-0.1605 
0.9127 
7.5 
7.5 
8.0 
8.0 
8.5 
7.5 
8.0 
4.5 
4.5 
 
2.14 TP276A 
C13H16N4O3Na 
C13H17N4O3 
C12H14N4O3 
C12H12N4O2 
C11H13N4O2 
C9H11O3 
C5H7N4 
299.1100 
277.1295 
262.1060 
244.0955 
233.1033 
167.0703 
123.0665 
299.1115 
277.1298 
262.1057 
244.0950 
233.1029 
167.0701 
123.0664 
-4.8334 
0.9900 
-1.6043 
-2.0123 
-1.8337 
-1.5766 
-0.8231 
7.5 
7.5 
8.0 
9.0 
7.5 
4.5 
4.5  
2.77 TP276B 
C13H16N4O3Na 
C13H17N4O3 
C12H14N4O3 
C12H12N4O2 
C9H11O3 
C5H7N4 
299.1100 
277.1295 
262.1060 
244.0955 
167.0703 
123.0665 
299.1115 
277.1283 
262.1059 
244.0952 
167.0701 
123.0665 
-4.8334 
-4.1236 
-0.6728 
-1.0746 
-1.0286 
-0.4512 
7.5 
7.5 
8.0 
9.0 
4.5 
4.5 
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8.6 Supporting figures and tables for objective 4: Demonstrating in-sewer biotransformation of micropollutants in full-scale 
sewer pipes 
 
Figure 8-31: Time series showing production and consumption of relevant activity parameters during full-scale experiments in RM in 
different pipe sections, i.e 15 m (#1)., 105 m (#4) and 210 m (#B7. A: Conversion of sulfur species sulfide-S (■) and sulfate-S (■). B: 
Conversion of organic compounds methane (▲) and VFAs acetate (●), propionate (♦), butyrate (○) and valerate (■). 
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Figure 8-32: Production rates of sulfur species, methane and VFA achieved by the RM 
microbial community between hourly pump events. Displayed substances are methane (■), 
sulfate-S (■), sulfide-S (■), acetate (■), propionate (■), butyrate (□) and valerate (■). The 
differences between the datasets were not significant (p>0.05).  
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Figure 8-33: Time series showing production and consumption of relevant activity 
parameters during full-scale experiments in RM with hourly pump events (HRT=8h). The 
vertical grey lines indicate the pump events, which had a duration of 1 min at a flow rate of 
237 L min-1. A: Conversion of sulfur species sulfide-S (■) and sulfate-S (■). B: Conversion 
of organic compounds methane (▲) and VFAs acetate (●), propionate (♦), butyrate (○) and 
valerate (■). 
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Figure 8-34: Time series showing production and consumption of relevant activity 
parameters during full-scale experiments in GS with recirculated sewage at a flow rate of 
125 L min-1. A: Conversion of sulfur species sulfide-S (■) and sulfate-S (■). B: Conversion 
of organic compounds methane (▲) and VFAs acetate (●), propionate (♦), butyrate (○) and 
valerate (■). 
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Figure 8-35: Evolution of trimethoprim, roxithromycin and sulfamethoxazole concentrations 
during full-scale RM experiments without pump events at different sampling locations. The 
solid lines represent the fitted first-order model. Dotted lines represent a zero-order model. 
A: Sampling location #1 (15 m after feed). B: #4 (105 m). C: #B7 (210 m). 
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Figure 8-36: Evolution of carbamazepine, diclofenac and tramadol concentrations during 
full-scale RM experiments without pump events at different sampling locations. The solid 
lines represent the fitted first-order model. Dotted lines represent a zero-order model. A: 
Sampling location #1 (15 m after feed). B: #4 (105 m). C: #B7 (210 m). 
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Figure 8-37: Evolution of caffeine and acetaminophen concentrations during full-scale RM 
experiments without pump events at different sampling locations. The solid lines represent 
the fitted first-order model. Dotted lines represent a zero-order model. A: Sampling location 
#1 (15 m after feed). B: #4 (105 m). C: #B7 (210 m). 
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Figure 8-38: Removal efficiency of investigated micropollutants during RM experiments without pump events at different sampling locations 
(#1, 15 m: white; #4, 105 m: yellow, hatched; #B7, 210 m: green). The removal efficiencies were extrapolated to 8 h. Removal phenytoin, 
fluoxetine, sertraline, dapsone and indomethacin at #4: -110±67%, -369±522%, -168±155%, -315±378% and -339±465%. Removal of 
doxylamine at location #B7: -122±42. 
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Figure 8-39: Evolution of PhAC concentrations during full-scale RM experiments with hourly 
pump events. The solid lines represent the fitted first-order model. Dotted lines represent a 
zero-order model. A: Spiked PhACs. B: Benchmarking compounds, monitored without 
spiking. 
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Figure 8-40: In-sewer transformation of TMP (●, solid line), 3-OH-TMP (▲, dashed line) 
and 4-OH-TMP (○, dash-dotted line) at different sampling locations during RM experiments 
without pump events. The lines indicate the model fit (first order). A: Sampling location #1 
(15 m after feed). B: #4 (105 m). C: #B7 (210 m).  
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Figure 8-41: In-sewer transformation of sulfamethoxazole (●, dashed line) and N4-acetyl-
sulfamethoxazole (▲, solid line) at different sampling locations during RM experiments 
without pump events. The lines indicate the model fit (first order). A: Sampling location #1 
(15 m after feed). B: #4 (105 m). C: #B7 (210 m). 
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Figure 8-42: Evolution of PhAC concentrations during full-scale GS experiments in 
recirculation mode. The solid lines represent the fitted first-order model. Dotted lines 
represent a zero-order model. A: Spiked PhACs and associated metabolites and TPs. B: 
Benchmarking compounds, monitored without spiking. 
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Figure 8-43: Removal [%] of selected micropollutants in RM during experiment with hourly pump events and GS during recirculation. The 
removal efficiencies were extrapolated to a HRT of 8 h. The removal of ranitidine was -136±30% in RM and -143±40% in GS. 
Sulfamethoxazole-d4 and N4-acetyl-sulfamethoxazole-d4 were not monitored in GS. 
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Table 8-6: Measured initial concentrations C0 [ng L-1] and associate standard error (n=2) obtained during the in-sewer biotransformation 
of the investigated micropollutants. Concentrations are normalised to the measured rhodamine concentration. 
 
RM, hourly pump 
events 
RM, no pump 
events; Location 
#1 (15 m) 
RM, no pump 
events; Location 
#4 (105 m) 
RM, no pump 
events; Location 
#4 (210 m) 
GS, 
recirculation 
 C0 SE C0 SE C0 SE C0 SE C0 SE 
Trimethoprim 4451 212 3519 484 3142 1 3086 108 5026 3897 
Roxithromycin 4579 371 2295 20 2335 1002 2237 720 1637 1206 
Sulfamethoxazole 4401 529 3242 306 2914 252 3343 33 3447 2187 
N4-acetyl-SMX 2229 46 2412 67 2176 5 2356 209 2094 274 
4-desmethyl-TMP 71 7 73 6 65 3 72 6 58 8 
3-desmethyl-TMP 126 7 150 2 135 16 133 15 125 5 
N4-acetyl-SMX-d4 3965 488         
DEET 1281 205 1655 108 1243 14 1390 139 1342 50 
Caffeine 33375 35 43654 5819 38462 3142 42579 2846 41437 2228 
Carbamazepine 1030 16 1273 160 1105 11 1157 30 1224 572 
Atrazin 6 1 25 1 15 5 31 10 54 28 
Sulfadiazine 172 21 1333 1169 1156 1015 997 831 210 29 
Phenytoin 48 4 59 6 55 5 61 1 126 61 
Tramadol 513 65 521 21 491 50 502 16 511 31 
Metoprolol 67 2 79 7 70 8 75 10 93 8 
Venlafaxine 864 112 937 126 823 73 933 16 857 4 
Sertraline 6 1 14 5 13 8 11 7 19 8 
Ranitidine 28 15 27 6 28 0 26 8 49 30 
Enrofloxacin 47 21 40 14 31 0 59 11 35 13 
Lincomycin 161 26 227 76 204 63 220 61 210 39 
Iopromide 40788 16502 47699 8485 43745 7094 45501 1343 29811 52 
Indomethacin 51 1 66 12 67 12 69 5 79 16 
Perindopril 62 0 88 12 74 15 87 10 124 50 
Propranolol 112 1 129 13 106 10 105 3 124 3 
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Atenolol 1427 43 1332 21 1194 4 1244 144 1238 87 
Doxylamine 220 8 165 114 154 79 140 92 198 7 
Erythromycin 621 110 541 13 336 88 492 47 521 40 
Fluoxetine 15 1 29 6 26 10 25 8 42 5 
Cephalexin 61 18 86 29 75 55 140 4 69 26 
Sulfasalazine 314 280 35 13 25 5 26 6 29 2 
Dapsone 258 9 204 18 196 23 168 18 266 16 
Citalopram 345 32 377 24 377 38 404 43 522 175 
Diclofenac 473 10 489 57 419 6 439 1 528 56 
Sulfamethoxazole-d4 577 60         
Acetaminophen 11309 1297 3637 865 3600 890 2706 0 4288 726 
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Table 8-7: First-order kinetic rate constants kbio [h-1] and associate standard error (n=2) yielded for the in-sewer biotransformation of the 
investigated micropollutants. 
 
RM, hourly pump 
events 
RM, no pump 
events; Location 
#1 (15 m) 
RM, no pump 
events; Location 
#4 (105 m) 
RM, no pump 
events; Location 
#4 (210 m) 
GS, 
recirculation 
 kbio SE kbio SE kbio SE kbio SE kbio SE 
Trimethoprim 0.0293 0.0089 0.0745 0.0277 0.0303 0.0215 0.0498 0.0339 0.0814 0.0318 
Roxithromycin -0.0037 0.0140 0.0020 0.0567 0.0570 0.0542 0.0546 0.0573 0.0044 0.0509 
Sulfamethoxazole -0.0032 0.0099 0.0311 0.0297 0.0177 0.0366 0.0277 0.0293 0.0324 0.0261 
N4-acetyl-SMX 0.0668 0.0113 0.0695 0.0309 0.0841 0.0214 0.0522 0.0235 0.0930 0.0357 
4-desmethyl-TMP 0.0118 0.0105 0.0697 0.0320 0.0452 0.0226 0.0600 0.0247 0.0364 0.0284 
3-desmethyl-TMP -0.0321 0.0095 0.0545 0.0258 0.0214 0.0362 0.0366 0.0194 0.0025 0.0250 
N4-acetyl-SMX-d4 0.0457 0.0098 
        
DEET -0.0079 0.0085 0.0283 0.0251 0.0002 0.0300 0.0386 0.0163 0.0266 0.0187 
Caffeine 0.0383 0.0082 0.0711 0.0278 0.0588 0.0209 0.0365 0.0167 0.0544 0.0215 
Carbamazepine 0.0197 0.0057 0.0235 0.0240 0.0065 0.0147 0.0224 0.0089 0.0517 0.0408 
Atrazin -0.0085 0.0369 0.2231 0.0685 0.0607 0.1409 0.2547 0.1098 0.0916 0.1432 
Sulfadiazine 0.0256 0.0554 -0.0129 0.0531 0.0202 0.0413 -0.0034 0.0269 -0.0538 0.1846 
Phenytoin -0.0563 0.0111 0.0048 0.0247 -0.0930 0.1232 0.0237 0.0109 0.0586 0.1072 
Tramadol 0.0054 0.0071 0.0479 0.0264 0.0419 0.0251 0.0206 0.0251 0.0084 0.0272 
Metoprolol -0.0385 0.0069 0.0361 0.0241 -0.0221 0.0677 0.0340 0.0243 0.0007 0.0322 
Venlafaxine 0.0052 0.0068 0.0380 0.0257 0.0420 0.0208 0.0350 0.0215 0.0015 0.0145 
Sertraline 0.0618 0.0321 0.0244 0.0832 -0.1231 0.2075 0.0481 0.0794 0.0287 0.0628 
Ranitidine -0.1073 0.0296 0.0002 0.1143 -0.0687 0.0512 -0.0451 0.0590 -0.1111 0.0830 
Enrofloxacin 0.0442 0.0359 0.0048 0.0586 -0.0476 0.1058 0.0828 0.0602 0.0621 0.0769 
Lincomycin -0.0186 0.0078 0.0502 0.0476 0.0418 0.0354 -0.0013 0.0263 0.0477 0.0297 
Iopromide 0.0071 0.0197 0.0481 0.0296 0.0575 0.0191 0.0187 0.0300 -0.0144 0.0204 
Indomethacin -0.0258 0.0048 0.0042 0.0228 -0.1849 0.3139 0.0364 0.0116 -0.0035 0.0309 
Perindopril -0.0262 0.0087 0.0432 0.0353 0.0421 0.0256 0.0339 0.0205 0.0696 0.0693 
Propranolol -0.0151 0.0052 0.0044 0.0222 -0.0081 0.0315 0.0173 0.0211 -0.0038 0.0131 
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Atenolol -0.0002 0.0073 0.0428 0.0272 0.0396 0.0307 0.0342 0.0285 -0.0064 0.0178 
Doxylamine -0.0842 0.0130 0.0222 0.0677 -0.0030 0.0606 -0.0996 0.0693 -0.0530 0.0324 
Erythromycin 0.0233 0.0172 0.0585 0.0437 0.0849 0.0385 0.0968 0.0381 0.0642 0.0353 
Fluoxetine 0.0194 0.0135 -0.0368 0.0497 -0.1932 0.3157 -0.0354 0.0408 0.0178 0.0498 
Cephalexin 0.0896 0.0417 0.0341 0.0570 0.0431 0.1086 0.0573 0.0707 0.3362 0.0826 
Sulfasalazine 7.7518 3.3541 0.1499 0.0686 0.1252 0.0715 0.0867 0.0687 0.1326 0.0599 
Dapsone 0.0115 0.0062 -0.0174 0.0257 -0.1778 0.2754 0.0012 0.0386 0.0204 0.0242 
Citalopram -0.0067 0.0073 0.0144 0.0291 -0.0190 0.0607 0.0095 0.0135 0.0148 0.0347 
Diclofenac -0.0041 0.0042 0.0176 0.0202 0.0079 0.0150 0.0214 0.0133 0.0036 0.0345 
Sulfamethoxazole-d4 -0.0732 0.0160 
        
Acetaminophen 0.1123 0.0137 0.0117 0.0309 0.0317 0.0352 0.0133 0.0371 0.1532 0.0368 
